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4. ABSTRACT 
Actin capping and cross-linking proteins regulate the dynamics and architectures of 
different cellular protrusions by controlling the number of free actin growing ends and 
organizing filaments into higher order structures, respectively. Eps8 is the founding 
member of a unique family of capping proteins capable of side-binding and bundling actin 
filaments. However, the structural basis through which Eps8 exerts these functions remains 
elusive.  
Here, we combined biochemical, structural and genetic approaches to dissect the 
molecular mechanism responsible for the distinct Eps8 activities. We show how diverse 
portions within the C-terminal region of Eps8 contribute to actin binding and mediate Eps8 
functions. An N-terminal amphipathic H1 helix, homologous to WH2 domains, is 
responsible for high affinity interactions with the barbed end unit of filamentous actin and 
is crucial for the capping activity of the protein. A four helix bundle represents the second 
interaction surface which mediates contact with the filament side and is crucial for the F-
actin bundling activity. Within this context, the two actin binding surfaces are spatially 
coordinated by a flexible linker that contributes to the high affinity interaction of Eps8 to 
filaments ends, ensuring a bimodal topological arrangement of Eps8 wrapped around actin 
filaments.  This bimodal way of association to the terminal ends of actin filaments also 
accounts for the dual modes of organizing F-actin, via capping and cross-linking, 
respectively. Single-point mutagenesis validated this mode of binding, further permitting 
us to dissect Eps8 capping from bundling activity in vitro and in vivo. Thus, Eps8 controls 
actin-based motility through its capping activity, while, as a bundler, is essential for proper 
intestinal morphogenesis of developing Caernorhabditis elegans strains.  
In summary, we provided molecular and structural details of how Eps8 uniquely 
associates with barbed ends and sides of actin filaments through distinct structural 
modules. We further showed that the capping and the bundling activities of Eps8 can be 
Abstract 
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fully dissected in vivo, demonstrating the physiological relevance of the identified Eps8 
structural/functional module. 
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5. INTRODUCTION 
5.1 The cell cytoskeleton 
A living cell constantly needs to dynamically change and modify its shape and internal 
organization in response to external stimuli. The cytoskeleton is mainly responsible of this 
dynamic behaviour.  The cytoskeleton carries out three main activities: i) it spatially 
organizes the content of the cell controlling the organization of protein complexes and 
organelles, also providing paths of communication between them; ii) it provides a 
connection between the cell and the external environment mediating both short and long 
timescale changes in the cellular behaviour; iii) it mechanically supports the cell 
generating coordinate forces that enable a cell to move and change shape thus controlling 
its physical properties [1].  The cytoskeleton performs this diverse set of functions thanks 
to its intrinsic dynamic properties, featuring a plastic structural architecture composed by 
protein polymers that can assemble and disassemble and organize themselves into higher 
order complex arrays. The dynamic and plasticity of cytoskeletal structures are tightly 
controlled by several classes of cytoskeletal regulatory proteins. There are three major 
kinds of protein filaments that make up the cytoskeleton: microtubules, intermediate 
filaments and actin filaments (Figure 1). 
Figure 1: Elements of the cytoskeleton 
The cell cytoskeleton is composed by three kinds of filaments: 
actin filaments, microtubules and intermediate filaments. 
Top panel: EM picture and cartoon representation of an actin 
filament. On the right the position of the actin cortex inside an 
epithelial cell is shown. 
Middle panel: EM picture and cartoon representation of a 
microtubule. On the right the microtubule organization from the 
cellular centrosome is shown.  
Bottom panel: EM picture and cartoon representation of an 
intermediate filament. On the left the position of the 
intermediate filaments in an epithelial cell is shown. (Modified 
from Molecular biology of the cell, Alberts, 1994). 
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These polymers differ mainly in their stiffness, dynamic of assembly, and type of 
molecular motors that can associate with. Because of these differences they mediate 
distinct functions, being however connected and coordinated to one another. 
Microtubules are very stiff polymers with a very complex dynamic of assembly and 
disassembly. They can switch between two states: stably growing and rapidly shrinking. 
They are polarized structures, made of dimers of α and β tubulin, with a fast end growth 
and a slow end growth that is associated with a centrosomal structure. They are mainly 
involved in the process of cell division, with a key role in controlling the correct 
chromosomal segregation in mitosis. They are also involved in vesicles and organelles 
transport through molecular motors such as kinesins and dyneins that move along them. 
Intermediate filaments are the least stiff of the three kinds of cytoskeletical 
polymers. They are not polarized and cannot support directional movement of molecular 
motors. 
Actin filaments are less rigid than microtubules, but they can generate very stiff 
cellular structures, such as intestinal microvilli and stereocilia of the inner hair thanks to a 
plethora of crosslinking proteins that can bind and bundle actin filaments together. The 
actin cytoskeleton forms also very dynamic structures such as lamellipodia and filopodia 
that have a critical role in controlling changes in cell shape during tissues morphogenesis 
and cell migration. These structures dynamically assemble and disassemble in a process 
referred to as actin dynamics. Actin filaments associated molecular motors are myosin 
proteins. As microtubules, actin filaments are polarized structures, with a net 
polymerization at one end (called plus or barbed end) and a net depolymerization at the 
other end (pointed or minus end). ATP bound actin monomers are incorporated at the plus 
end; as filaments growth ATP is hydrolyzed and ADP actin monomers are released from 
the minus end. Steady state of the filaments is thus controlled by ATP hydrolysis in a 
process that is called treadmilling. This process is controlled by several classes of actin 
Introduction 
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binding proteins (ABPs) that can both modify the rate of the treadmilling and drive the 
formation of distinct architectural structures. 
5.2 Actin and cell migration 
Cell migration is a stepwise process that can be generally divided into four phases. In a 
first step the cell arranges protrusive structures at the leading edge, which is the front of 
cell migration. The cell starts then to adhere to the substrate via the formation of focal 
adhesions that anchor it to the extra cellular environment. Next, the nucleus of the cell 
starts to be moved forward thanks to traction forces generated by the adhesive structures. 
Finally the rear of the cell retracts and the whole cell is thus moved forward (Figure 2). 
Actin is involved in every step of the process. Protrusive structures came mainly in the 
form of lamellipodia and filopodia, both composed of actin filaments arranged in a 
network or in bundles respectively (see below for further details). Adhesion to the 
substrate is achieved through the formation of focal adhesion structures that are connected 
on one end to the extracellular matrix via transmembrane proteins such as integrins, and to 
the other side to the stress fibers formed by actin filaments. Retraction of the back of the 
cell finally occurs through actin retraction fibers and acto-myosin contractility [2] (Figure 
2).  
The actin cytoskeleton rearranges in response to extracellular signals in order to 
form all these diverse structures. Key signalling regulatory proteins are small Rho 
GTPases, of which the best characterized are Rac, CDC42 and Rho, that mediate, in 
response to growth factors stimulation, the formation of lamellipodia, filopodia and stress 
fibers respectively [3]. Rho-GTPases are small proteins (between 20-30 kD) that can 
switch between an active (GTP-bound) and an inactive (GDP-bound) state. This switch is 
regulated by three distinct classes of proteins. Guanine-nucleotide exchange factors (GEFs) 
promote the GDP\GTP exchange and thus the GTP loading of the protein. GTPase 
activating factors (GAPs) promote the GTP hydrolysis. Guanine nucleotide dissociation 
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inhibitors (GDIs) finally inhibit the GDP dissociation from the protein thus acting as 
negative regulators of the protein activity [4]. Rho GTPases switch capability renders them 
ideal molecules to control changes in the cytoskeleton dynamics allowing a spactial and 
timing restricted response to extracellular stimuli.  
 
Figure 2: The actin cytoskeleton sustains cellular movement 
The different steps of the migratory process and the cytoskeletical structures involved are described.   
Cell motility initiates with the formation of actin protrusive structures at the leading edge, such as 
lamellipodia and filopodia (a).  The cell then adheres to the substrate through the formation of focal 
adhesions that anchor it to the substrate (b). Next, the cell starts to move forward through actomyosin-based 
contraction forces mediated by stress fibers anchored to focal adhesions (c). Finally retraction fibers pull the 
rear of the cell and the migratory event is completed by the disassembling of the adhesive structures and the 
retraction of the protrusions (d). Modified from [2]. 
 
Two elements make the actin cytoskeleton the key regulator of cell migration; i) its 
structural plasticity that enables actin polymers to form specific and distinct architectures 
with defined stiffness and physical properties; ii) its dynamic capability to assemble into 
filaments that undergo constant disassembly into monomers generating a treadmilling 
process, controlled by several actin binding proteins (ABPs), that maintains filament length 
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while ensuring polarized growth of their fast growing ends for generation of protrusive 
forces.  
5.3 Actin cytoskeleton architecture 
The actin cytoskeleton plays a pivotal role in maintaining the cell shape and structure and 
in promoting cell migration. The capability to control such a diverse array of cellular 
functions derives from its ability to organize filaments into higher-order, crosslinked 
structures, which sustain these biological processes and often correlate with specialized 
cellular functions. These features include protrusions such as microvilli, filopodia and 
lamellipodia. Microvilli and microvilli-like structures are finger-like protrusions, most 
recognizable at the luminal side of intestinal and kidney epithelial cells, but that can be 
found in a variety of polarized cells, including hepatocytes and lymphocytes. Intestinal 
microvilli are 1-2 µM long and 100 nm wide, supported by a single axial bundle of actin 
filaments [5]. Within the bundle, filaments are densely packed and uniformly polarized, 
with their plus ends towards the plasma membrane at the tip of the protrusion (Figure 3). 
Microvilli are very stable in length and shape, even if it has been recently demonstrated 
that actin filaments turnover takes place in the actin bundles, with continuous actin 
incorporation at the plus ends. 
Lamellipodia and filopodia are instead highly dynamic protrusive structures, present at the 
cellular leading edge and involved in cell migration. 
The lamellipodium is a sheet-like structure. It starts at the leading edge of the cell and, 
depending on the cell type, can vary in breath from 1 to 5 µm. It is composed by a dense 
array of branched actin filaments and is a primary site of actin incorporation (Figure 3). 
The filaments are oriented with the plus ends toward the plasma membrane, thus 
polymerization at the plus end can lead to membrane pushing and deformation [6]. 
Filopodia are finger-like structures that frequently emerge from the lamellipodium at the 
cellular leading edge. They are formed by bundles of 10 to 30 actin filaments, all parallel 
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together with the plus ends oriented toward the plasma membrane (Figure 3). Somewhat 
similar to filopodia are microspikes, often considered precursors of filopodia extension, 
albeit this is still matter of debate, since they are generally present embedded within the 
lamellipodium, rather than extending beyond the leading edge [6] [7].  
 
 
Figure 3: Actin based structures 
Bundles of actin filaments sustain a variety of cellular structures. 
Top part: EM images of intestinal microvilli on the apical surface of intestinal epithelial cells (right), a 
lamellipodium (centre) and a filopodium (left) at the cellular leading edge. Bottom part: cartoon 
representation of the three different structures. In the cartoon actin is represented in red. Modified from [5]. 
 
5.3.1 Crosslinking proteins  
The formation and the maintenance of each type of these structures is precisely controlled 
and determinated by actin bundling or crosslinking proteins that mediate the interaction 
between the filaments and thus their organization into different cellular structures [5]. 
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Several different classes of crosslinking proteins exist, each with slightly different 
biochemical properties. The heterogeneity of bundling proteins contribute to the plasticity 
of the actin cytoskeleton by finely tuning actin bundle stiffness and structural organization 
in order to adapt to the diverse mechanical requirement of the different cellular processes 
they form. Generally, actin crosslinking proteins bind F-actin through a bivalent 
interaction, needing to contact at least two filaments in order to crosslink them together. 
Often, however, crosslinking proteins have only one actin binding region, and is the 
dimerization of the molecule that leads to their activation as crosslinkers. This mechanism 
has been described for instance for Villin, a crosslinking protein mainly involved in 
microvilli organization [8]. Villin belongs to the gelsolin superfamily. It possesses six 
gelsolin like repeats, that form the core of the protein, and a carboxyl-terminal region 
called the headpiece domain. Two F-actin binding sites have been identified in the protein, 
one in the core and one in the headpiece domain. The F-actin interacting region in the core 
is solely responsible for a severing activity of the protein, while the headpiece domain is 
responsible for filament binding. This latter domain consists in a cluster of basic amino 
acids in which a KKEK motif is essential for the interaction with the actin filaments [9]. 
Activation of the crosslinking activity of the protein arises from its dimerization, with the 
headpiece domains of each monomer contacting a different filament.  
The distance between the two domains involved as actin binding sites and their 
orientation is emerging as crucial in determining the ultrastructural properties of the actin 
filament network. Fascin, for example, is a small monomeric actin-bundling protein. It 
contains two actin binding sites, located in the N and in the C terminus of the protein. The 
two F-actin binding domains are thus very close together, correlating with Fascin capacity 
to organize actin in very tight and stiff bundles, as the ones present along filopodia [1] 
(Figure 4). Filamin, instead, forms parallel dimers, each subunit containing two actin 
binding motifs separated by a very long and flexible region. This structural organization 
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allows Filamin to crosslink widely disperse actin filaments, playing a key role in 
organizing the branched array in the lamellipodium [5] (Figure 4).   
 
Figure 4: Crosslinkers affect the structural organization of the actin network 
Actin filaments network stiffness correlates with the structural properties of the crosslinking proteins that 
mediate its organization. 
A. Fascin is a monomeric crosslinking protein. It organizes actin in very tight and stiff bundles, as the ones 
present along filopodia. 
B. Filamin mediated actin filaments crosslinking. Filamin crosslinks widely disperse actin filaments, playing 
a key role in organizing the branched array in the lamellipodium. Modified from [1]. 
 
5.4 Actin dynamics 
Actin is among the most abundant and highly conserved protein in eukaryotes. In many 
cells, it accounts for more than the 10% of the total cellular protein content. Actin can 
polymerize into helical filaments changing from a monomeric or globular form (also called 
G-actin) to a filamentous one (also called F-actin). Upon polymerization, monomers 
undergo a change in their conformation that activates the ATPase activity of actin.  
5.4.1 Actin monomer structure 
Actin is a globular protein of 43kD. It stably binds an atom of Ca2+ or Mg2+ and a molecule 
of ATP or ADP. Actin consists of four subdomains, named from one to four. In the context 
of the filament, which is formed by two parallel protofilaments, the subdomains 1 and 2 
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are referred as the outer domains, while the 2 and 4 subdomains are reffered as the inner 
domains, because of their position with respect to the filament axis, where the inner 
domains are closer to the helix axis. Between the four subdomains there is the inner 
hydrophobic cleft in which the nucleotide and the metal ions are bound. The first high-
resolution structure of monomeric actin was reported in 1990, in complex with Dnase I, a 
monomeric binding protein that prevents actin polymerization [10]. Since then, several 
other structures have been solved of actin bound to different actin binding proteins, 
including profilin [11], gelsolin [12], vitamin-D-binding protein [13], and an hybrid 
between Gelsolin domain 1 and Thymosin-β4 [14]. In these structures actin appeared 
bound either to ADP or ATP, but crystals were invariably grown in the ATP state, thus 
ADP actin was only obtained after hydrolysis of ATP within the crystal. Only in 2001, 
instead, the first structure of isolated ADP-bound actin was reported [15]. In this case 
crystals were obtained in the presence of ADP and a small macrolide molecule, the 
fluorescent probe tetramethyl-rhodamine-5-maleimide (TMR), was used to avoid actin 
polymerization. It must be noticed that all these structures are largely superimposible and 
can be classified into two major categories, referred to as “open”, as observed in the 
profilin:actin and in the TMR:actin structure, or “close” conformation [16], as is seen in all 
the other cases. The main differences between the close and the open conformation are in 
the three dimensional organization of a loop of subdomain 2 (called D-loop) and in the 
surfaces between the two halves of actin that cause an opening of the nucleotide binding 
cleft (Figure 5). Since the close conformation is the one resolved by the majority of the 
published structures it is likley to represent the physiological and most thermodynamically 
favored form of an actin monomer. However, most of the proteins used to stabilize actin in 
these structures inhibits also nucleotide exchange, causing a narrowing of the nucleotide 
binding cleft that result in a locked form of actin. Moreover in the profilin:actin complex 
structure, whose biologically occurrence and relevance is well established, G-actin adopts 
an open conformation. Thus, despite the wealth of structural information, whether the “real 
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structure” of an actin monomer is the close or the open conformation remains still a 
controversial issue. A possibility that may reconcile this controvery is that actin can adopt 
both conformations, and that the switch between the two forms is coupled to the ADP/ATP 
exchange. Once ADP-bound actin may adopt an open conformation that would be 
permissible for nucleotide exchange (that is indeed accelerated by Profilin), while when 
bound to ATP the nucleotide binding cleft closes allowing slow hydrolysis of the 
nucleotide. 
 
 
Figure 5: Monomeric actin structure 
The structure of the actin monomer has been solved in a close and in an open conformation. 
A. An example of the closed form of the actin monomer (PDB code 2BTF). The nucleotide (ATP) is shown 
as a ball-and stick representation and the metal ion as a green sphere. The four subdomains are indicated in 
red circles and the hydrophobic cleft in which the nucleotide and the metal ion can bind is also indicated. 
B. The open conformation of the actin monomer (PDB code 1HLU). In the open conformation the two major 
structural differences are a change in the conformation of the D-loop in subdomain 2 and a slight rotation of 
the two halves of the monomer with an opening of the actin inner cleft. Modified from [16]. 
 
5.4.2 Actin filament structure 
Actin monomers polymerize leading to the formation of a helical structure. The F-actin 
helix is usually referred to as a right-handed long-pitch helix, formed by two parallel 
protofilaments, with 13 monomers per turn. Along the helix monomers rotate by 167° and 
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have an axial translation of 27.5 Å. Monomers arrange head to tail all having the same 
orientation within the filament that thus results structurally polarized. Subdomains 1 and 3 
are exposed at the plus or barbed end, while subdomains 2 and 4 are exposed at the minus 
or pointed end (Figure 6). Although the first atomic structure of G-actin appeared in 1990 
[17], structural details of the F-actin monomers remained elusive since 2009 when a high-
resolution structure of F-actin from analysis of X-ray fibre diffraction patterns was 
published [18].  
 
 
 
 
Figure 6: F-actin structure 
Atomic model of the F-actin helix. 
Actin filaments are formed by monomers that arrange head to tail. The 
resulting filaments are structurally polarized, with different monomer 
subdomains exposed at the two ends.  
Each monomer of the helix is shown in a different colour. The exposed 
subdomains at the two extremities of the filament are indicated with numbers. 
Modified from [19]. 
 
 
This finding was a great breakthrough accounting for two major open questions in the 
field: the mechanism of activation of the ATPase activity of actin that occurs at the G- to 
F-actin transition; and the higher affinity of myosin for F-actin with respect to G-actin. 
In the proposed model there is one essential difference between globular and filamentous 
actin. This change is a relative rotation of the two major domains of the actin monomer, 
the inner and the outer domain, by about 20° that flattens the molecule. This rotation brings 
an evolutionary conserved glutamine residue at position 137, which is implicated in the 
ATP hydrolysis mechanism, closer to the β and the γ-phosphate groups of the ATP 
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molecule. So it has been proposed that the rotation can be the switch for turning on the 
ATP-hydrolysis of actin. The rotation alters also the F-actin binding site of myosin, thus 
explaining the different affinity of myosin for F actin with respect to globular actin. 
5.4.3 Actin filament assembly 
Polymerization of actin filaments proceeds in three sequential steps. In a first phase the 
formation of a first oligomer of 3 or 4 actin monomers that assemble together occurs. This 
is the nucleation step, which represents a lag phase being kinetically unvafoured. After this 
first nucleation step the oligomers can act as seeds, which start to elongate in a filament 
with a rapid assemble of monomers into the filament. Both ATP and ADP bound 
monomers can associate and dissociate from either the plus or the minus end of the 
filament. Very different kinetic parameters, however, govern these reactions favouring the 
association of ATP bound actin at the plus end. The plus end, thus, represents the fast 
growing end of the filament during the elongation phase. As the filament grows the 
concentration of the free actin monomers that can assemble in the filament decreases until 
reaching an equilibrium, or steady state. At this stage, the polymerization at the plus end is 
counterbalanced by the depolymerization at the minus end, without change in the net 
length of the filament. The steady state is reached when the concentration of actin 
monomers is equal to the actin critical concentration (CC), which is the minimal G-actin 
concentration required for assembly of filaments ends, resulting from the ratio of the rate 
constants of dissociation and association of monomers with actin filament ends [4] (Figure 
7). Under typical in vitro conditions this value is equal to 0.1µM. The critical 
concentration is different between the two filament ends. At the plus end the CC (CC+) is 
equal to 0.1µM, while at the barbed end the CC (CC-) is equal to 0.8µM. At steady state this 
difference determines the net monomer association at the plus end and the net 
depolymerization at the minus end.  
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Figure 7: The three phases of actin polymerization 
Actin filament assembly proceeds in three sequential phases. 
During the first step (nucleation or lag phase) the actin monomers slowly assemble forming oligomers of 2 or 
3 actin subunits. These oligomers then act as seeds and the filament rapidly elongates during the elongation 
or growth phase. At the end of this step a steady state is reached with no more net growth of the filaments. 
Here an equilibrium between F-actin and free G-actin is reached. This equilibrium depends on the actin 
critical concentration, equal to 0.1µM. Modified from (Molecular biology of the cell, Alberts, 2001). 
 
5.5 Actin treadmilling 
The two ends of actin filaments have different kinetic constants of association and 
dissociation of the actin monomers. The barbed end has higher association and dissociation 
rates for actin subunits than does the pointed end and thus dominates the dynamics of 
filament assembly [20]. In addition to this, there is an irreversible ATP hydrolysis that is 
associated with the incorporation of monomers at the plus end of filaments. These two 
events generate a difference in the critical concentration between the barbed and the 
pointed end [4], and create a flux of monomers along the filament with ATP bound actin 
monomers that associate at the plus end and ADP actin monomers that dissociate form the 
minus end. This process can be described as a cycle with ATP bound actin monomers that 
assemble at the plus end of actin filaments; as filament grows ATP is hydrolyzed and ADP 
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actin monomers dissociate from the minus end of the filaments. Once ADP actin 
monomers are free in the cytoplasm the ADP\ATP exchange occurs and new ATP actin 
monomers are formed that can be reassembled in the filaments (Figure 8).  
 
 
Figure 8: Treadmilling of the actin filaments 
The treadmilling process describes the continuous assembly and disassembly of actin filaments. 
ATP bound actin monomers associate at the plus end. As filaments polymerize ATP hydrolysis occurs and 
ADP bound actin monomers are formed that detach from the minus end of the filament. Once in the 
cytoplasm the ADP to ATP exchange occurs and new ATP actin monomers are formed that can associate 
with the plus end again. 
 
The continuous process of assembly and disassembly of actin filaments, coupled with ATP 
hydrolysis, that maintains the constant length of the actin filaments at steady state, is called 
actin treadmilling [21]. Actin tredmilling is crucial for cell migration; indeed is the rapid 
filaments turnover that generates force propelling movement.  
At the leading edge filaments are oriented with the plus ends towards the plasma 
membrane, and is a rapid assembly of these filaments that generates the protrusive force 
able to deform the membrane and enables the generation of filopodia and lamellipodia. 
While net polymerization occurs at the front, net depolymerization occurs at the rear of the 
lamella and moreover the total overall F-actin content of the cell remains constant [21]. 
Notably also pathogens such as Listeria monocytogenes or Shigella flexineri are able to 
mimic the dynamic behaviour of the filaments at the leading edge inducing a rapid actin 
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polymerization on their surfaces and thus exploiting actin based motility to move inside the 
cell. This dynamic behaviour is achieved thanks to actin binding proteins that are able to 
accelerate and regulate the actin treadmilling. In vivo actin treadmilling is 100 time faster 
with respect to pure actin in vitro with typically 3µm long filaments turning over in 1 
minute [22]. The minimal set of proteins sufficient to sustain and accelerate actin 
treadmilling and actin based motility has been identified thanks to a series of in vitro 
biomimetic experiments in which actin-based motility of either bacteria or functionalized 
beads was reconstituted using purified proteins [23] [24, 25]. The identified proteins are 
able to promote actin nucleation, to influence actin depolymerization, and to block 
polymerization at the plus end. The first proteins that had been used in this assay were the 
nucleator complex Arp2/3 and its activators, ADF\Cofilin as depolymerizing factor and 
Gelsolin as a capping protein. Since then this assay has been widely used to identify 
proteins carrying one of these functions, by rescue experiments in which one of the 
established essential components of the system is substituted by the protein of interest [22].  
5.5.1 Nucleating factors 
The initial step of actin filaments assembly is kinetically unfavourable and thus inefficient. 
Nucleating factors directly nucleate actin thus overcoming this kinetic problem. For many 
years only the Arp2/3 complex, together with its activators, and Formins, had been known 
as actin nucleators. However more recently several new factors have been described as 
novel actin nucleators. 
5.5.1.1 The Arp 2/3 complex 
The first nucleating factor to be identified was the Arp2/3 complex. It is a 220kD complex, 
composed by seven stably associated proteins. These polypeptides include ARP2 and 
ARP3 and five additional subunits, named from ARPC1 to ARPC5 [26]. This complex 
localizes both at the cellular leading edge and on actin comet tails of rocketing vesicles or 
pathogens moving inside the cell [27]. The Arp2/3 complex is both able to nucleate and to 
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branch actin filaments. The complex binds to the side of a pre-existing actin filament and 
initiates the nucleation of a 70° angled, branched filament. EM analysis showed that the 
complex remains localized at the points of branching of actin filaments (Figure 9). Because 
of this property the Arp2/3 complex is thought to play a key role in the formation of the 
branched array of the lamellipodium. The isolated Arp2/3 complex is an inefficient 
nucleator. Its activity is increased by filament binding and by phosphorilation on Tyr 
residues in ARP2. To be fully active, however, the Arp2/3 complex requires the action of 
activators called nucleation-promoting factors (NPFs) [26]. 
 
 
Figure 9: The Arp2/3 complex structure at branches 
Structure of the Arp2/3 complex on actin filaments.  
The morphology of the Arp2/3 complex and of the branched actin filaments is shown in an electron 
micrograph (left) and in a structural model based on electron tomography (right). The complex is formed by 
seven subunits and remains attached at the site of nucleation and branching of the new filament. Modified 
from [26]. 
 
The majority of Arp2/3 activators (called of CLASS I) interact with Arp2/3 through a 
WCA domain. This domain is composed by one or more WASP homology 2 (WH2) 
domains that bind actin monomers, an amphiphatic connector region and an acidic 
polypeptide. Within this region, the connector and the acidic part contact different subunits 
of the Arp2/3 complex, causing a conformational change that activates Arp2/3 as 
nucleator. The WH2 domain, instead, is able to bind actin, thus delivering monomers to the 
growing filament end (Figure 10). 
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Figure 10: NPFs mediated Arp2/3 complex activation as an actin nucleator 
The Arp2/3 complex is activated at the membrane by the action of class I and class II NPFs. 
The Arp2/3 complex is recruited by the WCA domain of class I NPFs in proximity of the cell membrane (1). 
The complex is thus activated and the nucleation of a new branch filament occurs (2). The complex remains 
localized at the branch site, where it can be stabilized by Class II NPFs such as Cortactin (3).  
 
The Class I NPFs comprises several subfamilies, distinct for their mechanism of action and 
their cellular localization. We can distinguish in particular five groups: WASP and N-
WASP that were the first to be identified; three members of the WASP-family verprolin 
homologue (WAVE 1 to 3, also called SCAR); WASH (WASP and SCAR homologue) 
and WHAMM (WASP homologue associated with actin, membranes and microtubules); 
JMY (junction-mediating regulatory protein). WASP and WAVE subfamilies of NPF class 
I have a widespread tissues distribution, and play essential roles in a variety of general 
processes that relie on actin dynamics, ranging from vesicle and pathogens intracellular 
motility to cell migration [28]. The more recently identified NPFs display, however, more 
specialized functions: WASH for example mainly acts in endosomal and golgi traffic, 
whereas WHAMM is involved in golgi transport [26]. JMY instead has a double function 
acting both as an actin promoting factor and as a co-activator of p53. This double activity 
is reflected by its cellular localization. JMY is enriched in the nucleus upon DNA damage 
where it is though to mainly act in driving p53 response; in migrating cells JMY instead 
relocalizes to lamellipodia promoting cell migration.  Intriguingly, JMY is also able to 
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promote actin polymerization possessing a nucleating activity and to influence cell 
adhesion controlling Cadherin levels. The precise mechanisms controlling JMY activities 
remain to be defined. This is reflected in the current open debate as to whether JMY acts as 
a convergent point connecting p53-dependent apoptotic and p53-independent migratory 
pathways, or whether JMY multiple activities betray moonlighting, unrelated functions 
[29] [30]. Mammalian cells posses also class II activators of Arp2/3, such as Cortactin 
family proteins. These factors do not posses canonical WH2 domains and are weaker 
activators of the Arp2/3 complex [26].  
5.5.1.2 Formins 
Formins are nucleating factors that, unlike Arp2/3, produce linear filaments. They are 
present in all eukaryotes. In mammals at least 15 Formins have been identified. The 
common feature of all the different Formins is the presence of two conserved Formin 
homology (FH) domains, named FH1 and FH2. The FH1 domain consists of a Proline rich 
region able to interact with SH3 and WW domains containing proteins. This region can 
also recruit Profilin-actin complexes, thus delivering the monomers at the plus end of 
filaments. The FH2 domain is sufficient in vitro to trigger actin nucleation [31].  
Most notably, Formins act as processive nucleators, remaining attached to the plus end of 
the filaments while elongating. To perform this task, the FH2 domain is proposed to form a 
flexible homodimer that wraps around filament ends. One FH2 domain of the dimer, at 
time, detaches transiently from and moves toward the filament end, thus allowing the 
protein to remain attached while monomers become incorporated into the filament during 
elongation.  As a result Formins act as ‘’leaky cappers” directly competing with and 
protecting the plus ends from binding to capping proteins (Figure 11). While the 
biochemical mode of action of Formins has by and large been identified, their functional 
role remains to be fully investigated. Their peculiar ability to promote linear filament 
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elongation has suggested their requirement in structures that need the presence of long, 
linear filaments, such as stress fibers and filopodia.  
 
 
Figure 11: Elongation model of Formins 
A model of actin mediated polymerization by Formins.  
The FH1-FH2 domain localizes at the plus end of a growing filament. The FH2 domain adopts a dimeric 
conformation and wraps around the filament. The FH1 domain binds Profilin:actin and delivers the 
monomers to the growing end. The elongation proceeds in a stepwise manner with Formins remaining 
attached to the filament end. Modified from [26]. 
 
5.5.1.3 WH2 domain containing nucleators 
More recently a new class of actin nucleators emerged whose common feature is the 
presence of a tandem cluster of G-actin binding motifs, including WH2 domains. The 
WH2 (WASP homology domain) is a 20-30 residues binding module that is found in many 
different regulators of the actin cytoskeleton. It forms a short (usually three turn) 
amphiphatic α-helix that usually contacts the hydrophobic pocket present between the 
subdomain 1 and 3 of the actin monomer [32] (Figure 12). 
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Figure 12: WH2 domain–actin structures 
The WH2 domain is a common motif for actin monomer interaction. 
A-C. Structures of the WH2 domains of WASP (A), WAVE 2 (B), WIP (C) in complex with actin. D. 
Superimposition of  Ciboulot and Thymosin β-4 WH2 domains in complex with actin. Modified from [32]. 
 
This NPF class includes Spire, Cordonbleu (COBL) and Leiomodin families. Their WH2 
domains are proposed to promote nucleation by tethering more actin monomers together 
thus favouring the first kinetic unfavourable monomer association.  
Spire has been also described as a Formin interactor and a cooperation between the two 
proteins has been proposed to be important for enhancing Formin mediated actin 
nucleation and processive elongation [33] [34].  
5.5.2 Depolymerizing factor 
Actin depolymerizing factor (ADF, also called Cofilin) is an essential protein in 
controlling and accelerating the actin treadmilling. In vitro it is able to accelerate the 
turnover rate of actin filaments by more than one order of magnitude, and to accelerate 
actin based motility of pathogens such as L.monocytogenes [35]. ADF binds both G and F-
actin, with a high preference for the ADP bound state. It binds actin filaments at the 
pointed ends (where ADP-bound actin monomers are present) and accelerates the 
depolymerization from these ends. The increased pointed end off rate is counterbalanced 
by an increase in the rate of assembly at the barbed end, elicited by an increase in the 
Critical Concentration and in the treadmilling rate [35]. ADF\Cofilin has also a severing 
activity, meaning that it is able to cut actin filaments. This activity is mainly due to a 
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conformational change of the filament induced by ADF binding, that destabilizes F-actin 
leading to severing.  
5.5.3 Monomeric actin binding proteins 
The rapid turnover and polymerization at the cellular leading edge depends on the 
monomeric G-actin concentration within the cell. G-actin concentration in the cytoplasm is 
much higher than the critical concentration required for filament elongation. This means 
that in the cells mechanisms are present that allow the maintenance of a steady state actin 
monomer concentration higher than the critical concentration at the plus end, without 
polymerization of the filaments. This is achieved though the presence of proteins that bind 
monomeric actin and that are able to control its availability for polymerization, its 
nucleotide binding and its localization. 
5.5.3.1 Profilin 
Profilins are among the most highly expressed proteins in the cytoplasm and are key 
regulators of the actin treadmilling. They are small (12-19 kD) monomeric actin binding 
proteins, with a higher affinity for ATP-bound than for ADP-bound actin (Kd = 0.1µM and 
0.5µM respectively). Profilin acts by catalyzing the exchange of ADP for ATP. It achieves 
this function contacting the monomer between subdomain 1 and 3, and thus modulating the 
opening of the monomer cleft where the nucleotide binds.  Moreover, Profilin inhibits ATP 
hydrolysis thus maintaining the actin monomers in an ATP-bound state. Thus the pool of 
ADP-G-actin monomers depolymerizing from the pointed end is converted into an ATP-
bound Profilin actin complex that selectively associates at the plus end thus accelerating 
the treadmilling (Figure 13). This acceleration is particularly effective in the presence of 
ADF\Cofilin that acts on the other end of the filament. The synergistic effect of the two 
proteins can accelerate the treadmilling rate up to 125 fold [36]. 
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Figure 13: Role of Profilin in accelerating the actin treadmilling 
Profilin binds ADP-actin monomers and accelerates the ADP/ATP exchange.  
Profilin binds the ADP-actin monomers that detach from the minus end of the filament (i); Profilin then 
promotes the ADP/ATP exchange and ATP-bound Profilin actin complexes are formed (ii). These bound 
monomers can selectively associate only with the filament plus end thus leading to polymerization (iii). 
Modified from [37]. 
 
It is of note that profilin in addition to bind to monomeric actin can also associate with a 
variety of different proteins. Profilin possesses a poly-proline rich region through which it 
is able to interact with a plethora of ligands that are involved in different cellular 
processes. Most of these interactors are proteins that control cytoskeleton dynamics. For 
example, profilin binds WASP family proteins. This interaction acts in synergy with the 
binding of Cdc42 to promote WASP activation and thus Arp2/3-dependent actin 
polymerization [38]. Similarly, the binding of the prolifin:actin complex to the FH1 
domain of Formins is crucial for the delivery of actin monomers to the active FH1-FH2 
domain [31]. Notably, profilin has been also found to bind, through a mass spectrometry 
approach, proteins involved in membrane trafficking, such as clathrin or dynamin 1, 
suggesting a role of profilin in linking the actin cytoskeleton and the endocytic membrane 
machinery [39]. Finally profilin also binds nuclear-export receptors such as Exportin 6. In 
this latter case, Exportin 6 is thought to recognize specifically the profilin:actin complex 
and to ensure that this complex is transported into the cytoplasm and excluded from the 
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nucleus [37]. Profilin is, thus, emerging not only as a key regulator of different aspects of 
the actin cytoskeleton dynamics, but also as a central factor in the regulation of a complex 
network of molecular interactions.  
5.5.3.2 β-thymosins 
β-thymosins are a family of highly conserved actin binding proteins of about 5 kD present 
in vertebrates. Several family members exist with thymosin β-4 being the better 
characterized as an actin binding protein [40]. Thymosin β-4 interacts specifically with 
ATP-bound actin monomers through a WH2 domain. Upon binding it sequesters the 
monomers so that they cannot be incorporated in the filaments any more. NMR studies 
have shown that thymosin β-4 undergoes a dramatic conformational change upon binding 
to monomeric actin. In the cytoplasm the protein is mainly unstructured, while upon 
binding it adopts an L-shape conformation with a very extended central part and two 
external small α-helices at the N and C terminal that correspond to the actin binding 
surfaces. The key residues for the interaction with the actin monomer are found in the N-
terminal helix, that binds the monomer between subdomains 1 and 3. The C-terminal helix 
contributes to the binding interacting with the actin subdomain 2 [41]. 
5.5.4 Capping proteins 
Capping proteins bind the plus ends of actin filaments and block actin polymerization from 
these ends. They are essential for actin-based motility [23] and to accelerate the actin 
treadmilling. How Capping proteins may increase actin filaments turnover was firstly 
explained in 1997 by Carlier at al. [21] that proposed the so called “funnelling hypothesis”. 
According to this hypothesis capping of the fast-growing barbed ends of most of the actin 
filaments in the cell leads to an increase of the ATP-actin monomers concentration 
available for the polymerization of the few barbed ends that remained free. This would, 
ultimately, cause an increase in the steady-state concentration of monomeric actin and to a 
faster growth of the few free barbed ends (Figure 14). 
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Figure 14: Regulation of the actin treadmilling by 
capping proteins: the funnelling hypothesis 
According to the funnelling hypothesis capping 
proteins accelerate the treadmilling rate increasing the 
Cc of monomeric actin. Blocking the vast majority of 
filaments barbed ends would in fact lead to an increase 
monomeric actin concentration for the few barbed 
ends that remain free. Non-capped barbed ends 
therefore would growth faster. Modified from [22]. 
 
Recently, however, this model has been challenged by a series of experiments that revealed 
that a number of testable predictions (e.g. in the presence of cappers the amount of free 
monomeric actin should increase, the number of free barbed ends should decrease and 
there should be an increment in the rate of filament elongation) implicit in the funnelling 
model could not be experimentally verified [42]. It was, thus, proposed that capping 
proteins instead of generating a restriction, cooperate with actin nucleators (in particularly 
the Arp2/3 complex was used in the experimental setting) to increase filament nucleation, 
acting as “monomer gating”.  More precisely, cappers by blocking filament ends close to 
the surface where WCA-containing NPFs reach the maximal concentration, would 
compete with WH2 domain (part of the WCA) preventing its unproductive binding to 
filament ends, and favouring, instead, its association to actin monomers, which is required 
to prime Arp2/3 complex activation and filament nucleation. The role of capping proteins 
in actin-based motility would thus be not accounted by an increase in the treadmilling rate 
but by an increase in nucleation events. 
Several families of capping proteins have been identified in mammals so far and 
considerable effort has been devoted to explore their structural mechanism of action. 
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Capping proteins display, indeed, a variable and not conserved domain organization, 
suggesting different modes through which they cap filament ends.  
5.5.4.1 Capping Protein 
CP (Capping Protein), known also as β-actinin or CapZ in skeletal muscle, is an αβ 
heterodimeric protein. It is very conserved in eukaryotes, but show no similarity with any 
other capping protein family [20]. 
CP α and β subunits adopt a very similar conformation, despite lacking any amino acidic 
sequence conservation. The overall three dimensional structure of CP displays a mushroom 
like shape. The N-terminal regions of the two subunits create a six-helix bundle structure 
(3 helices coming from each subunit) that forms the stalk of the mushroom. The remaining 
parts of the subunits form a very intertwined β sheet that creates the cap of the mushroom. 
Each subunit ends at the C-terminus with an α helix that extends perpendicularly on the 
top of the mushroom (Figure 15A). These two helices have been proposed to act as two 
tentacles for binding to the end terminal region of the filaments (Figure 15B) [20]. 
 
Figure 15: Three-dimensional structure of CP 
CP forms a heterodimer that adopts a mushroom like shape with two α helices that act as tentacles for actin 
binding. 
A. Ribbon representation of the 3D structure of the CP αβ heterodimer. The α subunit is depicted in yellow 
and the β subunit in red. The C-terminal α helices of the α and β subunits are represented in green and blue 
respectively.  
B. Cartoon representation of the CP structure. The C-terminal α helices of the α and β subunits are flexible 
and can act as tentacles to bind the actin monomers at the filament end. Modified from [20]. 
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This model has been more recently confirmed and refined by Narita and colleagues that 
analyzed by EM CP bound on the barbed ends of actin filaments [43]. They could 
unambiguously identify the α and β subunits and their position with respect to the actin 
monomers. According to these results, they proposed a two steps binding model for CP 
interaction with the plus end. The first event is the binding of basic residues of the C-
terminal α subunit (first tentacle) with the acidic amino acids of the barbed end of a 
filament.  Next, the amphipatic C-terminal β subunit (second tentacle) would dock into the 
hydrophobic pocket of the actin protomer, stabilizing the interaction with the filament end 
(Figure 16). 
 
Figure 16: Two steps binding model for 
CP interaction with the plus end 
According to the model proposed by Narita 
and colleagues the first interaction between 
CP and actin would be between the basic 
residues on the α tentacle and the acidic 
residues on the barbed end of the filament 
(depicted in red) (A). After this first 
interaction the β tentacle would bind 
contacting the hydrophobic cleft on the 
terminal protomer (depicted in yellow) (B 
and C). Modified from [43]. 
 
5.5.4.2 Gelsolin 
Gelsolin is a member of a large family of actin binding proteins, including Villin and 
CapG.  
It was discovered in 1979 and was named according to its ability to mediate the gel-sol 
transition of the cytoplasm, in a Calcium-dependent manner [44]. Indeed, Gelsolin binding 
to filament ends occurs only in the presence of micromolar concentrations of intracellular 
Calcium [44].  
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Gelsolin family is characterized by the presence of a variable number of homologous and 
repeated Gelsolin domains of about 100-125 amino acids [45].  
Gelsolin itself contains six repeats (named from G1 to G6), distributed into two 
homologous parts of the protein. G1 to G3 are in the C-terminal, while G4 to G6 are in the 
N-terminal half of the protein, connected by a linker of 53 amino acids (Figure 17A). 
Within these repeats G1, G2 and G4 are able to interact with actin. At resting intracellular 
levels of Calcium, the protein assumes a very compact conformation and the actin 
interaction surfaces are hidden within the structure. Elevation of Ca2+ concentrations, 
releases latches within the constrained structure and produces large shifts in the relative 
positioning of the domains. This conformational change permits Gelsolin to bind to the 
actin filament. Firstly, an intramolecular contact between G6 and G2 is released revealing 
the G2 actin binding site. Secondly, in each half of the protein the third domain releases 
the first domain, thus exposing the actin binding sites in G1 and G4 [46].   
Biochemical and structural studies of the two first Gelsolin domains, G1 and G2, indicated 
that these two modules are sufficient to mediate Gelsolin capping activity. The G1 domain 
binds and blocks barbed ends, while the G2 domain contacts the side of the filament and 
stabilizes the binding (Figure 17B). 
Figure 17: Gelsolin domains 
organization and actin binding 
Gelsolin is composed by 6 repeats 
with the first two domains being 
required for plus end binding and 
capping. 
A. Scheme of the domains 
organization of Gelsolin. Gelsolin 
contains 6 repeats (G1 to G6). The 
protein is organized in two 
symmetrical halves, with 3 repeats 
each, divided from a flexible 
linker. B. Binding of Gelsolin at filament ends. Left: binding of Gelsolin at the end of the filament. The G1 
domain (depicted in blue-violet) binds the last monomer of the filament, while the rest of the protein contact 
the filament side. Right: cartoon representation of the G1-G2 domains binding at filament ends. These 
domains are sufficient to mediate the capping activity of Gelsolin. Modified from [45]. 
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Gelsolin is also able to sever actin filaments upon binding. As for capping, also severing 
requires the activation of the protein upon calcium binding, which induces a complete 
opening of its conformation. Once activated the F-actin binding domain G2 is exposed and 
binds to the filament side. Next, the G1-G2 linker, the G3-G4 linker and G6 wrap 
themselves around the filament, positioning G1 and G4 onto their binding sites. Finally a 
coordinated pincher movement of G1 and G4 causes disruption of intermolecular 
interactions between actin monomers within the filament leading to severing [47] [45]. 
These two distinct protein functions render Gelsolin a key member in regulating actin 
dynamics. 
5.5.4.3 Twinfilin 
Twinfilin is a conserved protein that, as Gelsolin, possesses distinct and diverse 
biochemical functions, being able both to cap actin filaments and to sequester monomeric 
actin. Twinfilin has a modular structure, with two ADF homology domains separated by a 
30 residue linker and followed by a C-terminal tail region of approximatively the same 
length [48] (Figure 18A). Twinfilin ADF domains have no sequence similarity but are 
structurally homologous to the Gelsolin domains (Figure 18B). Both ADF domains are 
able to bind monomeric actin and are required for the protein capping activity, with the 
ADF–C (for C-terminal) playing a critical role. The proposed mechanism for Twinfilin 
filament end capping is comparable to the one proposed for Gelsolin. Like Gelsolin G1 
domain, the ADF-N domain is proposed to bind the end of the filament, while the ADF-C 
domain would stabilize the binding by contacting the side of the filament, in fashion 
similar to the Gelsolin G2 motif (Figure 18C).  
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Figure 18: Comparison between Gelsolin and Twinfilin organization  
Gelsolin and Twinfilin are two capping proteins that show similarities in their structural organization and 
mechanism of action. 
A. Domain organization of Gelsolin and Twinfilin. Gelsolin is composed by six homologous domains, while 
Twinfilin is composed of two (N terminal and C terminal) ADF homology domains.  
B. Comparison of the ribbon structure of the Gelsolin G1 domain and the Twinfilin ADF-H N terminal 
domain showing their structure similarity.  
C. Comparison of Twinfilin and Gelsolin way of binding to filament ends. Model of Gelsolin G1-G2 and 
Twinfilin ADF-N and C domains bound to F actin (depicted in grey). Modified from [49]. 
  
5.5.4.4 Eps8 family 
Eps8 (EGF receptor pathway substrate #8) family has been more recently described as a 
novel class of capping proteins [50] [51]. In mammalian three Eps8 homologous exist, 
named Eps8-L1, L2 and L3. Eps8 homologues are present also in Drosophila 
melanogaster and in C.elegans, indicating an important and conserved role of the protein 
throughout evolution [52]. Eps8 family members show a modular structure, with a N-
terminal PTB domain, a central SH3 domain, and a C-terminal region, which retains the 
actin binding capability of the protein (Figure 19).  
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Figure 19: Schematic representation of the domain organization of the mammalian Eps8 family genes 
The principal Eps8 domains are boxed. In parenthesis the percentage of amino acidic identity between Eps8 
and each related protein is indicated, with respect both to the single domains and to the entire protein 
sequence. Modified from [52]. 
 
Eps8 and Eps8L2 have an ubiquitary pattern of expression, while Eps8L3 is selectively 
expressed in the colon and Eps8L1 in the prostate and in the colon. Functional redundancy 
between Eps8 and Eps8L2 is probably the cause of a lack of overt phenotypic alterations of 
EPS8-knock out mice. This latter notion is supported by the observation that in C.elegans, 
where only one eps-8 gene is expressed, genetic interference with ce-eps-8 causes early 
embryonic lethality, thus demonstrating an essential function of the protein in development 
[51]. The ce-eps-8 gene can give rise to two alternative splice variants, one retaining the C-
terminal region, including the conserved actin binding domain (named eps-8a), and a 
shorter that retains the PTB and SH3 domains only (named eps-8b). Remarkably, genetic 
disruption of the long isoform (eps-8a mutant) leads to strains that are able to overcome 
early embryonic lethality, suggesting that functions encoded by the N-terminal portion of 
eps-8 are essential for early development. eps-8a mutant strains, however,  display specific 
arrest at later larval stages (stage 4), with a defective intestinal morphogenesis and altered 
ultrastructural organization of intestinal microvilli, revealing a specific developmental 
function of the actin binding region of EPS-8 [51]. 
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The mammalian Eps8 protein organization and its biochemical functions will be discussed 
in more details in the following session.  
5.6 Eps8 
Eps8 (EGFR pathway substrate #8) is a 97kD protein identified through an expression 
cloning approach for substrates of receptor tyrosine kinase (RTK) [53]. It has a modular 
structure typical of a signalling molecule, and possesses different biochemical functions 
that render the protein a key regulator of the actin cytoskeleton remodelling.  
5.6.1 Eps8 structural organization 
Eps8 displays a domain organization that includes an N-terminal Phospho-tyrosine 
Binding domain (PTB), a central Src homology-3 domain (SH3), two Proline rich regions 
and a C-terminal “effector region” [54] (Figure 20). 
 
   
Figure 20: Eps8 structure 
Eps8 has a modular structure typical of a signalling protein. 
Eps8 domain organization is shown. Eps8 protein contains a PTB (Phospho-Tyrosine Binding domain), a 
central SH3 domain and a C-terminal effector region that mediates the interaction with actin. Two Proline 
rich regions are also present, flanking the SH3 domain. 
 
The PTB domain is a protein-protein interaction module, binding to a variety of Tyrosine 
containing motifs [54]. No physiological interactors for the PTB domain of Eps8 have 
been identified so far and its cellular function remains to be elucidated. However, an in 
vitro interaction between this domain and specific integrins β tails has been shown [55]. 
The binding has been so far demonstrated only by pull down assays but it is consistent 
with recent works suggesting the involvement of Eps8 in the transduction of integrin-
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induced signals. Eps8 has in fact been recently shown to control integrin mediated Rac1 
activation and cell migration in Oral Squamous Cell Carcinoma (OSCC) [56] and to 
increase the expression and the activity of focal adhesion kinase (FAK) in Colon Cancer 
cells [57]. 
SH3 domains mediate protein:protein interactions with Prolin-rich motifs. The 
canonical SH3 domain structure is formed by two small β sheets, packed against each 
other approximately at right angles [58].  Eps8 SH3 domain is somehow unconventional. 
First, two crystallographic structures exist, one indicating a monomeric structure of the 
domain, and one indicating that the SH3 domain can form an intertwined, domain-swapped 
dimer [59]. Secondly, Eps8 SH3 domain binds preferentially peptides containing a 
PXXDY consensus sequence, instead of the classical PXXP motif [54]. Two known 
interactors of the SH3 domain of Eps8 are Abi1 and 2 and RN-tre, indicating a role of 
Eps8 both in the Rho GTPase signalling cascade and in endocytosis. Together with Abi1 
and Sos1, in fact, Eps8 takes part of a trimeric complex that displays a specific Rac GEF 
activity in vitro and in vivo [60] [61]; RN-tre, instead, is a GAP for Rab5, Rab33 and 
Rab41 [62]. More specifically, RN-tre activity on Rab5, a protein essential for endosome 
biogenesis and maturation, revealed a role of Eps8 in RTKs internalization and recycling 
[54].  
5.6.2 Eps8 functions 
Eps8 has emerged as a key regulator in controlling actin cytoskeleton remodelling. It acts 
both by participating in signalling cascades downstream RTKs receptors, through its 
interaction with Abi1, Sos-1 and RN-tre, and by directly controlling the actin cytoskeleton 
dynamics and structural organization through its capping and bundling activity. All these 
functions are mediated by Eps8 C-terminal domain (aa 648-821), in which both the Sos-1 
and the actin binding surfaces are located. 
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5.6.2.1 Eps8 in the Rho GTPase signalling cascade 
Eps8 as a molecular adaptor participates to RTKs signalling cascade leading to Rac -
dependent actin cytoskeleton remodelling [3]. At the molecular level, Eps8 was shown to 
enter into a multimolecular complex, together with Abi1, the non catalytic subunit of 
PI3K, p85, and the dual GEF for Ras and Rac, Sos-1. Within this complex, Abi1 acts as a 
scaffold facilitating the interaction between Eps8, p85, and Sos1 [63]. The assembly of this 
signalling unit enables through mechanisms that remain to be fully elucidated to unmask 
the otherwise silent Rac-specific GEF activity of Sos-1, mediating actin cytoskeleton 
remodelling in response to growth factors stimulation [60]. Notably, the C-terminal region 
of Eps8 mediates in vitro a direct low affinity interaction with Sos-1, sufficient, however, 
to activate the Rac-specific GEF of the latter protein in cells, suggesting that this region 
acts as a bona fide effector region within Eps8, mediating all the functions so far ascribed 
to the protein both as signal adaptor as well as actin regulatory binding interactor.  
5.6.2.2 Eps8 and endocytosis 
Eps8 involvement in endocytic processes derives from its ability to bind yet another SH3 
interactor, RN-tre. RN-tre is a GAP specific for Rab family proteins, including Rab5 and 
Rab41 [64], indicating its involvement in trafficking processes. Most notably, RN-tre was 
originally demonstrated to function both in vitro and in vivo on Rab5, which is in turn 
essential for regulating multiple steps of internalization of various membrane receptors, 
including early endocytic events and early endosomal formation, maturation and 
trafficking [62].  
In particular, Rab5 is essential for EGF receptor endocytosis upon ligand binding. 
Interaction between Eps8 and RN-tre has been shown to be required for the activation of 
the Rab5-GAP specific activity of the latter protein. This leads to the inhibition of the 
small GTPase accompanied by increased EGFR at the cell surface due to impaired receptor 
internalization and increased signalling [65]. RN-tre has also been demonstrated to be a 
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direct effector of Rab5 in RTK-induced pathways leading to actin cytoskeleton 
remodelling and in particular to circular dorsal ruffle (CDR) formation [66]. CDRs are 
transient actin based structures which form on the dorsal, apical cell plasma membrane 
implicated in macropinocytosis and three dimensional cell migration [67] [68]. Within this 
signalling cascade, RN-tre has been proposed to mediate a three-pronged interaction 
between Rab5, which localizes on CDRs, actin and the actin crosslinker actinin4 (the latter 
two proteins bind RN-tre C-terminal region) thus restricting the localization of these 
proteins on PM sites where remodelling of the actin network through crosslinking results 
in CDRs formation. 
A recent work revealed an unexpected connection between Rab5-induced endocytosis and 
Rac activation. A Rab5 endocytic circuit was shown to be required for spatial restriction of 
Rac signalling at the plasma membrane leading to the generation of CDRs and impacting 
on the mode of tumour cell motility [69]. By activating endocytosis, Rab5 causes 
internalization of Rac, its activation in recycling endosomes and its subsequent redelivery 
through Arf6-dependent routes to specific regions of the plasma membrane [69]; there, 
polarized Rac dependent functions take place, leading to the formation of classical 
peripheral lamellipodia (PL), the first obligatory step in two-dimensional cell motility, and 
atypical, apically-restricted circular dorsal ruffles, a surrogate marker of macropinocytosis 
and 3D mesenchymal motility [70].  
Thus, Eps8 may regulate Rac activity either directly through assembly of a PM-
localized signalling complex that promotes optimal transmission of motogenic RTK 
signalling, and indirectly through endocytsosis that confers a spatial dimension to 
signalling that is ultimately required for regulation of polarized functions, first and 
foremost actin-dynamics based directional migration. 
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5.6.2.3 Eps8 and actin dynamics  
Eps8 is also able to control directly the actin cytoskeleton remodelling through its capping 
and bundling activity. As a capping protein, Eps8 can accelerate actin treadmilling, 
blocking polymerization at filament ends. As a bundler, instead, Eps8 can regulate the 
architectural organization of the actin cytoskeleton. These biochemical properties make 
Eps8 a key regulator both of actin based motility and of the formation of specific structures 
such as protrusions at the cellular leading edge. Eps8 functions are both mediated and 
retained by the protein C-terminal region, in which the F-actin binding surface is located. 
The full-length protein is instead regulated by protein-protein interactions.  
5.6.2.3.1  Eps8 capping activity 
A more recent work revealed that Eps8 acts not only as a signalling molecule, but is also 
the prototype of a new family of capping proteins thus controlling directly actin dynamics 
[50]. Eps8 capping activity resides in its conserved carboxyl-terminal region (aa 648-821), 
which, in substoichiometric amounts with respect to actin, is able to inhibit barbed end 
growth up to 90% in in vitro polymerization assays using spectrin actin seeds [50]. 
Consistently with its capping activity Eps8 enables propulsion of N-WASP coated beads in 
in vitro actin based motility assays in the absence of Gelsolin or other cappers, and it 
localizes in cellular regions where there is high actin turnover. Consistently, the protein is 
found at lamellipodia tip, on filopodia and microspikes, and is enriched in peripheral and 
dorsal ruffles. Eps8 also localizes in rocketing tails propelling phosphatidylinositol-4,5-
phosphate-(PI45P) enriched vesicles or intracellular pathogens such as Listeria 
monocytogenes or Shighella flexneri [50]. In keeping with this latter specific localization, 
eps8 -\- derived fibroblasts displayed a decrease in the number of PI5K-induced 
phosphatidylinositol-4,5-phosphate enriched vesicles and in the propulsion rate of 
intracellular pathogens [50]. While the isolated C-terminal region is fully active as a 
capper, the full-length protein is regulated by protein:protein interaction. Full-length Eps8 
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capping activity can only be induced upon binding to Abi1 [50]. While the mechanism of 
this regulation remains obscure, it is possible that the binding to Abi1 induces a 
conformational change that exposes the C-terminal region, which would otherwise be 
hidden in the context of full-length protein.  
Notably, a triple complex formed by Eps8 and Abi1, together with Sos1, was 
already been shown to be involved in Rac activation leading to actin remodelling [60]. 
Moreover Abi1 has been shown to be involved in WAVE2 activation and to interact with 
N-WASP [71] [72]. Thus, collectively these observations support the possibility that Eps8 
and Abi1 participate in actin cytoskeleton regulation by entering into different complexes, 
each possessing distinct regulatory activities. How the formation of these different protein 
complexes is regulated in space and time and the impact of these interactions on actin 
dynamics warrant further investigation.  
Eps8 capping activity is conserved throughout evolution. Like in mammalian cells, 
also in C.elegans, EPS-8A, the longer EPS8 isoform retaining the effector region, has been 
demonstrated to efficiently cap actin filaments through its C-terminal domain [51]. This 
isoform was also shown to be specifically required for proper intestinal microvilli 
morphogenesis and this phenotype was correlated with the capping activity of the protein 
[51]. The more recent discovery of the bundling properties of Eps8 raised the question 
whether the bundling, rather than the capping activity, could be linked to this specific gut 
phenotype. This issue will be specifically experimentally addressed in this work. 
5.6.2.3.2  Eps8 bundling activity 
Eps8 has been described to influence the architecture of the cytoskeleton by promoting 
bundle formation in at least two ways [73]. Firstly, it has been shown to possess a weak 
bundling activity in vitro, encoded by its C-terminal effector region. Remarkably, this 
domain is not only able to bind filament ends blocking their further growth and thus acting 
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crosslinking into bundles. The bundling activity of the isolated C-terminal region of Eps8, 
however, can only occur when the c-terminal region is fused to GST. Since GST drives the 
formation of dimers, it is possible that the bundling activity of Eps8 is specifically, but 
somewhat artefactually, observed only under these peculiar in vitro conditions that may or 
may not reflect a physiological situation. This issue will be specifically addressed in the 
thesis results session and ensuing discussion.   
Secondly Eps8 has been found to form a constitutive, relatively stable and abundant 
molecular complex together with the protein IRSp53 (Insulin Receptor Tyrosine Kineses 
Substrate of 53kD, also known as BIAP2 for binding partner of the Brain Specific 
Angiogenesis Inhibitor 1). This interaction is functional to the activation of the bundling 
activity of the complex. IRSp53 is, indeed, able to bind actin filaments through its N 
terminal IMD domain, which consistently possesses a weak bundling activity that is, 
however, autoinhibited in the context of the full length protein. The formation of an 
Eps8:IRSp53 complex is thought to release this inhibition, although an alternative 
possibility is that the dimeric nature of IRSp53 enhances the crosslinking activity of Eps8.  
Whatever the case, the enhanced bundling property of the Eps8:IRSp53 complex likely 
accounts, in vivo, for the increased filopodia protrusive activity that can be observed when 
the two proteins are concomitantly expressed in cells. IRSp53 has long been known to 
induce the formation of filopodia-like protrusions in a variety of cellular systems, mainly 
through its IMD domain [74], while Eps8 expression alone has no effect on filopodia 
formation. The concomitant expression of the two proteins, however, leads to a dramatic 
increase in filopodia number, length and arborisation.  
Several evidences suggest that this complex acts downstream of Cdc42: i) Cdc42 
mediated filopodia formation requires both Eps8 and IRSp53; ii) IRSp53 binds active 
Cdc42 and mediates the formation of a triple complex Eps8-IRSp53-Cdc42. Notably, 
however, Cdc42 has no effects on the in vitro biochemical bundling properties of either 
Eps8 or IRSp53, while it induces in vivo a redistribution of Eps8 and IRSp53 into 
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membrane-rich cellular fractions. Based on this evidence, Cdc42 has been proposed to act 
by promoting the recruitment of the IRSp53:Eps8 complex at plasma membrane clusters, 
where the combined membrane deforming property of IRSp53 and increased bundling 
activity of the complex may initiate the formation of filopodia. 
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6. RATIONAL 
The dynamic assembly of actin filaments and their architectural organization into higher 
ordered arrays is essential for a variety of cellular processes and is at the basis of cell 
motility. A large number of actin binding proteins (ABPS) regulates the turnover and the 
spatial organisation of actin filaments [75]. Among these are in particular capping and 
cross-linking proteins. Capping proteins cap the fast growing ends of filaments (barbed or 
plus end), and allow the actin treadmilling to take place playing an essential role in cell 
migration [25]. Several classes of capping proteins have been identified in mammalian 
cells and considerable effort has been devoted to explore their structural mechanism of 
action. Capping Proteins display a variable, not conserved domain organization, suggesting 
that they adopt different modes to cap actin filaments, and possibly exert different and 
specialized roles in controlling actin cytoskeleton dynamics.  
Cross-linking proteins, instead, organize actin into highly dynamic and 
architecturally diverse subcellular scaffolds. This is achieved by linking through a bivalent 
interaction adjacent actin filaments to form networks that support cellular structures such 
as lamellipodia, filopodia, stress fibers, focal adhesions or microvilli [76]. 
Eps8 defines a new family of capping proteins, Eps8LS (Eps8-like), which displays 
no homology with other known cappers, suggesting that it uses novel mechanisms to exert 
its biochemical function [50]. Eps8 and its family members are also capable of side-
binding and bundling actin filaments, thus playing an essential role in controlling not only 
the dynamics, but also the architecture of the actin cytoskeleton. The isolated C-terminal 
domain (residues 648-821) is sufficient to mediate both the capping and the bundling 
activity of the protein. This region however displays no similarity with any other capping 
or crosslinking proteins, suggesting that Eps8 exerts its biochemical activity through 
molecularly and structurally peculiar mechanisms that have remained by and large elusive. 
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  The aim of my project was thus to unveil the structural and molecular mechanisms 
underlining the different activities of Eps8, with the objective of defining features enabling 
this protein and in particular its C-terminal domain to exert the various and different 
functions associated to the protein.  
To this end, we utilized a multidisciplinary approach that combined biochemical and 
molecular biology with genetic approaches and structural analysis by Electron Microscopy 
(EM). 
First, we biochemically characterized the C-terminal region of the protein in order to 
identify the actin binding surfaces. We used several independent approaches such as 
biochemical assays of actin polymerization, mass spectrometry analysis and in vitro 
binding experiments to fluorescently labelled actin. We combined this approach with a 
structural analysis by EM to reconstruct tridimensionally the mode through which Eps8 
interacts with actin filaments. These biochemical and structural information were validated 
by point mutagenesis, which allowed us to dissect the minimal surfaces of Eps8 
responsible for its capping and bundling activity in vitro as well as in mammalian cell and 
in the nematode C.elegans as an in vivo model system. 
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7. MATERIALS AND METHODS 
7.1 Common laboratory Solutions 
7.1.1 Phosphate-buffered saline (PBS) 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
2 mM KH2PO4 
The solution is prepared by dissolving 8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, and 
0.24 g of KH2PO4 in 800 ml of distilled water. The pH is adjusted to 7.4 with HCl and 
distilled H2O is added to 1 litre. 
 
7.1.2 Tris HCl (1M) 
The solution is prepared by dissolving 121.1 g of Tris base in 800 ml distilled H2O. The 
pH is adjusted with HCl, and distilled H2O is added to 1 litre.  
 
7.1.3 10X Tris EDTA (pH 7.4-8.0)  
 100 mM Tris HCl (pH 7.4-8.0) 
 10 mM EDTA (pH 8.0) 
 
7.1.4 50x TAE (Tris-Acetate-EDTA) 
 242 g/l     Tris  
 57.1 ml/l  Acetic acid  
 20 ml/l      0.5 M EDTA pH 8  
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The pH is adjusted to 8.5 with HCl and distilled H2O is added to 1 litre. 
 
7.1.5 Tris-buffered saline (TBS) 
 137mM NaCl 
 2.7mM KCl 
 25mM Tris  
The solution is prepared by dissolving 8 g of NaCl, 0.2 g of KCl, and 3 g of Tris base in 
800 ml of distilled H2O. The pH is adjusted to 7.4 with HCl and distilled H2O is added to 1 
litre final volume.   
 
7.1.6  1.4x JS lysis buffer 
50 mM HEPES PH 7.5 
50 mM NaCl 
 1% glycerol 
 1% Triton X-100 
 1.5 mM MgCl2 
 5 mM EGTA 
To this solution phosphatases and proteases inhibitors are freshly added: 
 Protease inhibitor cocktail (Roche, Basel, Switzerland) 
1 mM DTT 
20 mM Na pyrophosphate pH 7.5 
 50 mM NaF 
 0.5 M Na-vanadate in HEPES pH 7.5  
 
7.1.7 5x (2x) SDS-PAGE Sample Buffer 
10% (4%) SDS 
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500 mM (200mM) Tris pH 6.8 
30% (12%) glycerol 
0.03% (0.0012%) saturated bromophenol blue 
15% (6%) (v/v) β-mercaptoethanol (14M) 
 Stored at 4°C, protected from light by foil. 
 
7.1.8 10x SDS-PAGE Running Buffer  
144 g/l Glycine 
30 g/l Tris base 
1% SDS 
 
7.1.9 10x Western Transfer Buffer  
144 g/l Glycine 
30 g/l Tris base 
 Diluted at 1x concentration in 20% EtOH. 
 
7.1.10 Ponceau S 
 0.1% (w/v) Ponceau (C22H12N4Na4O13S4) (Sigma) 
5% Acetic acid 
 
7.2 Reagents and antibodies 
The following antibodies were used: anti-actin (sigma aldrich), anti-GST (produced by the 
IFOM-IEO Campus Antibody facility). TRITC phalloidin was from Molecular Probes 
(Eugene, OR). The proteins Thymosin β4, Ciboulot, Gelsolin, ADF\Cofilin, Profilin and 
spectrin actin seeds were a kind gift from Dr Marie-France Carlier (LEBS-CNRS-Gif sur 
Yvette, France). Lifeact-cherry was a kind gift from Roland Wedlich-Soldner. 
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7.3 Cloning techniques 
7.3.1 Agarose gel electrophoresis 
DNA samples were loaded on 0.8% - 2% agarose gels along with DNA markers. Gels were 
made in TAE buffer containing 0.3µg/ml ethidium bromide or GelRedTM Nucleic Acid  
1:10000 (Biotium, Italy) and run at 90V until desired separation was achieved. DNA bands 
were visualized under a UV lamp. 
 
7.3.2 Minipreps 
E.coli Top10 Cells (Invitrogen) picked from individual transformed colonies were used to 
inoculate 3 ml LB (containing the appropriate antibiotic) and grown overnight at 37°C in 
15ml Falcon tubes. Cells were pelleted for 15 minutes at 2500 rpm. Minipreps were 
performed according to the manual instructions (Promega, Wizard Plus SV Minipreps). 
The final elution was made in 80µl of milli-Q water. DNA was checked performing an 
agarose gel electrophoresis using 5µl of the elution. 
 
7.3.3 DNA digestion 
Between 0.5 and 2 µg DNA was digested for 2 hours at 37°C with 10 units of restriction 
enzyme (New England Biolabs). For digestion, the volume was readjusted to 10 µl with 
the appropriate buffer and ddH2O (20µl in case of double digestions). 
 
7.3.4 Large Scale Plasmid Preparation 
E.coli Top10 Cells (Invitrogen) containing the desired DNA vector were expanded into 
500 ml cultures overnight with the appropriate antibiotics. Plasmid DNA was isolated from 
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these cells using the Qiagen Maxi-prep kit (Qiagen,Valencia, CA) according to the 
manufacturer’s instructions. 
 
7.3.5 Transformation of competent cells 
E.coli Top10 cells (Invitrogen) were used for cloning and large scale DNA preparation, 
while E.coli BL21 cells (Promega) were used for protein production. The transformation 
protocol used was the same for both strains. 
50 µl of fresh competent cells were thawed on ice for approximately 10 minutes prior to 
the addition of plasmid DNA. Cells were incubated with DNA on ice for 20 minutes and 
then subjected to a heat shock for 45 seconds at 42°C. Cells were then returned to ice for 2 
minutes. Then, 0.4 ml of LB were added and the cells were left at 37°C for 60 minutes 
(with 200 rpm shaking) before plating them onto plates with the appropriate antibiotic.  
200 µl of the transformed bacterial were usually plated. Plates were incubated overnight at 
37°C. 
 
7.3.6 DNA elution from agarose gel 
Dna elution from agarose gel was performed using the QIAquick Gel Extraction kit 
(Quiagen, Valencia, CA), following manufacturer’s instructions. 
 
7.3.7 PCR (Polymerase Chain Reaction) 
Sense and antisense oligos, of 20-30 nucleotides each, were generated, one annealing in 5’ 
(forward) and the other in 3’ (reverse) to the target sequence. The primers were designed 
of similar length and annealing temperature. Melting temperature of the primers was 
calculated according to the formula: Tm = 81.5+0.41(%GC) - 675\N - % mismatch. These 
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primers were used in a PCR reaction together with the DNA template and the high fidelity 
Pfu polymerase (Promega).  
Reaction mixture 
reaction buffer 10x (Promega)  5 µl 
DNA template   100-300 ng 
primer forward    0.2 µM 
primer reverse   0.2 µM 
dNTPs mix    0.2 mM 
Pfu (Promega)   5 U 
ddH2O     to a final volume of 50 µl 
There are three major steps in a PCR (denaturation, annealing and extension), which were 
repeated for 18 cycles. This was done on an automated cycler (GeneAmp PCR system 
9700, Applied Biosystems), which can heat and cool the tubes with the reaction mixture in 
a very short time. 
Cycling parameters:     
Step Temperature   Time            N° of cycles 
A) denaturation at 95°C   30 seconds            1 
B) denaturation at 95°C   1 minute             18 
 annealing at X°C  30 seconds   
 extension at 72°C   (2 minutes/each kb of target length) 
C) extension at 72°C  7 minutes     1 
 
7.3.8 Site directed mutagenesis 
Site directed mutagenesis was performed using the Quick Change mutagenesis kit 
(Stratagene), following manufacturer’s instructions. Briefly, a sense and an antisense oligo 
of about 30-45 nucleotides each, carrying the desired mutation in the middle of the 
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sequence, were generated and used in a PCR reaction using the wild type construct (100-
300 ng) as template. PCR was performed using the Pfu TURBO polymerase for 18 cycles.  
For the amplification step, 18 PCR cycles were performed with a denaturation step of 30 
seconds at 95ºC followed by an annealing step of 1 minute at 55ºC and an extension step at 
68ºC of 2 minutes/each kb of plasmid length. 
After amplification, 1 µl of DpnI restriction enzyme, which selectively cuts methylated 
DNA at the GATC sequence, was added to digest the wild-type parental DNA. After one-
hour incubation at 37˚C, the PCR product was used to transform competent E. coli Top10 
cells (Invitrogen) and single colonies were sequenced for the presence of the desired 
mutation and the absence of other, unwanted, base changes. The presence of the desired 
DNA amplification was also checked by DNA electrophoresis of 10µl of the product in a 
1-2 % agarose gel. 
 
7.3.9 Generation of EPS8 constructs 
Eps8 constructs containing different fragments of the C-terminal region of the protein (aa 
648-821) were obtained through PCR, using as template the pGEX6P1 vector (Pharmacia 
Biotech) containing the cDNA sequence of murine Eps8 C-terminal region (aa 648-821) 
cloned into BamH1-EcoR1 restriction sites. 
To clone the different constructs specific primers were designed flanked by BamH1 and 
EcoR1 sites. 
The DNA fragments were first cloned in a TOPO pCR 2.1 vector (Invitrogen) using the 
TOPO TA Cloning kit (Invitrogen) according to manufacturer’s instructions. 
DNA fragments were then subcloned in an empty pGEX6P1 vector after BamH1-EcoR1 
double digestion and subsequent ligation. 
 
USED PRIMERS: 
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constructs Primers 
Fwd: 5’ ggatcctacaaacaactcccagtgg 3’ (Tm=59.1°C) 
H1 (aa 674-703) 
Rew: 5’ gaattcagcactgcgccc 3’  (Tm=56.2°C) 
Fwd: 5’ ggatccgtctgcccggaaggtg 3’  (Tm=63.6°C) 
H5 (aa 765-788) 
Rew: 5’ gaattcattactgtcctccaaagcagc 3’  (Tm=62.5°C) 
Fwd: 5’ ggatcctacaaacaactcccagtgg 3’  (Tm=59.1°C) 
H1-2 (aa 674-737) 
Rew: 5’ gaattctccctttgactgcagccaagtc 3’  (Tm=69.5°C) 
Fwd: 5’ ggatcccagcctggtctgcctggg 3’  (Tm=59.1°C) 
L-H2-H5 (aa 701-821) 
Rew: 5’ gaattcattactgtcctccaaagcagc 3’  (Tm=62.5°C) 
Fwd: 5’ ggatccgtgatcaatatcacttatgactcc 3’ (Tm=58.5°C) 
H2-5 (aa 717-788) 
Rew: 5’ gaattcattactgtcctccaaagcagc 3’  (Tm=62.5°C) 
 
7.3.10 Generation of EPS8 point mutants 
The different EPS8 mutants were generated performing site directed mutagenesis using the 
Quick Change mutagenesis kit (Stratagene), following manufacturer’s instructions (see 
also section 7.3.8). Specific primers were designed: 
constructs Primers 
Δbundling (Villin) mut 
L757A K759A 
5’ ggagcacaactcttttctgccaacgcagacgaactgagg 3’ 
Δcapping (H1) mut 
V689D L693D 
5’ cccagatggaagaggatcaggatgaggacttccagaggc 3’ 
Δbundling (Villin) mut C.e. 
L849A K851A 
5’ gccaatctattctccgcgtcagcattgcatctgcaacaagc 3’ 
Δcapping (H1) mut C.e. 
L784E V788E 
5’ gaatcctcaagagattcaagaagagactgaaactgtggg 3’ 
Linker mutant R706A F708A 5’ gcgcagtgctgcgcaggcgaaggcccacgtgccacggc 3’ 
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7.4 Cell culture 
7.4.1 Cells culture 
MEF (mouse embryonic fibroblasts) and Phoenix cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM, Life Technologies, Inc.) supplemented with 10% foetal bovine 
calf serum (FCS), 100 µg/ml streptomycin, 100 µg/ml penicillin and 2 mM glutamine. 
Cells were grown at 37°C in 10% CO2. 
 
7.4.2 Transfection  
Transfections were performed using either the calcium phosphate method or 
electroporation. 
Phoenix cells were transfected using the calcium phosphate procedure. In this case DNA 
(10 µg for a 10 cm plate) was diluted in 439 µl of ddH2O and 61 µl of 2M CaCl2 were 
added. This solution was added, drop-wise, to 500 µl of HBS 2x. After 15 minutes 
incubation, the precipitate was added to the cells (plated on 10 cm dishes) and removed 
after 12-16 hours.  
Electroporation was used to transfect MEF cells for the live imaging experiments, using 
the MicroPorator system (Digital Bio Technology) according to manufacturer’s 
instructions. Cells were microporated with one pulse of 30 ms at 1350 V, with a cell 
density of 5*106 cells\ml. 
2x HBS pH 7.5 
50 mM Hepes pH 7.5 
10 mM KCl 
12 mM dextrose 
280 mM NaCl 
1.5 mM Na2HPO4  
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7.4.3 Retroviral infection 
Stable MEF Eps8 -/- cells re-expressing wt GFP-Eps8 FL or expressing GFP Eps8 FL 
carrying the different mutations (Δcap, Δbundle, and ΔcapΔbundle mutants) were 
generated by retroviral infection using a pBABE-GFP vector (Cellbiolabs) in which the 
different constructs had been cloned. Retroviruses were produced by transfecting Phoenix 
cells using the calcium phosphate procedure (2 plates of 10bcm diameter for each 
construct). 48 and 72 hours after transfection, supernatants were collected and passed 
through a 0.45 µm filter. 8 µg/ml Polybrene (Sigma-Aldrich) was added to the viral 
supernatant. Viral supernatant was added to cultured MEF Eps8 -/- cells in a 6 well plate. 
Two cycles of infection were performed, of 4h each. Infected cells were selected with 
Puromycin for 2 weeks. Expression of the different constructs was controlled by GFP 
expression and by Western Blot analysis.  
 
7.4.4 Cell lysis  
After washing with PBS 1x, cells were lysed in JS buffer directly on the plates using a cell-
scraper. About 200 µl of JS buffer/10 cm plates were used. Lysates were incubated on ice 
for 10 minutes and spun at 12000 rpm for 10 min at 4ºC. The supernatant was transferred 
into a new eppendorf and protein concentration was measured by the Bradford assay 
(Biorad), following manufactur’s instructions. 
 
7.5 Imaging techniques 
7.5.1  Immunofluorescence 
To perform immunofluorescence, cells were fixed in 4% paraformaldehyde (in PBS) for 10 
minutes, washed with PBS and permeabilised in PBS 0,1% Triton X-100 for 10 minutes at 
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room temperature. To prevent non-specific binding of the antibodies, cells were then 
incubated with PBS in the presence of 0.2 % BSA for 20 minutes. 
The coverslips were then gently deposited, face down, on 30 µl Alexa 594-conjugated 
phalloidin (Molecular Probes) at a concentration of 6.7 U/ml. 
After three washes in PBS, coverslips were mounted in mowiol (20% Mowiol (Sigma), 5% 
Glycerol, 2.5% DABCO (Molecular Probes), 0.02% NaN3 in PBS) and examined by 
fluorescent optical microscopy.  
 
7.5.2 Cell Spreading  
The spreading experiment was performed using MEF cells stabling expressing GFP Eps8 
(WT or mutated) produced with Retroviral infection (see section 7.4.3).  
Coverslips were coated with Fibronectin (5-7 µg\ml in PBS) o\n at 4°C. 
Cells were trypsinized and incubated with warm complete medium for 30 minutes under 
the hood. Cells were then plated on fibronectin coated coverslips. Attaching of the cells to 
the coverslips was monitored using a microscope with a 10X objective. After 30 minutes 
cells were fixed in 4% Paraformaldeyde and immunofluorecence was performed as 
described in section 7.5.1. 
 
7.5.3 Live cells imaging 
MEF -\- cells were co-microinjected with Myc-phosphaditylinositol 4,5 kinase (PI(4,5)K), 
lifeact-cherry and the different Eps8 constructs fused to GFP.  
100.000 cells for each condition were plated on 35mm dishes (Ibidi) with glass bottom. 
Cells were imaged using a spinning disk confocal microscope (Olympus) with a 60X oil 
objective. Cells were checked for GFP expression and then five minutes movies were 
taken, following only the cherry-lifeact signal. 
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The velocity of rocketing endomembranes was determined by manually tracking individual 
vesicles in at least 5-10 different cells using the ImageJ software. Statistical significance 
was evaluated with the Turkey-Kramer HSD test. 
 
7.5.4 FRAP experiments 
FRAP experiments were performed by Dr. Klemens Rottner. 
The experiments were performed on Mouse melanoma cells (B16-F1), from American 
Type Culture Collection (ATCC CRL-6323). Cells were maintained in DMEM 
(Invitrogen, Germany) with 10% FCS (PAA Laboratories, Austria) at 37°C in the presence 
of 5% CO2. 
Cells were observed in an open, heated chamber (Warner Instruments, Reading, UK) at 
37°C on inverted microscopes. FRAP experiments were performed using a double-scan-
headed confocal microscope (Fluoview1000, Olympus), allowing simultaneous imaging of 
EGFP- and/or RFP-tagged probes (with 30 mW 488 nm multilane argon and/or 20 mW 
561 nm solid-state lasers, respectively) and photobleaching/activation using a 20 mW 405 
nm diode laser.  
 
7.6 Biochemical procedures 
7.6.1 SDS polyacrylamide gel electrophoresis (SDS PAGE) 
Gels for resolution of proteins were made from a 30%, 37.5:1 mix of 
acrylamide:bisacrylamide (Sigma). As polymerisation catalysts, 10% ammonium 
persulphate (APS) and TEMED (Fluka) were used. 
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7.6.2 Western blot 
Desired amounts of proteins were loaded onto 0.75-1.5 mm thick polyacrylamide gels for 
electrophoresis (Biorad). Proteins were transferred in Western transfer tanks (Biorad) to 
nitrocellulose (Schleicher and Schuell) in Western Transfer buffer 1x (diluted in 20% 
ethanol) at constant Voltage (100V for 1 hour, 80V for 2 hours, or 30V overnight). 
PonceauS colouring was used to reveal roughly the amount of proteins transferred on the 
filters. Filters were blocked 1 hour (or overnight) in 5% milk or 5% BSA in TBS 0.1% 
Tween (TBS-T). 
After blocking, filters were incubated with the primary antibody, diluted in TBS-T 5% 
milk, for one hour at room temperature, or overnight at 4˚C, followed by three washes of 
five minutes each in TBS-T and then incubated with the appropriate peroxidase-conjugated 
secondary antibody diluted in TBS-T for 1 hour. After the incubation with the secondary 
antibody, the filter was washed three times in TBS-T and the bound secondary antibody 
was revealed using the ECL (Enhanced Chemiluminescence) method (Amersham).  
 
7.6.3 GST-fusion proteins production 
All the GST fusion proteins used were product in bacteria using E. coli BL21 cells 
transformed with the pGEX6P1 vector in which the desired construct had been cloned. 
7.6.3.1 Bacterial culture 
E. coli BL21 cells picked from individual colonies, transformed with the indicated GST-
fusion constructs, were used to inoculate 50 ml of LB medium (containing ampicillin at 25 
µg/ml) and were grown overnight at 37°C. 5 ml of the overnight culture was diluted in 0.5 
litre of LB and was grown at 37°C (240 rpm shaking) till it reached approximately 
OD=0.6.  
Then IPTG was used to induce the protein production using different conditions depending 
on the protein: 
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Construct IPTG concentration time temperature 
Eps8 648-821 wt \ carrying all the different 
mutations 
1mM 2h30 37°C 
Eps8 H1 (aa 674-703) 0.5mM o/n 16°C 
Eps8 H1-H2 (aa717-788) 0.5mM o/n 16°C 
Eps8 H5 (aa 765-788) 0.5mM o/n 16°C 
Eps8 L-H2-H5 (aa 701-821) 0.5mM o/n 16°C 
GST 1mM 2h 37°C 
 
After the induction cells were pelleted down at 4000 rpm for 15 minutes at 4°C and pellets 
were used immediately or conserved at -80°C after washing in PBS 1X. 
 
7.6.3.2 Protein production 
Pellets were suspended in GST-lysis buffer (20ml for 1l culture). Samples were sonicated 
3 times for 30 seconds/each on ice and were pelleted down at 40000 rpm for 45 minutes at 
4°C using a 55.2 Ti Beckman rotor. 1 ml of glutathione-sepharose beads (Amersham), 
previously washed 3 times with GST-lysis buffer, was added to the supernatants and 
samples were incubated 1 hour at 4°C while rocking. Beads were then washed 3 times 
(with 10 minutes of incubation at 4°C each) in the GST-lysis solution. Proteins were then 
eluted from the beads as GST fusion proteins or cleaved using prescission protease. 
 GST-lysis solution 
 50mM Tris pH 7.5 
 500mM NaCl 
1mM MgCl2 
0.1% triton X100 
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 protease inhibitor cocktail (Roche, Basel, Switzerland) (freshly added) 
 1 mM DTT  (freshly added) 
  
7.6.3.3 GST-fusion protein elution and PreScission protease cleavage 
Beads were washed once in the washing solution and than subjected to four cycles of 
elution (15 min each at RT) in the elution buffer. Eluted proteins were finally purified 
through gel filtration using a Superdex 200 10\30 column (GE Healthcare Life Science) on 
an AKTA purifier system (Amersham Bioscience) in the final storage buffer. Proteins were 
flesh frozen using liquid Nitrogen and stored at –80˚C. 
Washing buffer 
10 mM Tris-HCl pH 8.5 
75 mM NaCl 
Elution buffer 
20 mM Tris-HCl pH 8.0 
500 mM NaCl 
20 mM glutathione (Amersham) 
Storage buffer 
50 mM Tris-HCl pH 7.5 
50 mM NaCl 
1 mM DTT 
5% glycerol 
 
Proteins were cleaved from the GST using the PreScission protease (Amersham Pharmacia 
Biotech) according to the manufacturer’s instructions. Cleaved protein was then further 
purified and stored as described above. 
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7.6.4 PPDM cross-linking of Eps8 (648-821) and actin 
G-actin and Eps8 (648-821) were solubilized in a buffer containing 5 mM Hepes pH 7.8, 
0.2 mM CaCl2 and 0.2 mM ATP by using a D-Salt Extracellulose Desalting column 
(PIERCE). G-actin and Eps8 (648-821) were mixed and incubated for 5 and 10 minutes 
with 16 µM of PPDM (N,N’-(1,4-Phenylene)dimaleimide) (Fluka) at room temperature. 
Following addition of 10 mM DTT, samples were resolved by SDS-PAGE. 
 
7.6.5 Gel filtration analysis 
Size exclusion chromatography was performed on a Superdex 200 10\30 column (GE 
Healthcare Life Science) on an AKTA purifier system (Amersham Bioscience). Proteins 
were centrifuged for at least 10 minutes at 13.000 rpm before loading.  
Proteins were loaded in 500 µl volume using a Hamilton syringe. Typical flow rate was 0.5 
ml\min.  
 To study the EPS8-actin complex proteins were run in G buffer: 2 mM TRIS pH 7.8, 0.2 
mM ATP, 1 mM DTT and 0.1 mM CaCl2. 
To perform the hydrodynamic analysis and to evaluate the proteins stability elutions were 
performed in buffer A or in buffer F: 
Buffer A: 50 mM TRIS pH 8, 1 mM DTT, 1 mM EDTA, 50 mM NaCl, 10% glycerol 
Buffer F: 2 mM TRIS pH 7.8, 0.2 mM ATP, 1 mM DTT, 0.1 mM CaCl2, 1 mM MgCl2  
    0.2 mM EGTA, 0.1 M KCl. 
 
7.6.6 Hydrodynamic analysis 
Hydrodynamic analysis was performed coupling size exclusion chromatography and 
glycerol density gradient. 
Materials and methods 
Milanesi Francesca PhD thesis 70 
7.6.6.1 Size exclusion chromatography 
Size exclusion chromatography was performed on a Superdex 200 10\30 column as 
described above (see section 7.6.5) in buffer A. Markers of known Stoke radius were run 
in the same buffer. Elution volumes of the markers (bovine thyroglobulin, rabbit aldolase, 
hen egg albumin, and ribonuclease A) were plotted against their known Stokes radii to 
generate a calibration curve (R2 = 0.9775) from which the Stokes radius of GST-Eps8 
(648-821) was determined. 
 
7.6.6.2 Glycerol density gradient 
The glycerol density gradient was performed in a final volume of 5 ml.  
3 ml of a 10% glycerol buffer  (100 mM TRIS pH 8, 1 mM DTT, 1 mM EDTA, 500 mM 
NaCl, 10% v\v glycerol) were put in a 5 ml tube. Putting a syringe on the bottom, the tube 
was filled with a 40% glycerol buffer (100mM TRIS pH 8, 1mM DTT, 1mM EDTA, 
500mM NaCl, 40% v\v glycerol). The gradient was then created using a Gradient Master 
machine (Biocomp). 75 µl of the different proteins were placed directly on the top of the 
gradient. Centrifugation was protracted for 13h at 55.000 rpm on a Beckman SW41Ti 
swinging bucket rotor at 4°C, with low acceleration and no brake deceleration velocities. 
The gradient was fractionated in 250 µl volume fractions that were analysed by SDS-page.  
Sedimentation volume of the markers (Bovine Pancreas Chymotrypsinogen, albumine, 
aldolase and catalase) were plotted against their known Svedberg coefficient (2,58S, 4,22S, 
7,4S and 11,4S respectively) to generate a calibration curve from which the Svedberg 
coefficient (s) of GST-Eps8 (648-821) was determined. 
The molecular weight was calculated from the Stokes radius (a) in Ångstroms and from 
the sedimentation volume (s) according to the Monty-Siegel equation: 
 MW = α a *s 
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where α = (6πη0N)/(1 - νρ), N is Avogadro's number (6.02 × 1023), η0 is the viscosity of 
medium (g/(cm·s)), ρ is the density of the medium (g/ml), and ν is the partial specific 
volume of the analyzed particle (ml/g). In our experimental setting we calculated α = 0.41. 
 
7.7 Mass Spectrometry analysis  
The Mass Spectrometry analysis was performed in collaboration with the Mass 
Spectrometry facility of the IFOM-IEO Campus.  
7.7.1 Crosslinking reaction  
The complex between murine Eps8 (648-821) and actin was purified by gel filtration and 
crosslinked using 1:1 mixture of the bis [sulfosuccinimidyl]glutarate (BS2G-d0) and its 
deuterated version (BS2G-d4)  (Pierce). The reaction was carried out at room temperature 
using 100-fold molar excess of the crosslinker reagent with respect to the protein complex 
in a final volume of 200 µl of 50 mM Hepes pH 7.5 and 150 mM NaCl. BS2G contains a 
spacer of 7.7 Å length and crosslinks Lysines with side chains that can extend up to 6.0 Å. 
The reaction was stopped after 20 min with 5 µl of 1 M ammonium bicarbonate (Sigma).  
7.7.2 Protein digestion and chemical crosslinked peptide purification 
The protein sample was resolved by SDS-PAGE. Two bands with higher molecular 
weights, as compared to the control in absence of crosslinkers, were excised from the gel 
and Trypsin-digested. The enzymatic reaction was stopped by adding trifluoracetic acid 
(TFA) to a final concentration of 1%. The acidified peptide mixture was desalted and 
concentrated before injecting, via an Agilent 1100 Nano HPLC, into a C18 column 
(Reprosil-Pur C18-AQ 3 µm; Dr. Maisch GmbH) packed into a spray emitter (100 µm 
internal diameter, 8 µm opening, 70 mm length; New Objectives). The peptides were 
eluted in a gradient from buffer A (5% acetonitrile and 0.5% acetic acid) to buffer B 
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(acetonitrile and 0.5% acetic acid) going from 0% to 20% in 10 min at 300 nl/min-1. 
Spectra were recorded on a LTQ-FT mass spectrometer (Thermoelectron).  
 
7.8 Biochemical actin-based assays 
The following assays and the set of required purified proteins were generated following 
specific protocols derived from Marie-France Carlier Lab (CNRS, Gif-sur-Yvette, France). 
7.8.1 Common buffers 
Same buffers are commonly used in actin-based assay. 
G buffer is used to keep actin in the monomeric state (G = globular) 
Buffer G 
5 mM Tris-HCl pH 7.8 
0.2 mM ATP pH 7.0 
1 mM DTT 
0.1 mM CaCl2 
F buffer is used to keep actin in the polymerized state (F = filamentous) 
Buffer F 
5 mM Tris-HCl pH 7.8 
0.2 mM ATP pH 7.0 
1 mM DTT 
0.1 mM CaCl2 
1 mM MgCl2  
 0.2 mM EGTA 
0.1 M KCl 
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7.8.2 Actin purification 
Actin was purified starting from Rabbit muscle acetone powder (Pel-Frezez Biologicals, 
Rogrs, Arkansas) according to the following protocol. 
Nine gr of acetone powder were extracted with 270 ml cold buffer X on ice in a 500 ml 
beaker. Buffer was slowly added with gentle stirring with a glass rod to thoroughly wet 
powder. The resuspension was set on ice for 30 min and stirred gently once every 10 min. 
The preparation was then centrifuged at 25000 xg at 4˚C for 45 min. Supernatant was 
filtered using a cotton lint into a graduated cylinder and transferred into a beaker. Solid 
KCl was added to a final concentration of 3.3 M while stirring (at RT until temperature 
reaches 15˚C) and moved back on ice without stirring until temperature returned to 5˚C. 
The sample was centrifuged at 25000xg, for 30 min at 4˚C. Tight white pellets, if any, is 
actinin. Supernatant was dialyzed vs 32 volumes of buffer D overnight. Final KCl 
concentration was 0.1 M. 
After overnight dialysis 4M KCl was added to give a final concentration of 0.8 M and the 
prep was stirred for 1.5 hours at 4˚C in order to solubilize tropomyosin. The prep was then 
centrifuged at 100000xg for 3.5 hours at 4˚C. Supernatant was discarded. Pellets were 
homogenized with a potter in 25 ml buffer X. Once added 0.075 ml MgCl2 1 M and 0.375 
ml KCl 4 M, the volume was adjusted to 38.6 ml with buffer X and the prep was left at 4˚C 
overnight without stirring. 
The day after 9 ml KCl 4 M and 2.37 ml of buffer X were added and the prep was stirred 
for 1.5 hours at 4˚C and then centrifuged at 100000 xg for 3.5 hours at 4˚C. Pellet was 
homogenized in buffer X (20-30 ml) and the resuspension was dialyzed vs 1l G buffer. 
The day after the prep was briefly sonicated in the dialysis bag, 1 x 10 seconds. Dialysis 
buffer was changed. 
After 2 days of dialysis in G buffer (with daily change of the buffer) actin was clarified at 
230000 xg for 2 hours at 4˚C. The prep was loaded onto a Superdex 200 26/60 column 
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(GE Healthcare) and run using an Amersham Biosciences AKTA Purifier. Fractions of 5 
ml were collected. The protein concentration was measured using UV absorbance  (290nm 
instead of 280 nm because ATP interferes at 280 nm wavelength). Actin concentration was 
calculated using the following formula: 
[µM] = (OD 290nm\0.617) * (1\42) 
where 0.617 is the OD of actin at 290nm when concentrated 1mg\ml, and 42 is the actin 
molecular weight (kD). 
Buffer X 
2 mM Tris-HCl pH 7.8 
0.5 mM ATP pH 7.0 
0.1 mM CaCl2 
1 mM DTT 
Buffer D 
2 mM Tris-HCl pH 7.8 
1 mM MgCl2 
1 mM DTT 
 
7.8.3 Pyrenyl-actin labelling 
Actin was purified as described above and the labelling protocol was started at the end of 
the third day. Actin is labelled on cysteine 374. 
After centrifugation the pellet was resuspended in buffer A to a final concentration of 2 
mg/ml. 1:100 volume of N-(1-pyrenyl)iodoacetamide (Molecular Probes, Invitrogen) at 14 
mg/ml in DMF was added and the sample was gently mixed until it became white. Actin 
was then incubated overnight at 4°C rocking. From this moment actin has to be kept 
always in the dark. 
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After overnight incubation DTT was added to 1 mM final concentration and the sample 
was centrifuged at 4000xg for 15 min. Supernatant was then centrifuged again at 100000 
xg for 3.5 hours at 4˚C. Pellet was homogenized in 5 ml of buffer G and dialyzed vs 1 l of 
buffer G overnight at 4˚C. 
The day after the prep was briefly sonicated in dialysis bag, 1 x 10 seconds and the dialysis 
buffer was changed. 
After 2 days of dialysis in G buffer (with daily change of the buffer) actin was clarified at 
230000xg for 2 hours at 4˚C. The prep was loaded onto a Superdex 200 26/60 column (GE 
Healthcare) and run using an Amersham Biosciences AKTA Purifier. Fractions of 5 ml 
were collected. The protein concentration was measured using UV absorbance  (290 
instead of 280 nm because ATP interferes at 280 nm wavelength). Actin concentration was 
calculated using the following formula: 
[µM] = (OD 290nm\0.617) * (1\42) 
where 0.617 is the OD of actin at 290nm when concentrated 1mg\ml, and 42 is the actin 
molecular weight (kD). 
To evaluate the actin labelling OD was measured at 343 nm, that is the wavelength of 
maximum absorbance for Pyrene (N-(1-pyrenyl)iodoacetamide).  
The following formula was used to calculate the concentration of the labelled actin: 
[µM] labelled actin = OD 343 nm\54000 
where 54000 (M-1 cm-1) is the Pyrene ξ value at 343 nm.  
To evaluate the percentage of actin labelling the ratio between labelled and total actin 
concentration was then calculated. 
Buffer A 
5 mM Tris-HCl pH 7.8 
0.5 mM ATP pH 7.0 
1 mM DTT 
0.1 mM CaCl2 
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2 mM MgCl2 
0.1 M KCl 
 
7.8.4 NBD-actin labelling 
Actin was purified as described above and the labelling protocol was started at the end of 
the third day. Actin is labelled on lysine 373. 
After centrifugation the pellet was resuspended in buffer A without DTT to a final 
concentration of 2 mg/ml. 
NEM (N-ethylmaleimide) (Molecular Probes, Invitrogen) was added to a final 
concentration of 2.5 mM, starting from a solution of 100 mM NEM in water. The solution 
was incubated first 15 min at RT, then 15 min at 15°C and finally 3 hours at 4°C. After the 
incubations 5 mM DTT was added in order to stop the reaction and the sample was 
centrifuged for 2h at 200000xg at 4°C.  The surnatant was then taken and diluted two times 
in buffer G with DTT. The solution was dialyzed overnight in G-buffer (without DTT) at 
4°C. Dialysis was continued for 2 days in G buffer changing the buffer daily. Actin was 
then centrifuged 2 hours at 200000xg and the pellet was resuspended in F buffer (without 
DTT). Actin was let polymerize overnight in the dark at 4°C. 
The day after NBD (7-cloro-4-nitrobenzene-2-oxa-1,3 dyzole) was added to a final 
concentration of 0.4 mM and the sample was incubated 5 hours at 15°C.  
Actin was then centrifuged 2 hours at 200000xg and the pellet was resuspended in buffer G 
(with DTT). Actin was dialyzed overnight towards G buffer (with DTT). 
Actin was then clarified at 200000xg for 2 hours at 4˚C. The prep was loaded onto a 
Superdex 200 26/60 column (GE Healthcare) and run using an Amersham Biosciences 
AKTA Purifier. Fractions of 5 ml were collected. The protein concentration was measured 
using UV absorbance  (290 instead of 280 nm because ATP interferes at 280 nm 
wavelength). Actin concentration was calculated using the following formula: 
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[µM] = (OD 290 nm\0.617) * (1\42) 
where 0.617 is the actin OD at 290nm when concentrated 1mg\ml, and 42 is the actin 
molecular weight (kD). 
To evaluate the actin labelling OD was measured at 590 nm, that is the wavelength of 
maximum absorbance for NBD.  
The following formula was used to calculate the concentration of the labelled actin: 
[µM] labelled actin = OD 590 nm\13500 
where 13500 (M-1 cm-1) is the NBD ξ value at 590nm.  
To evaluate the percentage of actin labelling the ratio between labelled and total actin 
concentration was then calculated. 
Buffer A 
5 mM Tris-HCl pH 7.8 
0.5 mM ATP pH 7.0 
0.1 mM CaCl2 
2 mM MgCl2 
0.1 M KCl 
 
7.8.5 Actin polymerization assays  
Initial rate of filament growth from the barbed and the pointed ends was monitored by the 
increase in fluorescence of 10% pyrenyl-labeled actin using a Perkin Elmer (LS55) 
fluorescence spectrophotometer. Pyrenyl fluorescence increases of about 25 times from G-
to F-actin. Filaments growth can thus be followed looking to the increase of fluorescence.  
The used wavelengths are 366 nm for the absorption, 407 nm for the emission. 
Actin polymerization is induced starting from seeds, preformed nuclei of 2 or 3 actin 
subunits from which the polymerization can start avoiding the first lag phase. Either 
spectrin actin seeds or gelsolin actin seeds can be used, where spectrin and gelsolin are 
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proteins that bind specifically the plus and the minus end respectively. Spectrin actin seeds 
have thus only free barbed ends allowing actin polymerization only from the plus ends. 
Gelsolin actin seeds, at the contrary, can polymerize only from their minus ends.   
Seeded polymerization was induced by addition of 0.1 M KCl, 1 mM MgCl2 and 0.2 mM 
EGTA to a solution of Ca-ATP–G-actin (2.5 µM) in G-buffer containing spectrin–actin 
seeds (0.25 nM) or gelsolin actin seeds and the desired amount of purified protein in a final 
volume of 100 µl. 
Gelsolin-actin seeds were prepared by adding gelsolin and 2.5 molar equivalent Ca ATP-
G-actin in G-buffer. Spectrin actin seeds were a kind gift of Marie-France Carlier 
laboratory.  
The affinity for barbed ends was derived as follows: the initial rate of polymerization was 
taken as a measure of the free barbed ends at t0 (C0, equal to the concentration of actin 
seeds at t0). The following equation was used to fit the data, in which [C0] and [B0] are the 
total concentration of barbed ends and of the Eps8 fragments, respectively, and Kcap 
represents the equilibrium dissociation constant of the complex of Eps8 with barbed or 
pointed ends [BC]. The fraction R of Eps8-bound barbed ends is: 
R = [BC]/[B0] = (V0 – VC)/(V0 – Vmin) 
= ([C0] + [B0] + K ± (([B0] + [C0] + Kcap)2 + 4[B0].[C0])1/2)/2[B0] 
in which V0 is the initial rate of polymerization in the absence of capping proteins, VC is 
the initial rate of polymerization in the presence of capping proteins at total concentration 
[C0], and Vmin is the initial rate of polymerization in conditions of maximum inhibition 
(determined experimentally).  
 
7.8.6 In vitro actin-based motility assays 
This protocol describes the execution of an assay that reconstitutes the propulsion of N-
WASP-functionalized microspheres in a minimum motility medium containing Arp2/3 
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complex, ADF, gelsolin (or other capping proteins), profilin, and actin [23]. 
7.8.6.1 Beads coating 
Polystyrene carboxylated microspheres of diameters from 0.2 to 3 µm were incubated in 
N-WASP buffer A containing 400 nM N-WASP (added from a 4 µM stock) for 1 hour on 
ice. The quantity of microspheres in a 50 µl suspension was adjusted so that the total 
surface of solid per unit volume of solution was 7.5 x 109 µm2/ml, independent of the 
diameter of the microspheres. 5µl of 10 mg\ml BSA were added to block free adsorption 
sites and incubated 15 minutes on ice. The microspheres were then centrifuged 5 minutes 
at 1000xg at 4°C and then washed twice, each time by adding 250 µl N-WASP buffer A 
and centrifuging 5 minutes at 1000xg at 4°C. Final pellet was resuspended in 50 µl of N-
WASP buffer C containing 1 mg\ml BSA. Functionalized microspheres were stored on ice 
and used for up to 1 week without any change in their motile properties.  
7.8.6.2 motility assay 
Polystyrene carboxylated beads coated with N-WASP were placed in a reconstituted 
motility medium that consisted of 7 µM F-actin, 3.5 µM ADF, 2.4 µM profilin, 100 nM 
Arp2/3 complex, 50 nM capping protein (gelsolin or GST–Eps8-648–821), 4 µl 
ADP/DABCO/DTT mix in assay buffer 1% BSA (final volume 24 µl). An aliquot of 2.5 µl 
of the mix was placed between a slide (Superfrost plus, Menzel-Gläser, GmbH) and a 
coverslip, sealed with Valap (vaselin:lanolin:paraffin 1:1:1), and observed in phase 
contrast or in fluorescence using a CCD camera (Hamamatsu ORCA II ER) on an 
Olympus AX70 microscope equipped with a motorized stage (Märzhäuser). MetaMorph 
4,6 software for microscope control and image acquisition was used to calculate the speed 
of the beads in time-lapse experiments. 
Assay buffer:  
10 mM HEPES pH 7.5, 0.1 M KCl, 1 mM MgCl2, 0.1 mMCaCl2, 1mM ATP, 1 % BSA) 
ATP/DABCO/DTT mix: 
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15 µl of 0.2 M ATP, pH 7.0, and 6µl of 1M MgCl2 were added to 79 µl of distilled water 
to obtain a 30 mM ATP\60mM MgCl2 stock solution. The ATP\DABCO\DTT mix was 
prepared by mixing 40µl of the 30mM ATP\60mM MgCl2 stock solution with 20 µl of 
2.2mM 1,4-diazabicyclo[2.2.2]octane (DABCO; Molecular Probes) and 10 µl 0.2M DTT. 
The mix was stored in ice and used within 3 days. 
Methylcellulose,  1 %:  
1% (w/v) methylcellulose was prepared in distilled water, heated to 60°C, and stirred until 
the solution cleared.   
Mg-F-actin 
100 µl of Mg-F-actin were obtained by adding 5 µl of KME (2M KCl, 20 mM MgCl2, 4 
mM EGTA) to 95 µl Ca-G-actin in G-buffer. 
N-WASP buffer A:  
20 mM sodium phosphate buffer pH 7.8, 5% (v/v) glycerol, 0.3 M NaCl , 0.1% (v/v) 
Tween 20. Just before used, 1mM PMSF, 5 µg/ml leupeptin,  5 µg/ml chemostatin, 5 
µg/ml  pepstatin,  10 µg/ml benzamidine were added.  
N-WASP buffer C: 20mM sodium phosphate buffer, ph 7.5, 5% (v\v) glycerol, 0.3 M 
NaCl, 10mM imidazole , 1mM DTT. 
 
7.8.7 Actin low speed co-sedimentation assays 
This assay is used to evaluate the capacity of a protein of interest to bundle actin filaments. 
After a low speed centrifugation, actin filaments remain in the surnatant, and only actin 
bundles, if present, go to the pellet. The bundling activity of a protein can be thus 
evaluated looking at the presence of actin in the pellet fraction. Bundling proteins would 
go into the pellet together with actin.  
Monomeric rabbit G-actin was induced to polymerize at RT in F-actin buffer 
(polymerization buffer). Recombinant proteins or control buffer were subsequently 
incubated with F-actin for 60 min at room temperature and centrifuged for 30 min at 
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10000xg in a Eppendorf 5415D table-top centrifuge. Equal amounts of starting materials, 
supernatants and pellets, were solubilized in SDS-PAGE sample buffer, boiled and 
resolved on an SDS-PAGE gel. Actin and Eps8 proteins were revealed by Western Blot 
analysis using specific antibodies.  
 
7.8.8 Fluorescence microscopy of actin bundling  
Monomeric rabbit G-actin was induced to polymerize at RT in F-actin buffer 
(polymerization buffer) and was then diluted in F-buffer to a final concentration of 2 µM. 
A mix was then prepared, putting 5 µl of 2 µM actin, the protein of interest at the desired 
concentration, and bringing to a final volume of 10 µl with F-buffer. 
The reaction mix was incubated at room temperature for 30 min.  
9 µl of the reaction mix were then transferred into a new tube and mixed with 1 µl TRITC 
Phalloidin (very slowly, using cut tips). The reaction was incubated 10 minutes at room 
temperature in the dark. The reaction was then added to 2.5 µl of a 1:1 mixture of 0.1% 
DABCO and 0.1% Methyl Cellulose with careful mixing. 
The samples were finally mounted between a slide and coverslip coated with poly-Lysine 
and imaged by fluorescence microscopy with a 100x objective. 
 
7.8.9 NBD-actin and AEDANS -actin binding assays 
The change in fluorescence of NBD- or AEDANS-labelled actin was used as a probe for 
the formation of complexes of G-actin with Eps8 (648-821), H1-H2 or H5. Static 
fluorescence measurements were carried out on a LS55 fluorescence spectrometer from 
Perkin Elmer. Excitation and emission wavelengths were 475 nm and 530 nm for NBD-
actin and 340, 460 nm for AEDANS actin, respectively. The amount of complex was 
determined by setting at 100 % the change of fluorescence measured in the presence of 
saturating amounts of Eps8 (648-821), H1-H2, or H5. The equilibrium dissociation 
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constant (Kd) for the complex was derived from the curve obtained determining the 
different concentrations of the complex with respect to the total concentration of Eps8 
(648-821), H1-H2, or H5 using the following equations: 
[A] + [CA] = [A0]  
[C] + [CA] = [C0]  
[CA] = (1/2){[A0] +[C0]+Kc + (([A0] +[C0]+Kd)2-4[A0].[C0])1/2 
where [A], [A0], [C], [C0]  are the free and the total concentrations of G-actin and of the 
binding proteins (either Eps8 (648-821), H1-H2, or H5); [CA] is the concentration of the 
complex. 
 
7.8.10 Nucleotide Exchange on G-actin 
Kinetics of nucleotide exchange on monomeric actin were monitored using the change of 
fluorescence of εATP upon binding to G-actin.  
ATP-G-actin 1:1 complex was obtained by Dowex-1 treatment. Free nucleotide was 
removed just before starting the experiment by treatment with 20% v\v of a 50% 
suspension of Dowex 1-X2 ion exchange resin (sigma aldrich) for 4 minutes at 4°C. The 
Dowex resin was removed by filtration through a Millipore filter of 0.45 µm pore size. 
Actin was then diluted to 1 µM in the reaction buffer (5 mM Tris HCl, 0.1 mM CaCl2, 1 
mM DTT) in the presence of Eps8 (648-821). The increase in fluorescence (λexc = 350nm, 
λem= 410nm) upon addition of 5 µM εATP was monitored using a Safas flx 
spectrofluorometer. 
The observed first order rate constant displayed hyperbolic saturation behaviour with the 
concentration of Eps8 (648-821). The equilibrium dissociation constant for the Eps8 (648-
821)-actin complex was derived from the dependence of the apparent exchange rate 
constant on the concentration of Eps8 (648-821) as follows: 
![A] + [CA]" = [A0] # 
Materials and methods 
Milanesi Francesca PhD thesis 83 
![C] + [CA]" = [C0] #  
 kobs = (k1[A] + k2[CA])/[A0] = ([A]/ [A0]){k1 + k2([C0]-[A0] + [A])/kc} 
with  
[A] = (1/2) {[A0] - [C0] – Kc ± (([A0] - [C0] – Kc)2 + 4Kc[A0])1/2 } 
[CA] = (1/2) {[A0] + [C0] + Kc ± (([A0] + [C0] + Kc)2 -  4 [A0] * [C0])1/2 } 
where [A], [A0], [C], [C0] are the free and total concentrations of G-actin and Eps8 (648-
821) and [CA] is the concentration of the complex; k1 and k2 are the rate constants for 
nucleotide dissociation from G-actin and from the CA complex, respectively; KC is the 
equilibrium dissociation constant of the CA complex. The values of k1 and k2 were deter- 
mined experimentally in the absence and in the presence of saturating amounts of Eps8 
(648-821). The value of KC was derived from the adjustment of the calculated curves kobs 
([C0]) to the data. 
 
7.9 Electron microscopy 
Electron microscopy was performed in collaboration with Doris Hanein laboratory in La 
Jolla, California. 
7.9.1 grids preparation 
Rabbit skeletal muscle actin was prepared and stored as described in section 7.8.2. 
Filamentous actin (F-actin) was used within two to three weeks of preparation. F-actin 
samples were diluted to 0.03-0.07 mg/ml in buffer A just before the application to glow-
discharged 400-mesh copper grids coated with lacy carbon film. All protein samples 
(excluding F-actin) were spun at 4º C for 10 min at 15,000 rpm prior to dilution (Buffer 
A). Following 30-60 seconds of incubation in a humidity chamber, the sample was blotted 
and stained with 2% aqueous uranyl acetate. Images were recorded at a dose of ~50 e−/Å2 
with a Tecnai G2 T12 electron microscope (FEI Company, Hillsboro, OR) at 120 keV with 
a nominal magnification of 52,000 and 1.5 µm defocus. Images were digitized using a 
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SCAI scanner (Integraph Coorporation, Huntsville, AL) with pixel size of 0.4 nm on the 
sample.  
   Buffer A:   
5 mM NaPi pH 7.0  
20 mM NaCl  
1 mM MgCl2  
0.1 mM EGTA  
2 mM NaN3 
 
7.9.2 Image Processing 
To reconstruct Eps8 C-terminal domain (residues 535-821) bound to F-actin a modified 
version [77] of the iterative helical real space refinement method [78] was applied in order 
to select filaments that clearly showed decoration by visual inspection. The first step of the 
procedure is the selection of overlapping boxes containing short helical segments. A box 
size of 80x80 pixels with a 0.54 nm pixel size was used. This corresponds to about 15 
asymmetric units of the helix, a little over one actin crossover. An overlap of 60 pixels was 
chosen, allowing every asymmetric unit to contribute to four different views of the helix. A 
total of 36550 units contributed to the average. The twist of the reconstruction refines to 
2.14 subunits per turn, which corresponds to a rotation of -168º between symmetry 
neighbours along the short-pitch helix. Control reconstructions of F-actin alone were also 
calculated resulting in a twist of 2.16 subunits per turn, a rotation of -166.66º. After 
compensating for the difference in twist, the EPS8-decorated and undecorated F-actin 
reconstructions were optimal aligned using the density-fitting module of CoAn [79] and 
difference maps were calculated. 
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7.9.3 Docking and modelling of EPS8 C-terminal domain bound to F-
actin 
The difference density resulting from subtracting the control F-actin reconstruction from 
the Eps8 bound reconstruction was used to dock the atomic model of helices H2-H5 using 
the statistics-based density docking method implemented in CoAn [79, 80]. The statistical 
analysis indicated a rotational degeneracy along its long axis. The H1 model and its 
interactions with actin were taken straight from the Ciboulot crystal structure (1sqk) [81].  
H1 could bind in two ways between subdomains 1 and 3, either with the N-terminal at the 
front or at the back of the actin subunit. Both modes of binding have been observed for 
different actin binding proteins [82]. The modelled configuration (N-terminus at the back) 
is more consistent with the crosslinking studies presented here. The linker was modelled 
directly into the density using PyMOL [83]. Stereo chemistry constraints to avoid clashes 
and ensure connectivity were imposed using REFMAC [84]. Molecular representations 
were generated with Chimera [85] 
 
7.10 C. elegans techniques 
7.10.1 C. elegans strains and mantainment  
Worms were growth at 20°C on NGM agar plates seeded with the Escherichia coli strain 
OP50, a genetic modified bacteria not to overgrowth, under standard laboratory conditions. 
Cleaning worms protocols before performing IF experiments and freezing conditions of 
worm strains were performed following standard protocols listed below. 
 The wild-type C. elegans was variety Bristol, strain N2. 
 The eps-8(by160) strain was previously isolated and characterized in our laboratory [50, 
51]. The DLG-1::RFP strain was kindly provided by Martha Soto (Rutgers University). 
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eps-8(by 160) strains carrying different arrays in DLG-1 ::RFP trensgene-expressing strain 
were obtained by crossing. 
NGM agar plates for growing cultures 
3 gr NaCl, 2.5 gr Bacto-peptone and 17 gr Bacto-agar were dissolved in 800ml dH20. The 
solution was adjusted to a 1L volume and sterilized by autoclaving. After sterilization 1 ml 
of cholesterol (5mg\ml in EtOH), 1 ml CaCl2, 1 ml 1M MgSO4 and 25 ml 1M KH2PO4 
pH6 were added. Each plate was seeded with an overnight colture of E.coli OP50. The 
plates were put at 37°C overnight and then stored at 4°C. 
 
7.10.2 Cleaning worm cultures 
Two alternative procedures were followed. 
Bleaching protocol: 
Plates with many gravid adults and eggs were usually selected for this procedure. Plates 
were washed with dH2O and the worm suspension was transferred to a 15 ml falcon tube. 
Worms were centrifuged at 1500 rpm for 1 min at room temperature. The worm pellet was 
then resuspended into 2.5 ml of dH2O. An equal volume of 2X bleaching solution was 
added and the worm suspension was shacked for 5 min (or until no more worms were 
visible). 
The volume was brought to 15 ml with dH2O and the mixture was centrifuged at 1500 rpm 
for 1 min at room temperature. The worm pellet was washed twice with dH2O. 
Finally the supernatant was discarded and the pellet was resuspended in 50-100 µl of 
dH2O. The egg suspension was plated onto NGM plates seeded with OP50. 
If the bleaching procedure was done in order to obtain a synchronous worm population, the 
egg suspension was left overnight at room temperature to allow hatching. The L1 perfectly 
synchronized were then plated onto NGM plates seeded with OP50. 
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2X Bleaching solution 
250 ml dH2O 
1 ml of Alkaline Hypochlorite 
1.25 ml 2 N NaOH 
Sucrose protocol: 
Worms were washed off from plates with dH2O and placed in a 50 ml falcon tube. The 
worm suspension was putted on ice for 10 min and then centrifuged at 1700 rpm for 2 min 
at 4°C. The cold worm pellet was moved to 15 ml of cold 70% sucrose and a cold 35% 
sucrose was added very carefully in order to let it stratify onto the 70% phase. 
The mixture was then centrifuged for 2 min at 1700 rpm at 4°C. After centrifugation, 
bacteria, debris and dead worms were recovered on the bottom, while cleaned worms 
formed a ring between the 35% and the 70% sucrose solutions. Cleaned worms were taken 
from the ring and washed extensively with dH2O in order to eliminate the residual sucrose.  
 
7.10.3 Freezing worms 
It is important to enrich the worm population in L1 and L2 larvae, which better survive to 
the freezing procedure. Worms were washed off from 1 large plate or 3 medium plates 
with dH2O and then centrifuged for 1 min at 1500 rpm at room temperature. The worm 
pellet was resuspended in 2 ml of dH2O. An equal volume of 2X freezing solution was 
added and the suspension was mixed up well. One ml of the worm mixture was distributed 
in each cryogenic vial (from Nalgene). The freezing vials were moved to styrofoam boxes 
at –80°C, in order to cool worms very slowly. After one week one vial was thawed (just by 
warming the vial between hands) and the surviving rate was verified. If successful, the 
remaining three vials were moved to liquid nitrogen. 
2X Freezing solution: 
    100 mM  NaCl 
    50 mM KH2PO4 
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30 % glycerol 
The solution was prepared in a final volume of 2 L in dH2O and sterilized by autoclaving. 
300µM MgSO4 was then freshly added. 
 
7.10.4 Crossing 
Crosses were carried out by placing few young adult virgin hermaphrodites together with 
an excess of young adult males (3:7 ratio). Small NGM agar plates were used in these 
experiments. Hermaphrodites and males were moved to a new fresh plate every 12 hours, 
at least three times. In the case of successful mating, males will represent half of the 
progeny on the small plate. 
Source of males for crossings. Males are rarely found in a population of self-fertilizing 
hermaphrodites, thus it is necessary to have a source of males when crossing are planned. 
Method 1: crossings between hermaphrodites and the rare males found in the plates were 
performed. The worm population with a high number of males was kept in culture by 
picking few hermaphrodites and a large number of males. Method 2: the spontaneous male 
frequency was increased by heat shock treatment. From 10 to 20 hermaphrodites at mid 
L4 stage were incubated for 6 hours at 30°C, then animals were kept at the usual 
temperature of growth. In the progeny of the heat shocked hermaphrodites the percentage 
of males should be between 2% and 5%. 
 
7.10.5 C. elegans injection 
cDNAs of the wild-type (WT) EPS-8A or mutants were cloned under the intestinal opt-2 
promoter into the pPD95.75 vector that provides a C-terminal GFP tag (kindly provided 
by A. Fire, Stanford University, USA) and sequence verified.  
Mutants were EPS-8A Δcap =  L784E, V788E; EPS-8A Δbund =  L849A, K851A; EPS-
8A ΔcapΔbund =  L784E, V788E, L849A, K851A. 
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EPS-8 constructs were injected into eps-8(by160) heterozygous animals at a concentration 
of 5-20 ng ml-1.  
In details, DNA, coming from a maxi preparation, was centrifuged for 30 min at 4°C to 
pellet down debris and small particles that could clog the needle. 
DNA was injected into the cytoplasm of the syncytial mitotically active gonads, together 
with the ttx-3p::RFP selection marker expressed in the AIY neuron, in order to facilitate 
the identification of the transformants in the progeny. 
Injected animals were single out on different small plates and the F1 generation was 
analyzed for the presence of transformants. After two generations, the injected DNA is 
stably inherited to the progeny through the germline and maintained as an 
extrachromosomal array. 
 
7.10.6 Rescue experiments and phenotypical analysis 
Rescue of lethality was tested in two different transgenic lines for each construct. At least 
100 GFP positive L1 larvae (F1), from heterozygous eps-8 animals (F0), were individually 
plated and allowed to grow and self-fertilize. Rescued homozygous eps-8 mutants were 
recognized by loss of the genetic balancing markers (unc-26, dpy-4) and positivity for 
GFP expression. Confirmation for homozygosity for the mutated eps-8 allele was obtained 
by PCR. Alternatively, the entire progeny (ranging from 30 to 120 F1 animals) of at least 
three heterozygous adults was individually plated and allowed to grow and self-fertilize. 
Rescue of lethality analysis was performed as described above.  
Homozygous eps-8(by160) mutant worms are characterized by intestinal alterations, 
namely paleness, gut constipation, presence of clumped and more refractile gut granules. 
Rescue of this phenotype was scored in live L1/L2 larvae (at least 100) under a Zeiss 
Axioplan 2 plus microscope with Nomarski optics and epifluorescence. For the analysis of 
the gut phenotype in eps-8(by160);[opt-2:EPS-8AΔbund] and eps-8(by160);[opt-2:EPS-
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8A-ΔbundΔcap], homozygous larvae were identified by growth retardation respective to 
siblings in a synchronous F1 progeny from heterozygous worms.  
 
7.10.7 Single worm PCR 
A single worm was transferred into 10 µl of lysis buffer, in a cap of a 0.2 ml tube. After 
spinning it down for few seconds at maximum speed, the animal was incubated at 65°C 1 
hour, then at 95°C 5 min to inactivate the Proteinase K. 
The reaction was cooled to 4°C. The DNA worm preparation was either immediately used 
for a PCR reaction or stored for one night at 4°C. 
For the eps-8(by160) allele, primers used are: 
Forward: 5’-CGCCACTGTCGCAAATTCAAATTAC-3’  
Reverse: 5’-GGATTACATTGTGTTGGGAGC-3’ 
The wt band is 2229 bp, while the deleted one is 730 bp 
Lysis buffer 
50 mM KCl 
10 mM TrisHCl pH 8.3 
2.5 mM MgCl2 
0.45% NP40 
0.45% Tween 20 
0.45% Gelatin 
Before use, Proteinase K was added at a final concentration of 200 µg/ml 
 
7.10.8 C. elegans imaging 
Living animals, anesthetized into 2% of sodium azide, were transferred to a 2% agarose 
pad mounted on a slide, coverslip was then applied.  
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Nomarski and epifluorescence images were acquired on a Leica TCS SP2 AOBS confocal 
microscope. A 633/1.4 NA oil-immersion objective (HCX PL APO 63X Lbd Bl, Leica 
Microsystems) was employed for analysis. Image acquisition conditions were set to 
remove channel crosstalk, optimizing spectral detection bands and scanning modalities. 
Leica Confocal Software and ImageJ were used for data analysis.
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8. RESULTS 
8.1 Eps8 C-terminal region (aa 648-821) binds monomeric ATP 
and ADP actin 
Eps8 is a modular protein with a C-terminal domain (aa 648-821) that mediates the 
interaction with actin filaments and that is responsible for its biochemical activities: 
capping and bundling [50, 73]. This region displays no similarity with other known 
capping proteins or actin binding motifs and its mode of interaction with actin remains thus 
elusive. We investigated whether this region is also able to bind monomeric actin, a 
property that is displayed by several other capping and bundling proteins, such as Gelsolin, 
Twinfilin, and CP [45, 49]. Studying this interaction may provide novel insights into the 
mode of Eps8 association with actin contributing to elucidate Eps8 functions. We tested 
the possibility of an Eps8:monomeric actin interaction by monitoring the ability of the 
Eps8 C-terminal region to bind to fluorescent labelled, monomeric NBD-(7-chloro-4-
nitrobenzofurazan)-actin. In this fluorimetric in vitro assay the binding of a protein to the 
actin monomer can be monitored following the changes in the fluorescence intensity of the 
emission spectrum of the NBD fluorophore that is conjugated with actin. We, thus, 
measured the emission spectra of NBD-actin alone or in the presence of Eps8 (648-821). 
The addition of Eps8 C-terminal region significantly increased (by as much as 20%) the 
NBD-actin fluorescence, in low ionic strength condition (G-buffer), thus indicating its 
ability to bind monomeric actin (Figure 21A).  Dose dependence analysis of the binding 
curves indicated a saturation binding mode, consistent with the formation of a 1:1 complex 
between monomeric actin and Eps8 C-terminal region and an equilibrium dissociation 
constant Kd of 50 nM in low ionic strength conditions (G-buffer) and 1.7 µM, when 
physiological salt conditions (F-buffer) were used (Figure 21B and C respectively). 
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Figure 21: Eps8 C-terminal region (648-821) binds monomeric actin 
A. Fluorescent spectra of NBD-actin in the presence or absence of Eps8 (648-821). 
NBD-labelled actin (1.5µM) was incubated in the absence (red line) or in the presence (blue line) of 200nM 
Eps8 (648-821) for 60 minutes, before recording fluorescent spectra between 480nm and 600nm of 
wavelength.  
B-C. Binding affinity of Eps8 (648-821) for monomeric actin. 
(B) The change in fluorescence of 0.1µM NBD-Actin-actin was measured at different concentrations of Eps8 
(648-821) in low salt (G-buffer).   
(C) The change in fluorescence of 0.1µM NBD-Actin-actin was measured at different concentrations of Eps8 
(648-821) in high salt (F buffer) containing 0.1 M KCl and 1 mM MgCl2.  
Symbols indicate data; solid line indicates fitted binding curve for a complex with a 1:1 stoichiometry. The 
curve is calculated using the equation 1 in the “Experimental Procedure”. 
 
Monomeric actin can be present in the cell in an ATP or ADP bound state. Several 
monomeric actin binding proteins show a preferential interaction with either ATP or ADP 
actin, that often correlates with their cellular role [86]. We thus tested whether also the 
Eps8 C-terminal region could bind preferentially one of the two nucleotide bound forms of 
actin, monitoring the binding capacity of the C-terminal region of Eps8 to either ATP or 
ADP bound NBD-labelled actin. We score similar Kds values for both ADP and ATP actin 
(Kd = 120 nM and Kd = 75 nM respectively), indicating a similar affinity of Eps8 for both 
nucleotide-bound forms of actin (Figure 22A).  
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Figure 22: Eps8 (648-821) binding to ADP\ATP actin 
A. Eps8 (648-821) binds ATP or ADP monomeric actin with the same affinity. 
The change in fluorescence of 1.5 µM NBD-ADP-G-actin (blue line, closed squares) or NBD-ATP-G-actin 
(red line, closed circles) was measured at different concentrations of  Eps8 (648-821), in G-buffer. ATP to 
ADP exchange was performed using Hexokinase in the presence of 10 mM MgCl2 and 1 mM glucose. 
Symbols indicate data; solid lines indicate fitted binding curves for a complex with 1:1 stoichiometry.  The 
affinity constants calculated from these plots using the equation described in “Experimental Procedures” 
were Kd(ATP-Ca-G-Actin) = 75 nM,   Kd(ADP-Ca-G-Actin) = 120 nM.    
B. Eps8 (648-821) inhibits the dissociation of ATP from ATP-G-Actin.  
ATP-G-actin (2 µM, in G-buffer containing 20 µM of CaCl2) was supplemented with the indicated 
concentrations of Eps8 (648-821). The dissociation of bound ATP was monitored by adding 5 µM of εATP 
at time 0 and recording the subsequent increase of fluorescence of εATP. The pseudo-first order exchange 
rate constant is plotted versus the total concentration of Eps8 (648-821). 
 
Different G-actin binding domains are also able to modify the nucleotide dissociation rate 
from G-actin. WH2 or ADF homology domains, for instance, decrease the nucleotide 
dissociation rate from G-actin, while others, like profilin, enhance it. Among capping 
proteins, Twinfilin inhibits the nucleotide exchange from ADP-G-actin [87], whereas 
Gelsolin blocks nucleotide exchange from ATP-G-actin [88]. The presence of this effect 
on nucleotide dissociation rate upon binding could give thus also an indirect indication on 
the kind of structural interaction of a protein with the actin monomer. We tested the effect 
of Eps8 (648-821) on nucleotide exchange by monitoring the association of a fluorescent 
ξ-ATP analogue to ATP-G-actin. Eps8 (648-821) significantly diminished the nucleotide 
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exchange rate on G-actin by 5-fold (Figure 22B), similarly to what has been reported for 
the WH2 containing protein Ciboulot [89]. These results suggest that the Eps8 (648-
821):G-actin complex shares biochemical and, likely, structural features with G-actin in 
complex with either WH2 domains, S1-gelsolin, or Twinfilin. 
 
8.2 Eps8 C-terminal region (aa 648-821) and monomeric actin 
form a 1:1 complex 
We decided to further investigate the stochiometry of the Eps8 (648-821)-actin complex in 
other to confirm the 1:1 ratio that the fluorimetric experiments indicated. 
We used two independent techniques: a chemical cross-linking analysis and size-exclusion 
chromatography. 
In the first approach, we crosslinked either Eps8 (648-821) or actin alone, or the two 
proteins together, for different time points. At the end of the reaction we could detect a 
single band, only when both proteins were incubated together. This single covalently 
cross-linked protein had a size of ∼ 60 KD, equivalent to the sum of the molecular weights 
of Eps8 (648-821) and monomeric actin (Figure 23) and was thus a further indication of a 
1:1 ratio of the complex. 
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Figure 23: Eps8 (648-821) forms a 1:1 complex with monomeric actin 
Chemical crosslinking between Eps8 (648-821) and monomeric actin.  
10 µM Eps8 (648-821) and actin, either alone or in combination, were incubated for various lengths of time 
in the absence or in the presence of PPDM, separated by SDS-PAGE and detected by Comassie blue 
staining. Lines 1,2,3: 10µM of Eps8 (648-821) incubated in the absence (Lane 1) or in the presence of the 
crosslinker for 5 min (Lane 2) or 15 min (Lane 3); Lanes 4,5,6: 10µM of actin incubated in the absence (Lane 
4) or in the presence of the crosslinker for 5 min (Lane 5) or 15 min (Lane 6); Lanes 7,8,9: 10µM of Eps8 
(648-821) and actin incubated in the absence (Lane 7) or in the presence of the crosslinker for 5 min (Lane 8) 
or 15 min (Lane 9). 
 
We then used a gel filtration analysis in order to investigate the elution profile of the two 
proteins, either alone or in combination. When we run Eps8 (648-821) or G-actin alone, 
the two proteins eluted in distinct fractions, according to their respective molecular weight. 
Conversely, when mixed in a 1:1 molar ratio, they co-fractionated, forming a stochiometric 
complex. Addition of two fold molar excess of Eps8 (648-821) saturated the amounts of G-
actin and the excess of the former eluted with the expected retention volume (Figure 24). 
Collectively, all these experiments demonstrate the formation of a complex between actin 
and Eps8 C-terminal region with a 1:1 stochiometry.  
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Figure 24: Eps8 (648-821) and actin form 
a 1:1 complex in gel filtration 
Eps8 C-terminal domain and actin co-elute 
in gel filtration forming a 1:1 complex.  
Size exclusion chromatography experiment 
on a Superdex 200 10/30 column in G 
buffer (2mM TRIS pH 7.8, 0.2mM ATP, 
1mM DTT, 0.1mM CaCl2). Purified Actin 
and Eps8 (648-821) were analyzed by gel 
filtration either alone (blue and black line, 
respectively) or after pre-incubation on ice 
for 1h in a 1:1 or 1:2 molar ratio (red and 
green line respectively). In each case, 30µL 
fractions were collected and analyzed by 
Comassie staining on 10% SDS-PAGE gel 
that is shown beneath the elution profile. 
 
 
 
 
 
 
8.3 Eps8 C-terminal region sequesters monomeric actin 
The formation of an Eps8 (648-821):G-actin complex prompted us to revisit the effect of 
Eps8 (648-821) on actin assembly. Actin filaments expose ATP-actin monomers at the 
plus end, while at the minus ends monomers are in an ADP bound state. Due to the 
capability of Eps8 to bind both ATP and ADP actin, Eps8 could in principle affect 
filaments assembly at both ends of the filament. We thus measured Eps8 (648-821) activity 
on both extremities. At the plus end Eps8 is known to act as a capping protein [50].  
 We used spectrin actin seeds, purified actin oligomers with blocked pointed, but free 
barbed ends, to follow its capping activity. As previously reported, Eps8 (648-821) capped 
the plus ends of actin filaments with nM affinity (Kcap = 15nM) (Figure 25).  
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To monitor Eps8 effect at the other side of the filament, we used instead gelsolin actin 
seeds, which have blocked barbed but free pointed ends. Eps8 (648-821) also inhibited, in 
a concentration-dependent fashion, actin polymerization from pointed ends. In this latter 
case, however, stoichiometric concentrations of Eps8 (648-821) with respect to G-actin 
were required, with an apparent Ki (Constant of inhibition) of Eps8 (648-821) for pointed 
end filament growth of around 2.5 µM (Figure 25). Under these conditions, an Eps8 (648-
821):G-actin complex is formed that cannot be incorporated into a nascent filament; the 
complex, thus, fails to support pointed end growth, and this is reflected in the sequestration 
of monomeric actin.  
 
Figure 25: Eps8 (648-821) affects actin growth both at 
the plus and at the minus end 
Barbed and pointed end elongation rate of actin in the 
presence of Eps8 (648-821).  
The rate of elongation was measured from pointed ends 
(circles), using gelsolin-actin seeds (5nM) and 2 µM of 
G-actin (10% pyrenyl-labeled), or from barbed ends 
(triangles) using spectrin-actin seeds, in the presence of 
increasing concentrations of Eps8 (648-821), as 
indicated. Rates are normalized taking as 100 % the rate 
of elongation from either pointed or barbed ends 
measured in the absence of Eps8 (648-821). 
 
We thus showed that the C-terminal region of Eps8 (648-821) is able to bind monomeric 
actin and shares some properties of the WH2 actin binding domains. The formation of an 
Eps8:G-actin complex leads to the sequestering of the actin monomer that can not be 
incorporated in the filament any more. 
 
Results 
Milanesi Francesca PhD thesis 99 
8.4 The minimal actin binding region of Eps8 C-terminal 
domain encompasses its amphiphatic H1 helix 
The C-terminal region of Eps8, that has no homology with any other actin binding domain, 
is very conserved among Eps8 homologues and hortologues (Figure 26). 
 
 
Figure 26: Eps8 C-terminal region (648-821) is highly conserved 
Sequence comparison and secondary structure predicted organization of the Eps8 actin binding domain.  
Multiple sequence alignment of a collection of the C-terminal regions of Eps8 and its homologues. Protein 
sequences were aligned using the ClustalW program. Manual adjustments were introduced on the basis of 
secondary structure information, and the picture was produced using Jalview. Secondary structure prediction 
was made by using the prediction server SAM-T99. On top, a schematic organization into the predicted 
helices of the C-terminal actin binding domain of Eps8 is shown. Numbers indicate murine aa. 
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Due to this sequence similarity the secondary structure prediction is the same for the 
different Eps8 homologues. The domain is predicted to be organized in five α-helices, with 
a long linker connecting the first helix (H1) to the second one. An exception is represented 
by  Eps8L3 proteins, which have a shorter domain lacking the first H1 helix and part of the 
linker region.  Consistently, this member of the family is devoid of actin capping activity 
[50]. In order to investigate the minimal regions of the domain implicated in the binding to 
monomeric actin we created different fragments encompassing the different helices, alone 
or in combination, and we tested them for their ability to bind monomeric actin using 
NBD-labelled actin as a probe (Figure 27A). We discovered that the fragments 
encompassing the first two helices of the domain, H1-H2 (residues 674-737), and the last 
helix of the domain, H5 (residues 765-788), are the minimal fragments capable of 
increasing NBD-actin fluorescence by 17% and 12% respectively (Figure 27B). Next, we 
performed a dose response experiment using different concentrations of the two proteins in 
order to determine the affinity of these fragments for monomeric actin. The H1-H2 
fragment displays a high affinity for monomeric actin (Kd = 50nM), similar to the affinity 
of the whole C-terminal region (Figure 27C). The H5 helix displayed instead a lower 
affinity (Kd =3µM) (Figure 27D). Due to the formation of a 1:1 complex between actin 
and Eps8 (648-821), and to the similar affinity of the H1-H2 fragment and the whole C-
terminal domain for G-actin, we concluded that the H1-H2 region represents the major 
surface of interaction between Eps8 and the actin monomer, and that the interaction that 
we see with the H5 could probably be hidden in the context of the whole C-terminal 
domain.  
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Figure 27: Eps8 (648-821) possess two monomeric actin binding surfaces: H1-H2 and H5  
Summary of the binding ability of various helices of Eps8 (648-821) to G-Actin.  
A. The change in fluorescence of 1.5 µM NBD-Actin-actin was measured in the presence of the indicated 
Eps8 fragments in G-buffer. A change in fluorescence caused by the formation of the complex between actin 
and Eps8 fragments of at least 10% with respect to actin alone was scored as positive (+). 
B. Fluorescent spectra of NBD-actin in the presence or absence of either H1-H2, or H5 or Eps8 (648-821). 
Monomeric NBD-labelled actin was incubated in the absence (red line) or the presence of 20 µM of Eps8 
(648-821) (blue line), or H1-H2 (light blue line) or H5 (violet line) for 60 min, before recording fluorescent 
spectra between the indicated wavelengths.  
C, D. HI-H2 and H5 bind G-actin in a concentration-dependent manner. 
The change in fluorescence of 1.5 µM NBD-Actin-actin was measured at different concentrations of either 
H1-H2 (C) or H5 (D), in low salt (G buffer). Symbols indicate data; solid lines indicate fitted binding curves 
for a complex with 1:1 stochiometry.  
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To further characterize both fragments we decided to investigate their biochemical 
activities towards the two ends of the actin filament.  
The H1-H2 fragment was able to inhibit actin polymerization at both ends of the filament. 
At the plus end substochiometric amount of H1-H2 were able to completely block actin 
polymerization, with a calculated Kcap of 200nM (Figure 28A). This result indicates that 
H1-H2 is still able to cap in a significant way actin filaments, even if the lower activity 
with respect to the wt protein suggests that other structural determinants are likely involved 
in the capping of the filaments. Sequestration of ATP-G-actin by H1-H2, instead, 
completely accounted for the concentration dependent inhibition of pointed ends growth, 
in a stochiometric range of concentrations with respect to G-actin, with a Kseq of 2.5µM, 
identical to that calculated for the Eps8 (648-821) (Figure 28A).  
H5 was also able to inhibit actin filaments growth at the 2 ends of the filament. In this 
case, however, the thermodynamic parameters of inhibition were in the micromolar range 
(Kseqpointed = 32µM; Kcapbarbed = 40µM) indicating that supra-stochiometric amounts of 
H5 were required to block filament end growth, consistent with low sequestering activity 
(Figure 28B).  
To provide additional evidence that low affinity binding to filaments did not accounted for 
the observed inhibition, we performed barbed end polymerization assays at two different 
actin concentrations. Higher concentrations of H5 were required to inhibit polymerization 
when the concentration of G-actin was increased from 2 to 4 µM, accounting for the shift 
toward the right of the curves (Figure 28C). This result demonstrated that the inhibition by 
H5 is solely dependent on its ability to sequester monomeric actin and is not due to low 
affinity binding to filament ends. 
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Figure 28: H1-H2 and H5 influence the actin filaments elongation rate with different thermodynamic 
constants  
A, B. H1-H2 and H5 inhibit barbed and pointed end elongation rates with different thermodynamic constants.  
The rate of elongation was measured from pointed ends (circles), using gelsolin-actin seeds (5nM) and 2 µM 
of G-actin (10 % pyrenyl-labeled), or from barbed ends (triangles), using spectrin-actin seeds (2nM), in the 
presence of increasing concentrations of H1-H2 (A) or H5 (B), as indicated. Rates are normalized taking as 
100 % the rate of elongation measured in the absence H1-H2 or H5. Kds are reported in the text. 
C. H5 sequesters G-actin, but does not cap filaments ends.  
The rate of elongation from barbed ends was measured using actin seeds and 2 µM (closed triangles) or 4 µM 
(opened triangles) of G-actin (10 % pyrenyl-labeled) in the presence of increasing concentrations of H5. A 
shift toward the left of the rate of elongation by H5 as the concentration of G-actin used increased indicates 
that stoichiometric concentrations of H5 with respect to actin are required for the inhibition. 
 
Collectively, these data indicate that Eps8 C-terminal region binds monomeric actin 
mainly through a surface that encompasses the two first helices of the domain, H1-H2. 
This region retains also a significant capping activity and is thus probably binding actin 
monomers in a region that is exposed at the plus end thus blocking the further addition of 
actin subunits in the filament. The H5 shows instead a low binding to the actin monomer, 
is not able to cap actin filaments and retains only a low sequestering activity. This helix is 
thus likely to represent a secondary site of binding in the context of the full-length protein, 
contributing in Eps8 stabilization at the plus end of the filament.  
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8.5 The Amphiphatic H1 helix of Eps8 contacts the hydrophobic 
pocket between subdomain 1 and 3 of the actin monomer 
Our results indicated that the main surface of interaction between Eps8 C-terminal region 
and the actin monomer is represented by the H1-H2 fragment. Remarkably, sequence 
analysis of the single helices encompassing this minimal active fragment of Eps8, revealed 
that H1 helix possess all the feature of a WH2-like domain. WH2 domains consist of an α-
helix, with a few exposed hydrophobic side chains [82]. Similar features are shared by H1 
helix, which forms a short amphiphatic helix thus representing a WH2-like motif (Figure 
29).  
 
 
Figure 29: Helical wheel analysis of the predicted helix H1 of Eps8 
Eps8 H1 helix is predicted to be amphipathic. 
Left: alignment of mouse Eps8 H1 helix with the WH2 domains of either human Thymosin β-4 and 
Drosophila Ciboulot. 
Right: helical wheel analysis of the amphipathic helices of mEps8, hThymosin β-4 and DCiboulot. The helix 
is projected along its axis going into the page. The hydrophilic residues are presented as circles, hydrophobic 
residues as diamonds, potentially negatively charged as triangles, and potentially positively charged as 
pentagons. Hydrophobicity is colour coded as well: hydrophobic residues are green, hydrophilic residues are 
coded blue with the potentially charged residues in light blue.  
 
WH2 domains usually contact actin on a hydrophobic cleft present between subdomain 1 
and 3 of the actin monomer. This cleft is exposed at the plus end of the filament being a 
key point of interaction between monomers within the filament.  
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The binding to this cleft can, thus, provide a way to cap filament ends preventing the 
addition of new actin monomers.  
We thus investigated whether Eps8 binds to this cleft similarly to other WH2 domain 
containing proteins. To this end, we performed competition assays using NBD-labelled 
actin and saturating amounts of proteins that are known to bind the hydrophobic actin cleft, 
such as Ciboulot and Tymosin β−4 (which binds through a WH2 domain) or ADF/Cofilin 
[82, 90]. NBD-G-actin saturated with either Thymosin β-4 or Ciboulot displayed levels of 
fluorescence higher than NBD-G-actin in complex with Eps8 (648-821). The addition of 
increasing concentrations of Eps8 (648-821) to either Thymosin β-4:NBD-G-actin or 
Ciboulot:NBD-G-actin led to a decrease in fluorescence to levels consistent with the 
displacement of these proteins from actin and the concomitant formation of a Eps8(648-
821):actin complex (Figure 30A,B). Similarly, Eps8 (648-821) competed with ADF/cofilin 
for binding to ADP-G-actin. Binding of ADF/cofilin did not significantly affect the 
fluorescence of NBD-ADP-actin, but caused a large increase in the apparent Kd for 
binding of Eps8 (648-821) (Kd Eps8 648-821 = 50nM and Kd = 5µM in the absence and in 
the presence of Cofilin respectively) (Figure 30C). Thus, Eps8 (648-821) competes with 
Thymosin β-4, Ciboulot and ADF/cofilin for binding to monomeric actin, suggesting that 
the three proteins share the same interaction surfaces. We performed similar assays 
utilizing Ciboulot and either the isolated H1-H2 or H5. Only H1-H2, but not H5, displaced 
Ciboulot from actin (Figure 30D,E).  
These results suggest that the two Eps8 fragments, H1-H2 and H5, bind actin on two 
different surfaces, and that the H1-H2 region contacts the hydrophobic cleft on the actin 
monomer similarly to a WH2 domain. To further validate a bivalent mode of interaction of 
Eps8, we performed a competition experiment between the two isolated Eps8 fragments 
and actin. H1-H2 bound NBD-G-actin with identical affinity in the absence or presence of 
H5, at low ionic strength (Figure 30F) in keeping with the notion that the two regions bind 
to different actin surfaces. Notably, the increases in fluorescence of NBD-actin due to the 
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binding of H5 and of H1-H2 are additive, consistent with simultaneous binding of the two 
fragments. 
 
Figure 30: Eps8 (648-821), Thymosin β4, Ciboulot and ADF/Cofilin share common binding surfaces on 
actin 
A-C. Eps8 (648-821) competes with Thymosin β-4, Ciboulot and ADF/Cofilin for binding to monomeric 
actin.  
The change in fluorescence of 1.5 µM NBD-Actin-actin was measured in the presence of the indicated, 
increasing concentrations of Eps8 (648-821) and/or saturating amounts (25 µM) of either Thymosin β-4 (A), 
Ciboulot (B), or ADF/Cofilin (C) in low salt buffer (G-buffer). In the case of ADF/Cofilin (C), NBD-ADP-
actin was used. 
D, E. H1-H2, but not H5 competes with Ciboulot for actin binding.  
The change in fluorescence of 1.5 µM NBD-Actin-actin was measured in the presence of the indicated, 
increasing concentrations of Eps8 H1-H2 (D) or H5 (E) helices alone or together with saturating amounts (25 
µM) of Ciboulot, in low salt buffer (G-buffer). 
F. H5 and H1-H2 do not compete for binding to monomeric actin.  
Change in fluorescence of NBD-Actin-actin in the presence of increasing concentrations of Eps8 helices 
(H1-H2) alone or together with saturating amounts (25 µM) of Eps8 (H5) in low salt buffer (G-buffer).  
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We validated our findings by using also another type of labelled actin, 5-
(2((acetyl)amino)ethyl)amino-naphthalene-1-sulfonate (AEDANS)-Actin-G-actin, in an 
high salt buffer, which reassemble the physiological situation. Under these conditions we 
could confirm the competition between Thymosin β-4 and either Eps8 (648-821) or H1-H2 
(Figure 31A,B). In high salt however the interaction between actin and H5 was very weak 
and could not reliably be monitored. Thus, we were unable to perform competition assays 
using this Eps8 fragment.   
 
 
 
Figure 31: Competition experiments between Eps8 and Thymosin β4 for actin binding 
A. Eps8 (648-821) competes with Thymosin β4 for AEDANS actin binding at high salt (F-buffer).  
The change in fluorescence of 1.5 µM AEDANS-Actin-actin was measured in the presence of increasing 
concentrations of Thymosin β4 and 0, 15 µM or 30 µM of Eps8 (648-821) in 0.1M KCl and 1mM MgCl2. 
Under these conditions, the Kd of Thymosin β4 is 3 µM, and the Kapp (K apparent) are 9 µM and 14 µM in 
the presence of 15 µM and 30 µM of Eps8 (648-821), respectively.  
B. The H1-H2 fragment is sufficient to compete with Thymosin β4 for binding to monomeric actin.  
The change in fluorescence of 1.5 µM AEDANS-Actin-actin was measured at increasing concentrations of 
Thymosin β4 and 0, 10 µM or 15 µM of H1-H2 in presence of 0.1M KCl and 1mM MgCl2. In these 
conditions, the Kd of Thymosin β4 is 3 µM, and the Kapp (K apparent) are 6 µM and 11 µM in the presence 
of 10 µM and 15 µM of H1-H2, respectively.  
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To obtain direct validation of our findings with an independent approach, we performed 
mass spectrometry analysis after crosslinking of actin and Eps8 (648-821).  
We generated isopeptide bonds between side chains of actin and Eps8 (648-821) by 
incubating these proteins alone, as a control, or in combination with a crosslinking agent 
(see Matherials and Methods). SDS-PAGE separation of the resulting reaction products, 
revealed two slower-migrating protein species, only when Eps8 (648-821) and actin were 
simultaneously present in the crosslinking mixture (Figure 32A). We isolated these 
products and subjected them to mass spectrometry analysis (Figure 32B). A number of 
Eps8-actin, crosslinked peptides could be identified (Figure 32C). All actin-derived 
peptides contained either K330, located in subdomain 3, or K375, located in subdomain 1, 
whereas, Eps8-derived fragments contained K675 and K683, which are located just before 
or in the predicted H1, respectively, or K707, located in the linker region connecting the 
predicted H1 and H2 (Figure 32D).  
These results are in good agreement with our biochemical mapping, confirming the 
binding between the Eps8 region encompassing the H1-H2 helices and the subdomain 1 
and 3 of actin. These findings corroborated the notion that H1 helix plugs into the 
hydrophobic cleft of the actin monomer, similarly to a WH2 domain. 
Notably, we isolated also one crosslinked peptide that is the result of an intramolecular 
interaction within Eps8 (648-821), occurring between H1 and the linker region, thus 
suggesting the possibility that these regions of Eps8 may fold one over the other in a 
configuration that may be relevant for regulation of the protein activity.  
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Figure 32: Mapping of the interaction surfaces between Eps8 (648-821) and G-actin by mass 
spectrometry 
A. Crosslinking of Eps8 (648-821) and actin.  
Eps8 (648-821) and actin, either alone or in combination, were incubated in the absence (-) or presence (+) of 
BS2-GD4 (Bis(sulfosuccinimidyl02,2,4,4-glutarate-d4), as a crosslinker, for 45 min. The reaction products 
were separated by SDS-PAGE and detected by Coomassie blue staining (shown in greyscale). Two cross-
linked protein bands, indicated as 1 and 2, were specifically detected only when actin and Eps8 (648-821) 
were concomitantly incubated with the cross-linker.  
B-D. Identification of Eps8 (648-821)-Actin chimaeric peptides by mass spectrometry.  
B. Eps8 (648-821) and G-actin were incubated in the absence (-) or presence (+) of the crosslinking agent, as 
described above. The two indicated cross-linked species were subjected to mass spectrometry analysis.  
C. Table summarizing the sequences of peptides derived from mass spectrometry analysis of gel band 1 and 
2 of the Eps8 (648-821):G-actin complex or of Eps8(648-821), containing crosslinked lysines (K). Numbers 
on the left indicate the number of times the peptide was found in a typical mass spectrometry analysis.  
D. The positions of BS2G-d0-cross-linked Lysine residues of the peptides identified by mass spectrometry 
on actin are indicated in red and circled.  The corresponding crosslinked Lysines of H1 and H2 helices of 
Eps8 (648-821) are indicated at the bottom. Actin subdomains (1-4) are also indicated. 
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8.6 H1 is connected to the H2-H5 globular core via a cleavable 
linker 
In order to better understand the way of binding of Eps8 on the actin filaments we set out 
to obtain structural information on the three dimensional organization of murine Eps8 C-
terminal region. 
To this end, we took advantage of a recently solved NMR structure of the C-terminal 
region of human Eps8L2 (residues 612-697, 1WWU), a member of the Eps8L family 
protein [91] and of human Eps8 (residues 699-784, 2E8M) (Figure 33), deposited in the 
PDB database (Structural genomic program- RIKEN Genomic Sciences Center, 
Yokohama 230-0045, Japan).  
 
 
Figure 33: Modelling Eps8 tertiary structure 
Ribbon diagrams of the resolved, NMR, tertiary structures of the C-terminal region of human Eps8 (aa 699-
784) (PDB ID: 2E8M), human Eps8L2 (aa 612-697) (PDB ID: 1WWU) and of the predicted tertiary 
structure of the C-terminal region of murine Eps8 (703-794) obtained by Phyre software. Please note that in 
the NMR structures of human Eps8 (PDB ID: 2E8M) and Eps8L2 (PDB ID 1WWU) the linker, L1, appears 
in a disorder state suggesting that is not part of the compact globular core (not shown). 
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These fragments, which include the most C-terminal four helices, H2 to H5 (Figure 26), 
fold into a globular, helical core. Notably, murine and human Eps8 C-terminal actin 
binding domains are nearly identical predicting that they adopt a similar fold. Structural 
atomic modelling using the Phyre software (Protein Homology/analogy Recognition 
Engine) confirmed this prediction (Figure 33, right). Conversely, the absence of 
experimental structural information on the first α-helix of Eps8 and Eps8L2 prevented 
modelling the folding of this helix with respect to the globular core. This region of Eps8 
appears connected to the core helical bundle by an unstructured and presumably flexible 
linker of 20 residues (Figure 26). This latter notion is supported by the observation that in 
the more closely related ESP8 and EPS8L2 NMR structures (PDB ids 2E8M, 1WWU), the 
linker is in a disordered state and not part of the compact core. We also performed a 
limited proteolysis experiment in order to identify regions of the protein that are resistant 
to digestion, meaning that they adopt a compact conformation. Limited proteolysis of Eps8 
(648-821) resulted in the generation of a fragment encompassing the proteolytic-resistant, 
helical globular core, which is, thus, connected by an exposed, cleavable linker to H1 
(Figure 34), confirming the hypothesis derived from the structure. 
 
Figure 34: Limited proteolysis analysis of the C-terminal Eps8 fragment 
Limited proteolysis of the C-terminal Eps8 fragment shows a major band of degradation. 
Eps8 (648-821) (0.5 mg/ml) was digested with chymotrypsin (CT), trypsin (T), Elastase (EL) and proteinase 
K (PK) at the dilution 1/10000 in the buffer (50 mM Tris pH 7.5; 50 mM NaCl; 1 mM DTT) for the indicated 
time at room temperature. Digestion was terminated by the addition of phenylmethylsulfonyl fluoride (1 
mM). Aliquots of the protelytic peptides were resolved by SDS-PAGE and stained with Coomassie Blue. 
The proteolytic-resistant fragments, indicated by boxes, were subjected to N-terminal sequencing. The 
resulting amino acid sequence is reported at the bottom.  
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8.7 The Eps8 actin binding domain wraps around actin 
filaments 
Next we decided to investigate how Eps8 could bind actin filaments. To answer this 
question we adopted a combination of electron microscopy, three-dimensional image 
reconstruction and modelling. We performed EM experiments using actin filaments and 
Eps8. In order to visualize Eps8 bound on the filaments we used a fragment of the protein 
that span residue 535 until the end of the protein thus encompassing not only the C-
terminal actin binding region, but also the SH3 domain of Eps8. The presence of this 
additional portion of the protein did not interfered with our structural analysis. 
Additionally, it had been already previously demonstrated that this fragment possessed the 
same biochemical characteristics of the C-terminal region of Eps8, and moreover that the 
SH3 domain itself could not bind actin [50]. Eps8 bound on the filaments was clearly 
visible in the EM images (Figure 35A). By subtracting the density of the undecorated 
filaments from the one in the presence of Eps8 we were able to obtain the extra density due 
to the presence of Eps8 on the filaments (depicted in red, Figure 35A). The difference 
density partitions into two main regions (Figure 35B). One part forms a big lobe that 
contacts three actin subunits; one subunit is mainly contacted at the back of subdomain 1 
and 2 (grey subunit), one on the back of subdomain 3 (blue subunit) and one on the top of 
subdomain 4 (yellow subunit). The second region is located on the hydrophobic pocket 
present between subdomain 1 and 3 of the actin monomer. The third small density finally 
connects the other two contacting a region between the subdomains 3 and 4 of the actin 
monomer. We next docked into these densities our structural model for the C-terminal 
region of Eps8 (see material and methods section).  
In the first density we could accommodate the structure corresponding to the H2-H5 lobe, 
while the H1 helix could be placed in the density that contacts the cleft between subdomain 
1 and 3 on the actin monomer, in agreement with our biochemical predictions. In the 
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absence of structural information on this H1 helix, the H1 model and its interaction with 
actin were taken from the ciboulot crystal structure (PDB code 1sqk) [81] due to the 
already described similarity between the two proteins (Figure 29). Finally the linker 
connecting H1 and H2 could be docked into the third density that contact the region 
between subdomain 3 and 4 of the actin monomer. We could also observe an extra density 
region (showed by the arrow in Figure 35B), which accounted for the additional part of the 
protein that was not directly contacting the filament.  
 
 
Figure 35: Three-dimensional reconstruction of Eps8 (535-821) bound to actin filaments 
A. Three-dimensional reconstruction of Eps8 (535-821) bound to actin filaments by EM.  
A reconstruction of undecorated actin filaments is shown for reference on the left, the reconstruction of actin 
filaments with bound Eps8 is shown on the right. The four actin subdomains are marked on one actin subunit 
on the filament reconstruction. The difference map corresponding to actin-bound Eps8 (535-821) is 
highlighted in red. Representative images of undecorated actin (left) and actin decorated with Eps8 (535-821) 
(right) are also shown. Some of the more obvious attached Eps8 (535-821) particles are marked by red 
arrowheads.  
B. Difference map generated by subtracting the undecorated actin filament reconstruction from the 
reconstruction of the Eps8 (535-821) bound to actin filaments (grey transparent surface).  
For clarity, only one asymmetric unit along the filament is shown. Two views, related by a 60º counter 
clockwise rotation around the filament axis, are shown. The pointed end is to the top of the figure. Three 
actin subunits (blue, yellow and light grey surfaces) are shown for reference. Subdomains 1-4 are labelled on 
the actin subunits. The difference density partitions into two main regions. At lower contour levels, these 
parts are connected by a bridge of density. The docked model of Eps8 (648-821) is shown in red cartoon 
representation.  
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This structural reconstruction is also in agreement with our mass spectrometry data (Figure 
32D); the residues crosslinked in the mass spectrometry analysis are indeed in 
juxtaposition in our model. 
We could also observe a change in the twist of the filament upon Eps8 binding, going from 
2.14 to 2.16 subunits per turn. This indicates that Eps8 binding interferes with the contact 
between adjacent actin subunits within the filament. 
We thus obtained structural information regarding the way of binding of the C-terminal 
region of Eps8 on the filaments, showing that the H2-H5 lobe and the H1 helix represent 
the 2 major surfaces of interaction between the two proteins, with the H1 binding the 
hydrophobic cleft between subdomain 1 and 3 as predicted by the biochemical analysis. 
This reconstruction suggested once more that the H1 helix is critical in mediating the 
capping activity of the protein blocking the further addition of actin monomers to the 
filament.  
 
8.8 Eps8 capping and bundling activities can be biochemically 
dissected 
Looking at Eps8 bound on actin filaments by EM we detected two major interaction 
surfaces, connected via a flexible linker. One of these surfaces is represented by the H1 
helix of the C-terminal region of the protein, and contacts actin between subdomain 1 and 
3, in the cleft that is exposed at the plus end of filaments. The other surface is composed by 
the H2-H5 lobe, and contacts the actin filament mainly on the side, interacting with 3 
different monomers.  
Eps8 can either cap barbed ends or crosslink actin filaments. The distinct topological 
distribution of the two surfaces of Eps8 on actin suggests the possibility that each of them 
may be specifically involved in mediating either capping or bundling. Indeed, filament 
capping is generally achieved by preventing the further addition of new monomers at the 
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end of the filaments, while in order to bundle actin proteins should contact the side of 
adjacent filaments crosslinking them together.  Due to the incapability of the H1 helix 
alone to cap and bind actin, we also reasoned that the interaction mediated by the linker 
may primarily stabilize the binding of both the H1 and the lateral lobe, rather than directly 
participating in blocking monomer association.  
We tested this hypothesis by generating mutants that selectively and specifically 
compromise one of the surfaces of interaction between Eps8 and actin. To this end, we; i) 
generated a mutant in the linker region (R706A, F708A, hereon refereed as linker mutant), 
which might weaken both protein functions as it may serve to stabilize the binding of Eps8 
C-terminus around filament ends; ii) generated a double mutant (V689D, L693D, herein 
referred to as H1 or Δcapping mutant) in which we substituted two hydrophobic residues 
with two charged amino acids in order to destroy the non polar side of the amphipathic 
helix that is predicted to bind the hydrophobic actin cleft; iii) we identified within the H2-
H5 lobe a motif (LNKDE, aa 757-761) that resembles the F-actin binding site of the Villin 
head piece domain (herein refereed to as Villin-like motif) [9]. Within this motif we 
mutated two residues that had been described as critical in mediating the interaction 
between actin filament and Villin, generating a mutant L757A-K759A, that we called 
Villin-like or Δbundling mutant. Finally, as a control, we also generated a double mutant in 
H1 and in the Villin like motif, that we called ΔcappingΔbundling mutant. We engineered 
these mutants in the contest of the C-terminal region of Eps8 (aa 648-821) fused to a GST 
moiety. This latter strategy was prompted by the observation that the crosslinking activity 
of the Eps8 C-terminal region is dependent on the presence of GST, which drives the 
formation of dimers (see below). Accordingly, we detected bundling of actin filaments 
only when Eps8 C-terminal fragments were fused to GST, (Figure 36) using low speed 
cosedimentation assays. 
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Figure 36: Dimerization drives Eps8 (648-821) bundling activity 
The F-actin bundling ability of GST-Eps8-WT or Eps8-WT GST cleaved was determined by low speed co-
sedimentation assays. F-actin (1 µM) was incubated either alone or in the presence of the indicated 
concentrations of GST, as control, or GST-fused Eps8 (648-821) or Eps8 (648-821) cleaved from the GST 
moiety. The mix was subjected to centrifugation at 10000 xg for 30 min. Aliquots of the pellet (P) and 
supernatants (S) were analyzed by immunoblotting.  
 
 
We obtained similar results also employing a fluorescent-based in vitro assay of actin 
bundling. To this end, we incubated Eps8 (648-821) either cleaved from or fused to GST, 
together with F-actin. We then stained the filaments using rhodaminated-phalloidin to 
reveal the presence of bundles. Only GST-fused Eps8 caused the formation of prominent 
actin bundles (Figure 37). One possible explanation of these results is suggested by the fact 
that the GST moiety is a dimer [92], which might be necessary to enable two molecules of 
Eps8 to bind, and subsequently crosslink two adjacent actin filaments. We performed a 
hydrodynamic analysis in order to calculate the exact molecular weight of the GST fused 
Eps8 and thus to assess if the GST constructs behaved really like dimers.  
 
Results 
Milanesi Francesca PhD thesis 117 
 
 
Figure 37: Dimerization drives Eps8 (648-821) bundling activity  
F-actin (1 µM) was incubated with either 5 µM of GST, as control, or with the indicated concentrations of 
Eps8 (648-821) cleaved from the GST moiety or GST-fused Eps8 (648-821). Actin filaments were labelled 
with rhodamine-phalloidin and imaged using a fluorescence microscope. Data are representative fields 
acquired with a 100X magnification. Three independent experiments per condition were performed, all 
yielding similar results. Bar is 1 µM. 
 
We first performed a gel filtration analysis of the GST-Eps8 (648-821) to calculate its 
Stokes radius, using markers of known stokes radii as standards to create a calibration 
curve. The GST Eps8 (648-821) calculated stokes radius was 59.44Å (Figure 38). 
 
Figure 38: Gel filtration analysis of GST Eps8 (648-821) 
Determination of the stoke radius of GST Eps8 (648-821) by gel filtration analysis. 
Right panel: Superdex 200 elution profile of GST-Eps8 (648-821) and of markers of known Stoke radius. 
Left panel: elution volumes of the markers (bovine thyroglobulin, rabbit aldolase, hen egg albumin, and 
ribonuclease A) were plotted against their known Stokes radii to generate a calibration curve (R2 = 0.9775) 
from which the Stokes radius of GST-Eps8 (648-821) was determined.  
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Next we determined the sedimentation behaviour of GST-Eps8 (648-821) using a glycerol 
density gradient. We determined a sedimentation coefficient of 4 Svedberg (Figure 39).  
 
Figure 39: Glycerol density gradient of GST 
Eps8 (648-821) 
Determination of the Svedberg coefficient of 
GST Eps8 (648-821). 
Top panels: Glycerol (10-40%) gradient 
sedimentation of markers of defined Svedberg 
coefficient and of GST-Eps8 (648-821). 
Coomassie blue staining of aliquots of gradient 
fractions resolved by SDS-PAGE is shown. 
Samples were loaded directly onto 5-ml 10–
40% glycerol gradient (gradient buffer = 100 
mM Tris-HCl, pH 8, 500 mM NaCl, 1 mM 
dithiothreitol, 1 mM EDTA). Centrifugation 
was protracted for 13 h at 55,000 rpm on a 
Beckman SW41Ti swinging bucket rotor at 4 
°C. The gradient was fractionated in 250-µl 
fractions. Bottom graph: Sedimentation volume of the markers (Bovine Pancreas Chymotrypsinogen, 
albumine, aldolase and catalase) were plotted against their known Svedberg coefficient (2,58S, 4,22S, 7,4S 
and 11,4S respectively) to generate a calibration curve from which the Svedberg coefficient (s) of GST-Eps8 
(648-821) was determined. 
 
With these values we used the Siegel and Monty equation (see the material and methods 
section) to calculate the molecular mass of the protein. We obtained a value of 97.4 kD, in 
excellent agreement with the predicted dimeric nature of the protein (the molecular weight 
of the monomeric GST Eps8 (648-821) would be 47.8 kD. 
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Next, we tested the capping activity of our mutants with respect to the Wt Eps8 using 
pyrenyl labelled actin and spectrin actin seeds in a fluorimetric assay (Figure 40). The 
linker mutant displayed a decreased, but still significant capping activity (Kcap = 180nM 
with respect to the WT Kcap = 7nM) (Figure 40A). The H1 mutant, instead, showed only a 
residual ability to decrease actin polymerization from the plus ends, with a significant 
reduction in the binding affinity that was in the submicromolar range (Kcap = 700nM with 
respect to the WT Kcap = 6.5nM) (Figure 40B). The Villin mutant had a capping activity 
similar to the WT protein, with only a slight decrease in its Kcap (Kcap =20nM with 
respect to the WT Kd = 4nM) (Figure 40C). Finally, the double mutant, as expected, was a 
very poor capper (Kcap = 4µM with respect to the WT Kcap = 16nM) (Figure 40D). 
Collectively, these results reinforced the notion that the H1 helix is critical in mediating the 
capping activity of the Eps8 C-terminal domain. The slightly diminished capping activity 
of the linker mutant and, to a minor extent, of the villin mutant, are consistent with a role 
for these two surfaces in the stabilization of Eps8 at the plus end. 
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Figure 40: Eps8 capping activity requires an intact H1 helix and H1-to-H2 linker region 
A. The barbed end capping activity of Eps8 requires an intact H1-to-H2 Linker region.  
The rates of elongation from barbed ends using spectrin-actin seeds and 2 µM of G-actin (10% pyrenyl-
labeled) in the presence of increasing concentrations Eps8 (648-821)-R706A-F708A-(Eps8-Linker mutant) 
(red line) with respect to Eps8 (648-821)(Eps8-WT) (black line) are shown. Rates are normalized taking as 
100 % the rate of elongation from barbed ends measured in the absence of Eps8-WT. Symbols indicate data; 
line indicates fitted binding curves for a complex with 1:1 stoichiometry. The kinetic constant (Kcap) of 
barbed end inhibition for Eps8- Linker mutant = 180 nM; Eps8-WT = 9 nM. On the top the position of the 
critical, mutated residues of the H1-to-H2 Linker in the modelled complex Eps8 (648-821):G-actin are 
indicated by a star. 
B. The barbed end capping activity of Eps8 requires an intact H1 amphipathic helix. 
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The rates of elongation from barbed ends using spectrin-actin seeds in the presence of increasing 
concentrations of Eps8-WT (black line) or Eps8 (648-821)-V689D -L693D (Eps8-Δcap) (red line) are 
shown. The Kcap of the Eps8-Δcap = 700 nM. On the top the position of the critical, mutated residues of the 
H1 in the modelled complex Eps8 (648-821):G-actin are indicated by a star. 
C. The capping activity of Eps8 (648-821) is not mediated by a Villin-like motif in the globular, helical 
domain.  
The rates of elongation from barbed ends in the presence of increasing concentrations of Eps8 (648-821)-
L757A-K759A (Eps8-Δbund) (red line) with respect to Eps8-WT (black line), are shown (Kcap of Eps8-
Δbund = 20 nM). On the top, the critical, mutated residues in the Villin-like motif of Eps8 (648-821) are 
indicated in red, their position in the modelled complex Eps8 (648-821):G-actin is indicated by a star.  
D. Actin capping activity of Eps8 (648-821) is impaired by a mutation in the helix H1 and in the Villin-like 
motif (Eps8-ΔcapΔbund), whose position within the complex Eps8 (648-821):G-actin is shown on top. 
 
We then tested the bundling activity of our mutants in low speed co-sedimentation assays.  
The linker mutant showed only a marginal reduction in the capacity of the protein to 
mediate bundling of actin filaments (Figure 41A). The H1 mutant was as efficient as the 
WT protein (Figure 41B), while the Villin mutant was no longer able to bundle actin 
filaments even at high micromolar concentrations, thus confirming the importance of this 
latter motif in mediating Eps8 crosslinking of actin filaments (Figure 41C). As expected, 
the double mutant ΔcappingΔbundling was also impaired in bundling actin filaments 
(Figure 41D). 
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Figure 41: Eps8 bundling activity is mediated by a Villin – like motif in the globular domain 
A. The bundling activity of Eps8 doesn’t require an intact H1-to-H2 Linker (Linker mutant) region. Left, the 
position of critical, mutated residues of the H1-to-H2 Linker in the modelled complex Eps8 (648-821):G-
actin are indicated by a star. Right, The F-actin bundling ability GST-fused Eps8-WT or Eps8-Linker mutant 
was determined by co-sedimentation assays. F-actin (1 µM) was incubated either alone or in the presence of 
the indicated concentrations of GST, as control, or GST-fused WT or mutated Eps8 (648-821). The mix was 
subjected to centrifugation at 10000 xg for 30 min. Aliquots of pellets (P) and supernatants (S) were analyzed 
by immunoblotting with the antibodies indicated on the right.  
B. The bundling activity of Eps8 doesn’t require an intact H1 amphipathic helix.  
Left, the position of critical, mutated residues of the H1 in the modelled complex Eps8(648-821):G-actin are 
indicated by a star. Right, The F-actin bundling ability of the indicated Eps8-Δcap was determined as 
described in A. 
C. The bundling activity of Eps8 (648-821) is mediated by a Villin-like motif in the globular, helical domain.  
Left, the critical, mutated residues in the Villin-like motif of Eps8 (648-821) are indicated in red, their 
position in the modelled complex Eps8(648-821):G-actin is indicated by a star. Right, the F-actin bundling 
ability of GST-Eps8-Δbund was determined as in A.  
D. Actin bundling activity of Eps8 (648-821) is impaired by a mutation in the helix H1 and in the Villin-like 
motif (Eps8-ΔcapΔbund), whose position within the complex Eps8 (648-821):G-actin is shown on the left. 
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We obtained similar results also by analyzing the bundling activity of our mutants by 
fluorescence staining of the filaments with rodhaminated phalloidin (Figure 42). 
 
 
 
Figure 42: The Eps8 Villin-like motif is responsible for Eps8 bundling activity 
Immunofluorescence visualization of actin bundles induced by wild type and GST-Eps8(648-821) mutants.  
F-actin (1 µM) was incubated either alone (Actin) or together with 5 µM of GST, as control, or with Eps8-
WT or the indicated Eps8 mutants fused to GST. Actin filaments were labelled with rhodamine-phalloidin 
and imaged using a fluorescence microscope. Data are representative fields of view acquired at 100X 
magnification. For each condition three independent experiments were performed yielding similar results. 
Bar represents 5 µM. 
 
Since aggregation of partially misfolded protein could lead to artificial bundling of actin, 
caused by an aspecific binding to filaments of the aggregated proteins, we tested the proper 
folding and the stability of our mutants using a set of hydrodynamic biochemical assays. 
Using size exclusion chromatography, WT and mutant proteins displayed identical elution 
profiles both when kept at 4°C and after exposure for 1 hour at room temperature, 
suggesting that the proteins are properly folded, stable and do not obviously aggregate 
(Figure 43). 
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Figure 43: Hydrodynamic analysis of wild type and GST-Eps8 (648-821) mutants 
The Eps8 mutants do not aggregate both at 4°C and at room temperature. 
Size exclusion chromatography (SEC) of the purified Eps8 (648-821) wild type and of the various indicated 
mutants fused to GST was performed on a Superdex200 10/30 column. The elution profile of markers of 
defined molecular weight is reported along the profile of the various Eps8 (648-821) proteins detected by 
measuring the absorbance at 280nm wavelength. Comassie blue staining of aliquots of eluted fractions 
resolved by SDS-PAGE are shown below the elution profile. SEC was performed after incubation of the 
samples for 1h at room temperature (Red line and RT) or at 4ºC (blue line) with identical results.   
Results 
Milanesi Francesca PhD thesis 125 
8.9 Eps8 capping and bundling properties correlate with a 
specific cellular localization of the protein 
Using a mutagenesis approach we next generated mutants selectively deprived either of 
their capping (Δcapping mutant) or bundling (Δbundling mutant) activity in the context of 
full length Eps8 and engineered them into eukaryotic expression vectors in order to assess 
whether these distinct actin related functions were responsible for the cellular localization 
of Eps8. Full length Eps8 localizes in correspondence to specific cytoskeletical structures. 
The wt protein is mainly localized at the cellular leading edge, both along the lamellipodia 
tip as well as on filopodia and microspikes. Notably, actin filaments within the 
lamellipodia form a meshwork of differentially angled filaments oriented with their plus 
ends towards the cell membrane. Filaments barbed ends are thus concentrated at the 
lamellipodia tip, correlating with the restricted localization of several capping proteins. 
Filopodia and microspikes are instead formed by bundles of actin filaments crosslinked 
together with their tip occupied by a large protein assembly, the tip complex, that is though 
to exclude capping proteins [93]. 
We analyzed the cellular localization of the protein in MEF (mouse embryonic fibroblasts) 
cells derived from Eps8 KO mice, and thus not expressing the endogenous protein and 
stably expressing GFP Eps8, either WT or carrying the different mutations (Figure 44). 
In order to better visualize the lamellipodium, that in this cell line is usually very thin, we 
performed a spreading experiment. Cells were tripsinized, incubated 30 minutes with warm 
medium and replated on fibronectin-coated cover-slips. Cells were then fixed after 30 
minutes, while they were still attaching to the plate. As expected Eps8 localized both at the 
lamellipodia tip and on microspikes. The Δcapping mutant retained the microspikes 
localization, but showed a broader distribution within the entire lamellipodium. The 
Δbundling mutant, on the contrary, retained the specific restricted localization on the 
lamellipodia tip, but completely lost the microspikes localization. With the double mutant, 
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we had a diffused localization, without correlation to any specific cytoskeletical structure. 
Thus, different Eps8 biochemical activities appear responsible of its localization into 
specific actin structures. 
 
 
Figure 44: Differential requirement of Eps8 actin activities in architecturally diverse actin-based 
processes 
Eps8 -/- mouse embryo fibroblasts (MEFs) expressing GFP or GFP-Eps8 (full length) or the indicated GFP-
Eps8 mutants were trypsinized, incubated with warm complete medium before plating them on Fibronectin-
coated cover slips. After 30 min cells were fixed and counterstained with phalloidin to detect F-actin (red) 
and the respective GFP-tagged protein (Green). Representative merged images are shown. Magnified images 
corresponding to the boxed insets on top panels are shown as merge (Middle panels) or GFP (lower panels), 
to evidence the localization of Eps8 and the various Eps8 mutants. Red arrows points to microspikes, Green 
arrowheads indicate the leading edges of lamellipodia. Bar represents 10 µm.  
 
We confirmed our results also in another cell line. We used B16-F1 mouse melanoma 
cells, which possess very large and flat lamellipodia and thus allow a better discrimination 
between subtle differences in the cellular localization of the proteins.  
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In this cell line, we could confirm the requirement of Eps8 capping activity for its proper 
localization at the lamellipodia tip. The H1 mutant, in fact, assumed a very diffuse 
distribution within the whole lamellipodium, loosing the restricted localization at the tip 
(Figure 45). We also confirmed that the bundling activity of Eps8 is required to localize 
the protein on microspikes; the Δbundling mutant was indeed completely excluded from 
these cytoskeletical structures (Figure 45). The double mutant, finally, showed a very 
diffuse distribution like in MEF (Figure 45). 
 
 
Figure 45: Differential requirement of Eps8 activities in architecturally diverse actin-based structures 
in B16 melanoma cells 
Mouse melanoma B16-F1 cells transfected with GFP-Eps8 WT or the indicated mutants together with 
mCherry-actin were plated on laminin-coated cover slips and monitored by live-cell confocal microscopy. 
Stills visualizing GFP constructs (top panels) or mCherry-actin (middle panels) or both as merged images 
(bottom panels) are shown. Red arrows points to microspikes, green arrowheads indicate lamellipodia. Bars: 
10 µM.  
 
We also looked at the dynamics of Eps8 WT and of the different mutants in these cellular 
structures by Fluorescence Recovery After Photobleaching (FRAP) analysis. 
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Because of the restricted localization of the Eps8 Δbundling mutant in the lamellipodium 
we performed the FRAP experiment by bleaching a region encompassing the 
lamellipodium tip to analyze the behaviour of this mutant (Figure 46 left and see also 
movies 1 and 2 in the Supplementary material). We measured a significant difference 
between the time of recovery of the wt protein (Eps8wt T 1\2 = 9.2 sec) and of the 
Δbundling mutant (Eps8 Δbundling T1\2 = 1.9 sec) (Figure 46 right).  
 
Figure 46: Eps8 dynamics at the cellular leading edge 
Eps8 Δbundling mutant shows a less stable association to the filaments ends. 
Left: FRAP experiment on B16-F1 melanoma cells expressing GFP Eps8 either WT or Δbundling. Still 
images of a FRAP experiment at the reported time points are shown (see movies 1 and 2 in the 
supplementary material). The four second time point corresponds to the bleaching of the cell. The bleached 
area is indicated in a white rectangle.  
Right: the percentage of the fluorescence recovery is plotted over time. Data are means and s.e.m. of five 
different movies. Half-time of fluorescence recovery (t1/2) was calculated from best linear fit (green curve). 
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This result suggests a less stable association of the mutant at the ends of actin filaments, 
indicating a possible role of the H2-H5 lobe in the protein stabilization at the plus ends. 
The H1 mutant showed, instead, a very broad distribution within the lamellipodium. We 
thus performed the FRAP experiment on microspikes. We took two other regions in order 
to calculate the background signal coming from both the cover slip and the cellular body 
(Figure 47 left and see also movies 3-4 in the Supplementary material). We could not score 
any differences in the dynamic of Eps8 wt or of the Δcapping mutant on microspikes, 
indicating a dispensable role of the H1 helix in the binding of Eps8 on the filaments side 
(Figure 47 right). 
 
Figure 47: Eps8 dynamics on microspikes 
Eps8 Δcapping mutant shows the same dynamic of the wt protein on microspikes. 
Left: FRAP experiment on B16-F1 melanoma cells expressing GFP Eps8 either WT or Δcapping. 
Still images of a FRAP experiment at the reported time points are shown (see movies 3 and 4 in the 
Supplementary material). Four second corresponds to the bleaching of the cell. The bleached area is indicated 
in a yellow or red rectangle. The areas taken as background are also indicated. Right: the percentage of the 
fluorescence recovery is plotted over time. Data are means and s.e.m. of five different movies. Half-time of 
fluorescence recovery (t1/2) was calculated from best linear fit (black curve). 
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8.10 Eps8 capping activity mediates the sustaining of actin 
based motility 
The availability of mutants selectively deprived of one of Eps8 biochemical activities 
prompted us to investigate whether these two distinct biochemical properties are linked to 
specific cellular functions. It is well established in the literature that capping activity is 
required to sustain actin treadmilling and thus processes such as actin based motility. 
Reconstitution of actin based motility in vitro can be achieved using functionalized beads, 
coated with the Arp2/3 activator N-WASP, and a minimal set of purified proteins, among 
which a capping protein is essential [24]. We tested our mutants in order to test weather the 
capping activity of Eps8 was the only function required to sustain actin treadmilling and if 
our mutants behaved consistently with the previous biochemical assays. As expected, the 
wt protein was able to reconstitute the treadmilling leading to beads movement in the 
absence of other capping proteins. The Δbundling mutant was also able to induce beads 
movement, even if at slightly higher concentrations, possibly reflecting its decreased, but 
still significant, ability to cap actin filaments. The Δcapping and the double 
ΔcappingΔbundling mutants were, instead, completed unable to sustain beads movement, 
even when tested at very high concentrations (up to 10 µM) (Figure 48 and see movies 
from 5 to 10 in the Supplemental Material). 
We also tested the H1-H2 and the H2-H5 fragments behaviour and confirmed that the 
region encompassing the first two helices of the domain is the only one retaining the 
protein capping activity. H1-H2, but not H2-H5, was in fact still able to sustain the 
treadmilling and the beads actin based motility (Figure 48 and see movies 11-12 in the 
Supplementary Material). 
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Figure 48: The Eps8 capping, but not its bundling activity, is required to reconstitute actin-based 
motility in biomimetic motility assays 
N-WASP coated beads (2µM) were mixed with a biomimetic motility medium in the absence of any capping 
protein or in the presence of 50 nM of Gelsolin, or 150nM of GST-fused Eps8 (648-821), or 500 nM of 
Eps8-Δbund mutant, or 10µM of Eps8-Δcap mutant, or 10µM of Eps8-ΔcapΔbund mutant or 2 µM H1-H2 or 
10 µM H2-H5 fragments. Reactions were incubated for 30-to-60 min before starting imaging recording. In 
the picture images taken at the indicated time points from 20 minutes movies are shown (see also movies 
from 5 to 12 in the Supplementary Material). Bars, 5 µm. 
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We next investigated whether we could confirm these findings also in a cellular system. 
We transfected MEF cells ko for Eps8 with GFP Eps8, either wt or carrying the different 
mutations, together with cherrylifeact, to visualize actin filaments, and 
Phosphatidylinositol 5-Kinase (PI5K). PI5K over-expression induces the formation of 4,5-
bisphosphate (PIP2) enriched vesicles, whose propulsion is sustained by the actin 
treadmilling with the formation of a clearly visible actin comet tail. This system mimics 
cellular propulsion of pathogens such as L.monocytogenes or Shigella, whose optimal 
motility has been already reported to be dependent on Eps8 [50]. 
We first checked by immunofluorescence Eps8 localization on these comets. We could not 
score major differences within wt and mutants localization, with the exception of the 
double mutant ΔcappingΔbundling that as expected showed a very diffuse distribution 
loosing a clear localization on the actin comet tails (Figure 49A). We next performed time-
lapse analysis to calculate comets velocity when the different proteins were expressed. 
Manual tracking of at least 30 comets per condition was performed and the vesicle 
propulsion rate was calculated. We scored a diminishing of the vesicle velocity when GFP, 
Eps8 Δcapping or Eps8 ΔcappingΔbundling mutants were expressed. The Δbundling 
mutant showed at the contrary a propulsion rate similar to the wt protein (Figure 49B and 
see movies from 13 to 17 in the Supplemental Material). 
We thus confirmed that Eps8 capping activity is required for optimal actin based motility 
both in vitro and in a cellular system.   
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Figure 49: Requirement of Eps8 capping activity for optimal rocketing velocity of PIP2-rich 
endomembranes 
A. Localization of Eps8 FL either WT or carrying the different mutations on actin comet tails. 
eps8-null MEFs co-microinjected with Myc–Phosphaditylinositol 4,5 kinase [PI(4,5)K], lifeact-cherry (a 
kind gift from Roland Wedlich-Soldner) [94] and the indicated Eps8 mutants fused to GFP or GFP alone, as 
control, were processed for epifluorescence. Bar, is 10 µm. 
B. Tracking of the velocity of rocketing endomembranes. 
The same cells were subjected to video microscopy. The first frame of each representative movie (see also 
movies from 13 to 17 in the Supplemental Material) is show to visualize Cherry-lifeact. The velocity of 
rocketing endomembranes was determined by manually tracking individual vesicles in at least 5-10 different 
cells using imageJ software. Data are shown as whisker plots, the median, quartiles and highest and lowest 
values are indicated; ** indicates HSD (honestly significant difference), alpha-value < 0.05, Turkey-Kramer 
HSD test.  
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8.11 Eps8 bundling activity is required for proper intestinal 
morphogenesis in vivo 
Next, we set out to identify biological processes in which the bundling, but not the 
capping, activity of Eps8 is involved. To this end, we utilized as model system the 
nematode Caernorabdtitis Elegans, which express one single Eps8 hortologue that 
displays a significant level of colinearity and identity to mammalian Eps8, encompassing 
the critical residues for the capping and bundling activity, respectively (Figure 50). 
 
 
Figure 50: EPS-8 in C. elegans  
The critical residues mediating barbed end and side binding of EPS8 are conserved in the nematode 
homologue of EPS8 (Ce-EPS8). Sequence Alignment of the C-terminal region of human (Hs), mouse (Mm) 
and C. elegans (Ce) Eps8. The organization into 5 α-helices is indicated on top. Red and green stars indicate 
the conserved amino acids required to mediate capping and bundling, respectively. Amino acids positions are 
shown on right and left. 
 
It has been previously demonstrated that deletion of the eps8-A gene in C.elegans leads to 
larval lethality, due to intestinal dysfunctions caused by an altered microvilli morphology 
[51]. Two splice EPS-8 isoforms are expressed in C.elegans, a long one (EPS-8A) and a 
short one (EPS-8B) that lacks the C-terminal region, including the determinants 
responsible for the interaction with actin. Importantly, only the intestinal expression of 
EPS-8A rescues both the lethality and the intestinal defects, thus indicating that the 
function of Eps8 is linked to its C-terminal region [51]. It is relevant to underline that at 
the time these findings were obtained only the capping activity of Eps8 was known, thus a 
precise correlation between Eps8 biochemical activities and the in vivo observed 
phenotype had not been performed. Microvilli, however, are made of parallel bundles of 
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actin filaments crosslinked together, suggesting that their proper formation requires a 
bundling activity, which may be provided by Eps8. To test this possibility, we first 
engineered the corresponding Δcapping, Δbundling and the double ΔcapΔbund mutants in 
the context of the C.elegans Eps-8A C-terminal region (aa 714-917) that recapitulates the 
actin binding properties of full length Ce-EPS-8A and tested their biochemical actin 
related activities. Capping activity was tested using pyrenyl actin and spectrin actin seeds. 
Similarly to mammalian Eps8, mutations in the Ce-Eps-8A H1 helix, but not in the Villin 
motif of the H2-H5 lobe, led to a significant decrease of the capping activity of the protein. 
The double mutant displayed an even reduced capping activity (Figure 51).  
 
 
Figure 51: Analysis of the capping activity of the nematode EPS-8A mutants 
The capping activity of the C.e. mutants reflects the one of their mammalian counterparts. 
 The barbed end capping activity of the indicated mutants fused to GST (A, Δcap; B, Δbund; C, ΔcapΔbund) 
is shown. The mutants were engineered in the context of a C-terminal fragment of Ce-EPS-8A (aa 714-917, 
WT in all panels) that recapitulates the actin binding properties of full length Ce-EPS-8A. Rates of 
elongation from plus ends using spectrin-actin seeds and 2 µM of G-actin (10% pyrenyl-labeled) in the 
presence of increasing concentrations of the indicated constructs are shown. Rates are normalized taking as 
100 % the rate of elongation from barbed ends measured in the absence of Ce-EPS-8A-WT. The kinetic 
constants (Kcap) of barbed end inhibition were: WT, 108 nM; Δcap, 980 nM; Δbund, 205 nM; ΔcapΔbund, > 
4000 nM.  
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To test the mutants bundling activity we used a low speed co-sedimentation assay.  
The WT EPS-8A showed a detectable bundling activity, comparable with the mammalian 
protein. This bundling capacity was retained by the Δcapping, but not by the Δbundling or 
by the double ΔcapΔbund mutant (Figure 52). 
 
 
Figure 52: Analysis of the bundling activity of the nematode EPS-8A mutants 
The bundling activity of the C.e. mutants reflects the one of their mammalian counterparts. 
The F-actin bundling activity of the indicated mutants fused to GST is shown. The mutants were engineered 
in the context of a C-terminal fragment of Ce-EPS-8A (aa 714-917, WT in all panels) that recapitulates the 
actin binding properties of full length Ce-EPS-8A. The F-actin bundling ability of the indicated constructs 
was determined by co-sedimentation assays. F-actin (1 µM) was incubated either alone or in the presence of 
the indicated constructs. The mix was subjected to low-speed centrifugation for 30 minutes. Aliquots of 
pellets (P) and supernatants (S) were analyzed by IB, as shown.  
 
We then generated heterozygous eps-8 transgenic lines expressing either EPS-8A mutant 
or WT. The constructs were fused to GFP in order to visualize them by fluorescence and 
were expressed under control of a specific gut promoter in order to restrict their 
localization in the intestine. EPS-8 constructs were injected into the eps-8(by 160) deletion 
mutant strain, [51]. All the proteins were correctly targeted to the intestine (Figure 53). 
The morphology of the EPS-8 WT and EPS-8 Δcapping expressing worms looked normal, 
comparable to a wild type C.elegans strain (Figure 53). 
On the contrary, the worms expressing the Δbundling or the double ΔcappingΔbundling 
mutants had the same intestinal morphological defects as the eps-8(by 160) strain, showing 
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constipation and/or paleness, with the presence of clumped and more refractile gut 
granules. 
 
 
 
Figure 53: morphological analysis of the intestine of C.e. strains expressing EPS-8A WT or mutant 
proteins 
The intestinal expression of EPS-8A bundling deficient mutants cause morphogenetic defects in the 
nematode gut. 
Photomicrographs depicting intestinal morphology of wild-type (WT), eps-8(by160) and eps-8(by160) 
expressing EPS-8 WT or mutant proteins (Δcap, Δbund, and ΔcapΔbund) under a gut specific promoter. 
Fusion of the EPS-8 constructs to GFP allowed their visualization in epifluorescence. Merges of Normaski 
and epifluoresence photomicrographs are shown (proteins are in green). To facilitate visualization of the gut 
phenotype, cartoon panels are depicted underneath each merged image. The intestinal lumen is also 
indicated. Bar, 10 µm. Worms are oriented with the head pointing down or to the left.  
 
Importantly, analysis of the intestine at higher magnification by confocal microscopy 
revealed that Ce-EPS-8A likewise all the mutants generated not only properly localized to 
the intestine, but were specifically targeted to the apical brush border (Figure 54). 
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Figure 54: CeEPS8::GFP WT and mutant proteins expressed in the intestine display an apical-
restricted localization 
Localization study of CeEPS8::GFP WT and mutant proteins.  
Photomicrographs depicting intestinal morphology of eps-8(by160) heterozygous worms expressing EPS-8 
WT or (Δcap, Δbund, and ΔcapΔbund) under a gut specific promoter, opt-2. Fusion of the EPS-8 constructs 
to GFP allowed their visualization in epifluorescence to evidence their restricted gut expression (upper 
panels). Nomarski, epifluoresence, overlays of epifluorescence over Nomarski photomicrographs are also 
shown (proteins are in green). Overlays of magnified boxed areas are shown at the bottom. Red arrowheads 
indicate the intestinal lumen. Yellow arrows point to the brush apical intestinal border. Worms are oriented 
with the head pointing down or to the right. Bar, 10 µm. 
 
To further strengthen this latter finding, we compared the pattern of expression of EPS-8A 
with that of DLG-1::RFP transgene, that encodes for Discs, large homolog-1 (DLG-1), an 
intestinal brush border apical marker. WT EPS-8A or the various mutants were invariably 
localized on the luminal intestinal surface, apical, with respect to DLG-1, thus confirming 
our localization analysis (Figure 55).  
Results 
Milanesi Francesca PhD thesis 139 
 
 
Figure 55:  Specific localization of CeEPS8::GFP WT and mutant proteins along the brush border 
Localization study of CeEPS8::GFP WT and mutant in the intestine. 
Photomicrographs depicting the apical localization of GFP::EPS-8 WT or mutant proteins (Δcap, Δbund, and 
ΔcapΔbund) arrays under a gut specific promoter, opt-2, in DLG-1::RFP transgene expressing worms. 
Intestinal sections in the merged epifluorescence green and red channels (top) and overlays of 
epifluorescence channels over Nomarski (bottom) photomicrographs are shown. Yellow boxed insets are 
transversal Z sections of nematode intestines to visualize the more luminal localization of WT EPS8::GFP 
and mutant proteins with respect to DLG-1::RFP. Red arrowheads indicate the intestinal lumen. Bar,10 µm. 
 
We finally performed a rescue experiment analyzing the survival of the progeny of 
heterozygous eps-8 mutants expressing the different arrays. Lethality of the F1 eps-8 
homozygous worms was rescued by the EPS-8A Δcap mutant but not by the EPS-8A 
Δbundling or by the double mutant EPS-8A ΔcappΔbundling one (table 1). 
Thus we demonstrated that the bundling, but not the capping activity of EPS-8 is 
responsible for the proper intestinal morphology in C.elegans, reflecting its requirement in 
the architectural organization of actin in this tissue. 
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table 1: Summary of the rescue of lethality and intestinal morphogenetic defects by the expression of 
CeEPS-8 mutants 
1Rescue of lethality was tested in two different transgenic lines for each construct. At least one hundred GFP 
positive L1 larvae (F1), from heterozygous eps-8 animals (F0), were individually plated and allowed to grow 
and self fertilize. Rescued homozygous eps-8 mutants were recognized by loss of the genetic balancing 
markers (unc-26, dpy-4) and positivity for GFP expression. Confirmation for homozygosity for the mutated 
eps-8 allele was obtained by PCR [51]. Alternatively, the entire progeny (ranging from 30 to 120 F1 animals) 
of at least three heterozygous adults was individually plated and allowed to grow and self fertilize. Rescue of 
lethality analysis was performed as described above.  
2 Intestinal alterations in homozygous eps-8(by160) mutant worms are characterized by constipation and/or 
paleness, with the presence of clumped and more refractile gut granules. Rescue of this phenotype was 
scored in live L1/L2 larvae under a microscope with Nomarski optics and epifluorescence. For the analysis of 
the gut phenotype in eps-8(by160) opt-2:EPS-8AΔbund, and eps-8(by160) opt-2:EPS-8A-ΔbundΔcap, 
homozygous larvae were identified by growth retardation respective to siblings in a synchronous F1 progeny 
from heterozygous worms. The % of worms displaying intestinal defects is shown. In parentheses, the 
number of analyzed animals is reported. 
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9. DISCUSSION 
This work investigates the structural and molecular bases of the barbed end capping and 
crosslinking activities of Eps8. 
Through EM, biochemical, cellular and mutagenesis studies we have elucidated the 
mechanism through which Eps8 binds both the side and the filament ends, exerting its 
bundling and capping activity respectively (Figure 56). 
We have shown how distinct portions within the C-terminal region of Eps8 contribute to 
actin binding. Eps8 contains two actin-binding surfaces linked by an unstructured loop 
(Figure 56A). The first region, H1, displays secondary structure similar to a WH2 domain 
and is crucial for capping, whereas the second surface, composed of four alpha helices 
organized into a globular core (H2-H5), is crucial for bundling. The long flexible linker 
between the two regions contributes to the stabilization of the Eps8:actin interaction on the 
filament side and allows the amphipathic helix H1 to plug into the actin hydrophobic 
binding pocket at barbed ends, acting as a lock that increases the binding affinity of Eps8 
actin binding domain from 106 to 109 M-1, as typically observed for cappers (Figure 56B-
C).  CP, for instance, adopts a similar mechanism whereby full capping activity is achieved 
when a flexible domain swings into the hydrophobic pocket, locking barbed ends [20, 43]. 
Thus, the capping activity of Eps8 appears to be determined by a clamp mechanism by 
which the extended C-terminal Eps8 domain fasten around the barbed end actin unit 
blocking further filament elongation. Within this context, both the side binding of the 
globular core and the end binding mediated by H1 are spatially coordinated by the linker 
that contributes to the high affinity interaction of Eps8 to filaments ends (accounting also 
for the slightly reduced affinity for barbed ends of the bundling-deficient mutants). The 
flexibility of the linker ensures also a bimodal topological arrangement of Eps8 with 
respect to either the side or the barbed end of the filaments, reflecting its bundling or 
capping activities, respectively. These two latter functions of Eps8 can, indeed, be 
dissected and consistently exert distinct roles in diverse actin-based processes.  
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Figure 56: A schematic model for the binding modes of Eps8 to actin 
A. A cartoon representation of Eps8 actin binding regions and monomeric actin. The N-terminal amphipathic 
helix, H1, the connecting linker, L1, and the globular helical core, H2-H5, of Eps8 are indicated. Monomeric 
actin is oriented with its barbed end downwards. Actin subdomains are numbered from 1 to 4.  
B. The binding of Eps8 C-terminal region to the side of actin filaments is mainly mediated by the globular 
helical bundle (H2-H5). The helical bundle (H2-H5) positions in the long grove of the filament, contacting 
three actin subunits. The amphipathic helix (H1) does not contribute significantly. The H1 binding site may 
not be fully exposed in filamentous actin.  
C. At the barbed ends, the H1 binding site is fully accessible and H1 can bind within the hydrophobic pocket 
blocking further addition of monomeric actin.  
D. A similar arrangement as seen at the barbed end is presumably occurring on monomeric actin, accounting 
for the sequestering activity of Eps8. 
In B-D, two views, related by a 60º counter clockwise rotation around the filament axis, are shown. 
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9.1 Eps8 H1 helix is crucial for the capping activity of the 
protein 
We have shown through several and diverse approaches that the H1 actin-binding surface 
of Eps8 is critical for capping. Several lines of evidences indicate that this helix behaves as 
a WH2 domain.  
The WH2 domain is a motif that is emerging as a common actin binding surface shared by 
several classes of ABPs, including Ciboulot and WASP homology domain-2 (WH2)-
related proteins such as Thymosin β−4. It consists in a short α helix, with few exposed 
hydrophobic side chains, which binds in a hydrophobic cleft between actin subdomains 1 
and 3 [82]. 
Firstly, we showed through competition binding studies that an Eps8 fragment 
encompassing the entire five terminal α-helices (Eps8 648-821) or the isolated H1-H2, but 
not H5, can displace the WH2 domain-containing proteins, Ciboulot and Thymosin β-4, as 
well as ADF/Cofilin, from actin, indicating a common surface of interaction on the actin 
monomer. Binding of all these proteins to the hydrophobic pocket on the actin monomer is 
well established. Secondly, a mass spectrometry analysis of chemically cross-linked 
peptides of the Eps8:actin complex revealed that the residues K675 and K683 on H1 are in 
close proximity with the K375 of actin, which is located in the hydrophobic cleft on 
subdomain 1. Additionally, helical wheel analysis confirmed that H1 forms an amphipathic 
helix, which displays the same “signature” of conserved hydrophobic residues as the helix 
of the WH2 domain.   
Finally and most importantly, the relevance of the hydrophobic contacts of the amphipathic 
helix H1 for Eps8 capping activity is demonstrated by the observations that a mutant in 
these residues, both in mammalian Eps8 and in the nematode Eps-8A, has a significantly 
reduced capping activity in vitro with respect to wild type, and fails to support actin-based 
motility. 
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Strikingly there is no sequence similarity between WH2 domains of the different actin 
binding proteins, indicating that the actin cleft is very adaptable, being able to 
accommodate interactions with a wide range of unrelated ABPs with the sole requirement 
of possessing patches of ordered hydrophobic residues. Moreover it has been demonstrated 
that this cleft is able to accommodate protein-protein interactions either at its front or back 
halves, or throughout its entire length [82]. This latter feature is important since it renders 
the cleft accessible for binding to interacting proteins not only when it is exposed on the 
last actin unit of a protomer, but also when actin monomers are linked to form the helical 
filament, where part of the surface is occupied by the contact between monomers. The 
flexibility of the actin cleft in accommodating interactors has already been demonstrated 
for Thymosin β-4, which tightly binds G-actin up to a certain concentration threshold, 
upon which it becomes incorporated in the filament [95]. Binding of Thymosin β-4 to F-
actin changes the twist of actin from 2.16 to 2.14 subunits per turn, interfering with some 
inter-subunit contacts in the filament [96]. Notably, in our EM analysis we show the same 
change in the filament twist to occur upon Eps8 binding, which further suggests a similar 
mode of interaction.  
The WH2 domain is a common motif of several nucleating promoting factors, such as 
WASP, N-WASP or Spire, Cordonbleau and Leiomodin families, which by binding on 
more monomeric actin units or on the Arp2/3 complex promote filament nucleation [26]. 
Eps8 amphipatic helix, despite structural similarity, cannot support nucleation even at high 
concentrations, tightly capping, instead, filaments barbed ends. One of the biochemical 
reasons preventing Eps8 to switch from capping to nucleation, may be found in the finding 
that Eps8 associates with equal affinity to ATP or ADP bound actin. Thus, at variance with 
respect to NPFs, which show a higher affinity for ATP-bound actin and detach from the 
filament after ATP hydrolysis, Eps8 after binding tightly to filament ends remains 
associated to the ends with relative low koff, ultimately blocking further filament assembly. 
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9.2 The H2-H5 helical globular lobe is responsible for Eps8 
bundling activity   
The globular lobe, composed of H2-H5 helices, represents the second distinct binding site 
of Eps8 and is primarily responsible for the bundling activity the protein. Indeed, the 
isolated H2-H5 domain of Eps8 is sufficient to bind and bundle F-actin. Moreover, 
mutations in key conserved residues within this domain completely abrogate Eps8 
bundling activity, both in the mouse and in the C.elegans nematode, while leaving 
unaffected the ability of the domain to cap filament ends. In the 3D reconstruction the H2-
H5 lobe appears to slot in between three actin subunits of the filament, with the major 
contacts with the subdomain 3 of the actin subunit that has the H1 bound and with the 
subdomain 4 of the actin subunit below. This is significantly different from other F-actin 
binding proteins, such as Fimbrin and Vinculin, which share common actin interacting 
surfaces, associating along the filament between subdomains 1 and 2 of two adjacent actin 
protomers [97, 98]. These structural differences may underline functional specificity since 
Fimbrin and Vinculin organize actin into higher order cross-linked, stable structures, 
whereas Eps8-actin assemblies are likely more dynamics. Conversely, the helical lobe of 
Eps8 binds actin filament mainly through a critical stretch of amino acids (LNKDE), 
which resembles those identified in the headpiece of Villin (LKKEK) [99] and in a variety 
of other actin-binding proteins homologous to the Villin headpiece [100]. Interestingly, 
EM reconstructions show Villin as well as Demantin headpiece to bind in a similar 
location on F-actin as the H2-H5 lobe of Eps8 [101]. 
Bundling proteins usually promote filament bundling through a bivalent interaction with F-
actin, contacting at least two actin filaments in order to crosslink them together. 
Accordingly, bundling proteins either posses two distinct actin binding sites or acquire 
them through dimerization when they posses a single surface of interaction [5]. 
Alternatively, since actin filaments are poly-electrolytes, proteins rich in basic residues 
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can, by associating to the side of actin filaments, neutralize the repulsive charges of the 
actin polymer driving bundling [102, 103]. In the case of Eps8 this latter hypothesis 
appears unlikely since the minimal, isolated C-terminal region (aa 648-821), cleaved from 
GST, displays no bundling activity. Conversely we showed that the GST–tagged C-
terminal region dimerizes and possesses bundling activity. In the context of the full-length 
protein, moreover, the bundling activity of Eps8 is enhanced by association of Eps8 with 
IRSp53, which has been demonstrated to dimerize through its IMD domain. Thus we 
propose that Eps8 crosslinks actin filaments by forming homo- or hetero-dimers, in this 
latter case, presumably together with IRSp53, which was previously shown not only to 
bind tightly to Eps8 but also to form dimers [73].  
 
9.3 The flexible linker between H1-H2 connects the two Eps8 
actin binding surfaces 
The H1 helix and the H2-H5 lobe are separated by a linker, which winds around 
subdomain 3 and accommodates toward the cleft between subdomains 3 and 4 of actin, 
physically connecting the capping with the bundling surfaces, and accounting for the extra 
density observed in the 3D reconstruction of Eps8 bound to the filament. This arrangement 
is also consistent with the actin:Eps8 crosslinking experiments, indicating a juxtaposition 
between the residue K707 of the linker and the Lysine K330 of subdomain 3 of actin. We 
can thus position the linker just in front of the cleft between subdomains 3 and 4 (Figure 
56C).  
The presence of flexible linkers interconnecting actin-binding domains is a common 
occurrence in capping proteins. However, the orientation of the Eps8 linker and its contacts 
with actin are somehow unique. For instance, in Gelsolin, the G1 and G2 repeats are 
separated by a linker segment, which extends upwards and away from G1, along the face 
of actin, in a direction that enables positioning G2 along the same long-pitch helical strand 
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of the actin bound to G1 [104, 105]. Similar overall architectural organization with respect 
to actin has also been proposed for Twinfilin C and for the N-terminal ADF domain [48]. 
In the case of the Eps8 capping domain, the H1 helix, like the G1 and WH2 domains, plugs 
into the hydrophobic cleft between subdomains 1 and 3 of the barbed end of actin. 
Remarkably, however, the peptide linker, extending from the H1 amphipathic helix, adopts 
a significantly different orientation that enables positioning the globular lobe (H2-H5) in a 
cleft formed by the adjacent actin unit of the second protofilament. This mode of binding 
predicts that residues in the linker between H1 and H2 are critical for its orientation, and 
suggests that their mutation may switch the architectural organization and position of the 
H2-H5 lobe to resemble that of Gelsolin G1-G2 repeat bound to actin. A possibility that 
warrants further investigation.  
 
9.4 Correlating Eps8 dual functions and actin-binding modes 
from in vitro to in vivo 
In this work, we have provided evidence that two segregated actin binding domains confer 
Eps8 with bimodal functionality; capping and bundling. We had previously shown in the 
laboratory that this dual function is regulated in the context of the full-length protein by 
activation of different effectors (IRSp53, and Abi1 [50, 73]). Our data further support the 
notion that this bimodal functionality in the context of one single protein can be dissected 
and exert independent, cell- and tissue-specific roles.  
The bundling, but not the capping function of Eps8 appears essential for the proper 
structural organization of gut microvilli, which are composed of parallel, highly cross-
linked actin filaments.  Importantly, the role of Eps8 in the intestine is conserved also in 
mice, where Eps8 genetic removal disrupts intestinal morphology leading to reduced fat 
absorption, calorie restriction and improved metabolic status [106].  Filament side binding 
and bundling of Eps8 are also critical to direct the protein to microspikes. This is 
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consistent with the role of Eps8 (together with IRSp53 [73]) in filopodia formation and 
also suggests that Eps8 through its crosslinking properties may be generally implicated in 
the regulation of highly dynamic structures composed of parallel actin bundles. 
The capping activity, instead, is required to reconstitute actin-based rocketing 
motility in vitro and for optimal velocity of intracellular pathogens [50] or PIP2-rich 
endomembranes in vivo; to restrict localization of Eps8 to the leading edge of the cell in 
migratory cells; and to control the number of axonal filopodia in primary hippocampal 
neurons [107]. In these latter cells, Eps8 acts, like capping protein CP [108], by negatively 
regulating, through barbed end binding, the filament lengths of the actin network from 
which filopodia then arise.  
Finally, the role of Eps8 as a bifunctional actin remodeller further suggests that this 
protein by controlling various actin-based protrusions regulates optimal cell locomotion 
both in physiological and in pathological contexts, such as during tumour development. In 
keeping with this latter possibility, Eps8 has been reported to be unregulated in a variety of 
tumour types and to be specifically required for optimal cell migration and invasion in a 
subset of metastatic oral squamous carcinoma cells [56, 109]. Whether the capping or 
bundling activities are critical for Eps8 to exert this pro-invasive functions remains to be 
tested. However, the availability of Eps8 mutants specifically impaired in either one or the 
other of its actin-related functions will be instrumental in addressing this issue and 
certainly worth to be investigated. 
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9.5 Perspectives 
The sum of our results provides a molecular framework to account for the role of Eps8 as a 
key regulator of the actin cytoskeleton underneath membrane protrusion. Eps8 can regulate 
both the rate of filament elongation and the cytoskeletal architecture trough its capping and 
bundling activities, respectively. These two distinct Eps8 functions are regulated by 
diverse protein:protein interactions whereby the binding to Abi1, mediated by the SH3 
domain of Eps8, triggers the capping activity, while the association with IRSp53 promotes 
actin crosslinking. Thus, the dynamic interplay between different Eps8-based complexes is 
likely to be critical for the generation of different actin-based migratory structures. Within 
this context, Eps8 and its interacting partners represent components of a larger network of 
signalling proteins whose activities and modes of regulation remain largely ill-defined. For 
instance, IRSp53 in addition to associate tightly with Eps8 can form mutually exclusive 
complexes with VASP family members [110], which possess anticapping and crosslinking 
properties. Additionally, IRSp53 is a direct effector of Cdc42 and Rac, which are critical 
regulators of actin remodelling and can bind and deform the plasma membrane 
contributing to generate protrusions. Consistently, IRSp53 and its interactors (namely 
Eps8/Abi1 complex and VASP) are all present at the cellular leading edge, raising the 
issues as to how they are organized into a dynamic, spatially and temporally controlled 
network, capable of generating the formation of diverse cellular protrusions.  
 Our present and future aim is to investigate how this “minimal protein network” is 
regulated in order to establish the basic principles and mechanisms of its action. We will 
then enrich, in stepwise mode, the levels of complexity of the system by adding further 
layers of proteins and lipid interactions and regulation with the ultimate goal to built a 
dynamic map of the network responsible for the generation of actin-based cellular 
protrusions. 
In order to achieve these goals we plan to combine in vitro in vivo approaches. 
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An in vitro system will be used to reconstitute, using purified proteins, the minimal protein 
network with the specific goal to define the contribution of Eps8 and its interacting 
proteins (IRSp53, VASP and Abi-1) in coupling membrane deformation and actin 
cytoskeleton remodelling. An in vivo approach will be then implemented in order to define 
the exact dynamics of all these proteins at the cellular leading edge.  
These approaches should set the stage defining the dynamic parameters of Eps8 
and of its actin related functions at the leading edge with respect to actin and a number of 
actin binding proteins [111].  
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11. SUPPLEMENTRY MATERIAL 
Movies 1-2: FRAP experiments on BL16-F1 melanoma cells expressing GFP Eps8 
either WT (movie 1) or Δbundling (movie 2). 
Movies have been performed as indicated in Figure 46 and in the Material 
and Method section 7.5.4. 
Movies 3-4: FRAP experiments on BL16-F1 melanoma cells expressing GFP Eps8 
either WT (movie 3) or Δcapping (movie 4). 
Movies have been performed as indicated in Figure 47 and in the Material 
and Method section 7.5.4. 
Movies 5-12: Time-lapse phase contrast microscopy of in vitro actin based motility 
assays performed as described in Figure 48.  
Video represents a time period of 20 minutes.  
The movies are performed: 
Movie 5: in the absence of capping proteins.  
Movie 6: in the presence of the capping protein Gelsolin. 
Movie 7: in the presence of wild type Eps8 (648-821). 
Movie 8: in the presence of EPS8-Δbundling mutant.  
Movie 9:in the presence of EPS8-Δcapping mutant.  
Movie 10: in the presence of EPS8-Δcap Δbund mutant.  
Movie 11: in the presence of H1–H2.  
Movie 12: in the presence of H2–H5.  
 
Movies 13-17: Time-lapse fluorescent microscopy of PIP2-rich vesicles performed as 
described in  Figure 49.  
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Only the dynamic of lifeact-cherry is shown to facilitate the visualization of 
rocketing vesicles. Frames were taken every 3.3 to 7.1 s for a total time 
period of 5 min using a Spinning Disk confocal microscope Ultra VIEW 
VoX, Perkin Elmer 100× objective, 1.49 N.A, Nikon TiEclipse. 
The movies were performed by expressing PI4,5K together with: 
Movie 13: EPS8(648–821) (Eps8-WT). 
Movie 14: EPS8-Δbundling.  
Movie 15: Eps8-Δcapping.  
Movie 16: GFP.  
Movie 17: EPS8-Δcap Δbund.  

 
